Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014133	s-koirhie	— (—)	3010	3090	100.00%	Distribution not available
3014133	s-koirhie	u/ml (u/ml)	2727	2896	2.45%
3014133	koira,hils	— (—)	568	599	100.00%	Distribution not available
3014133	igekoira	u/ml (—)	225	240	100.00%	Distribution not available
3014133	koirae	u/ml (—)	171	188	100.00%	Distribution not available
3014133	koira,hils	u/ml (u/ml)	163	165	0.00%
3014133	s-koiranhilse,igevasta-aineet	u/ml (—)	127	130	100.00%	Distribution not available
3014133	s-allige,koira(hilse)/hund(mjäll)osa	u/ml (—)	51	52	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1303

4107

3.17

308.56

1.1

4.84

4.06

u/ml

0.81

811

1822

Asthma (only as main-diagnosis), excluding more controls

1906

2092

5.39

307.65

1.1

1.0

6.58

2.76

u/ml

10.42

1178

784

Allergic asthma (mode), excluding more controls

987

1366

7.54

307.65

1.1

1.0

8.44

3.04

u/ml

10.04

726

557

Asthma, excluding more controls

1963

2092

5.05

307.65

1.1

1.0

6.51

2.76

u/ml

10.37

1201

784

Allergic rhinitis

1482

2492

6.36

307.65

1.1

1.0

6.66

3.39

u/ml

5.53

975

1106

Asthma and allergy, excluding more controls

731

870

9.11

307.65

1.1

1.0

9.56

2.85

u/ml

9.87

551

369

Chronic lower respiratory diseases

2672

4080

3.57

307.65

1.1

1.0

6.37

2.54

u/ml

14.31

1574

1700

Asthma (only as main-diagnosis)

1915

2110

5.43

307.65

1.1

1.0

6.55

2.74

u/ml

10.49

1183

791

Asthma

1983

2110

5.08

307.65

1.1

1.0

6.45

2.74

u/ml

10.38

1213

791

Asthma, hospital admission 2, infections

1237

3262

3.81

307.65

1.1

1.0

7.41

3.08

u/ml

8.43

786

1418

Asthma/COPD (KELA code 203)

2120

4058

3.67

307.65

1.1

1.0

6.75

2.54

u/ml

13.25

1270

1695

Allergic asthma (mode)

987

1368

7.53

307.65

1.1

1.0

8.44

3.04

u/ml

10.04

726

557

Asthma, including avohilmo

2916

3782

4.46

307.65

1.1

1.0

6.33

2.30

u/ml

17.17

1686

1567

Asthma (mode)

1991

2117

5.20

307.65

1.1

1.0

6.42

2.74

u/ml

10.39

1229

794

Asthma and allergy

730

860

9.21

307.65

1.1

1.0

9.56

2.89

u/ml

9.67

550

359

Asthma-related infections

1237

3262

3.81

307.65

1.1

1.0

7.41

3.08

u/ml

8.43

786

1418

1070

2750

3.99

307.65

1.1

1.0

7.92

3.21

u/ml

7.85

682

1228

Asthma, hospital admissions , main diagnosis only

2025

4675

3.94

307.65

1.1

1.0

6.77

3.06

u/ml

10.89

1270

2025

Vasomotor and allergic rhinitis

1561

2493

6.55

307.65

1.1

1.0

6.55

3.76

u/ml

4.79

1004

1090

Pollen allergy

1168

1755

7.35

307.65

1.1

6.76

3.40

u/ml

4.29

776

816

Asthma (diagnoses ohter than nonallergic)

2090

4558

3.92

307.65

1.1

1.0

6.84

2.88

u/ml

12.83

1329

1945

Allergic conjunctivitis

1344

4352

3.10

305.21

1.1

4.81

4.22

u/ml

0.55

837

1944

Asthma, unspecified (mode)

939

1845

3.91

286.80

1.1

1.0

4.69

2.85

u/ml

2.35

500

697

Asthma, unspecified (mode), excluding more controls

936

1833

3.90

284.12

1.1

1.0

4.70

2.87

u/ml

2.32

499

692

Conjunctivitis

1570

4897

2.74

276.68

1.1

5.13

4.39

u/ml

0.66

954

2236

Chronic sinusitis

807

2104

3.93

269.25

1.1

1.0

3.44

3.50

u/ml

0.04

423

869

Atopic dermatitis

1410

4203

2.82

260.84

1.1

8.03

3.15

u/ml

10.30

871

1869

Other diseases of upper respiratory tract

1675

3255

2.72

257.28

1.1

1.0

5.27

3.65

u/ml

1.97

909

1391

Disorders of conjunctiva

1598

5001

2.62

255.97

1.1

5.07

4.34

u/ml

0.66

968

2279

Desensitization to allergens

372

551

7.80

245.59

1.1

5.64

4.43

u/ml

0.56

258

280

Chronic rhinitis, nasopharyngitis and pharyngitis

647

1599

4.17

233.27

1.1

1.0

4.20

3.35

u/ml

0.44

339

675

Obesity related asthma

603

1532

4.04

209.21

1.1

1.0

6.42

2.41

u/ml

4.05

355

593

Atopic dermatitis, strict definition with reimbursement

876

2767

3.17

205.26

1.1

10.06

3.38

u/ml

10.62

618

1287

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

792

2437

3.22

194.42

1.1

1.0

3.95

3.49

u/ml

0.20

402

1001

Dermatitis and eczema

1748

4856

2.26

193.28

1.1

6.69

3.04

u/ml

8.08

1010

2146

Nasal polyp

339

597

5.86

183.53

1.2

1.0

4.02

2.98

u/ml

0.53

217

251

Suggestive for eosinophilic asthma

223

259

9.08

177.59

1.2

1.0

4.04

1.85

u/ml

1.36

162

104

Other pulmonary diagnosis

1126

2143

2.67

165.04

1.1

1.0

4.24

2.80

u/ml

1.36

591

810

COPD differential diagnosis

1106

2117

2.65

160.38

1.1

1.0

4.18

2.74

u/ml

1.33

581

794

ILD differential diagnosis

1105

2117

2.65

159.95

1.1

1.0

4.19

2.74

u/ml

1.34

580

794

Excluding asthma or asthma-COPD overlap

1108

2143

2.62

157.55

1.1

1.0

4.27

2.80

u/ml

1.37

581

810

Atopic dermatitis, strict definition

822

3017

2.76

150.86

1.1

10.74

3.62

u/ml

10.71

580

1453

Oral corticosteroids

1573

4443

2.13

148.48

1.1

1.0

5.91

3.56

u/ml

3.89

874

1985

ILD medications: prednisolone, methylprednisolone, prednisone

1649

4488

2.08

144.91

1.1

1.0

5.89

3.75

u/ml

3.40

908

2030

Undetermined asthma

246

442

5.74

130.46

1.1

1.0

3.31

2.04

u/ml

0.72

136

167

Undetermined asthma, excluding more controls

246

444

5.72

129.83

1.1

1.0

3.31

2.04

u/ml

0.72

136

167

Childhood asthma (age<16)

439

951

3.79

128.24

1.1

1.0

10.12

3.21

u/ml

7.68

326

425

Childhood asthma (age<16), excluding more controls

439

951

3.79

128.14

1.1

1.0

10.12

3.22

u/ml

7.67

326

424

Biological medicines for asthma

126

108

13.88

127.10

1.3

1.0

8.88

4.09

u/ml

1.41

Diseases of the respiratory system

834

1559

2.71

126.57

1.1

1.0

3.55

2.47

u/ml

1.41

425

575

Asthma, hospital admissions 3, pneumonia

451

1370

3.34

119.18

1.1

1.0

6.52

2.38

u/ml

3.67

297

572

Asthma-related pneumonia or sepsis

451

1370

3.34

119.18

1.1

1.0

6.52

2.38

u/ml

3.67

297

572

ILD medications

1663

4718

1.93

118.68

1.1

5.77

3.99

u/ml

2.59

918

2187

Asthma-related pneumonia

449

1367

3.33

118.23

1.1

1.0

6.39

2.38

u/ml

3.49

296

570

Cough

621

2148

2.78

117.58

1.1

3.93

4.59

u/ml

0.33

316

1019

FESS (DNB20)

295

687

4.48

116.02

1.2

1.0

2.77

3.34

u/ml

0.31

175

318

Ethmoidectomy

298

704

4.41

114.99

1.2

1.0

2.74

3.30

u/ml

0.30

177

324

Inflammatory bowel disease treatment related agents

1628

4887

1.88

108.65

1.1

5.82

3.86

u/ml

2.94

887

2245

Abnormalities of breathing

1390

4138

1.97

107.42

1.1

4.12

4.71

u/ml

0.54

728

1970

Deviated nasal septum

394

1208

3.31

102.86

1.1

1.0

3.33

3.27

u/ml

0.03

197

491

Chronic diseases of tonsils and adenoids

1051

3208

2.09

97.44

1.1

1.0

4.15

3.69

u/ml

0.39

533

1372

First line medication for Crohn's disease

1574

4683

1.83

96.30

1.1

5.61

3.94

u/ml

2.29

862

2170

Symptoms and signs involving the circulatory and respiratory systems

1492

4167

1.81

86.14

1.1

4.20

4.69

u/ml

0.41

759

1982

Childhood allergy (age < 16)

513

1721

2.56

77.48

1.1

10.08

4.32

u/ml

5.67

382

905

Insomnia

1227

5141

1.76

69.63

1.1

3.91

4.32

u/ml

0.34

548

2490

Dermatitis due to ingested food

180

413

4.58

69.00

1.1

11.99

3.36

u/ml

5.24

143

226

Acute upper respiratory infections

1282

4616

1.72

66.26

1.1

4.84

4.12

u/ml

0.62

661

2171

Adverse effects, not elsewhere classified

390

1539

2.60

64.97

1.1

6.88

4.64

u/ml

1.23

262

753

Sleep disorders

1210

5148

1.71

63.08

1.1

3.82

4.35

u/ml

0.48

546

2506

Acute upper respiratory infections of multiple and unspecified sites

1026

4409

1.74

56.89

1.1

5.27

4.19

u/ml

0.86

533

2078

Sleep apnoea, including avohilmo

1105

4026

1.71

55.98

1.1

4.22

3.84

u/ml

0.24

523

1852

Urticaria

509

2430

2.13

54.27

1.1

3.72

4.80

u/ml

0.85

304

1187

Behavioural syndromes associated with physiological disturbances and physical factors

1208

5272

1.64

53.09

1.1

4.21

4.45

u/ml

0.18

561

2596

Bronchitis

1315

5182

1.61

52.74

1.1

5.24

3.96

u/ml

1.27

701

2419

Dyspnoea

1000

4343

1.71

52.71

1.1

3.73

4.30

u/ml

0.53

528

2005

Other medical care

447

1835

2.21

51.99

1.1

5.22

3.43

u/ml

1.37

285

836

Asthma mixed form (mode)

167

5.87

51.86

1.2

1.0

5.34

3.26

u/ml

0.50

Asthma mixed form (mode), excluding more controls

168

5.84

51.53

1.2

1.0

5.34

3.26

u/ml

0.50

Any reimbursement code in KELA

1039

3059

1.72

50.72

1.1

1.0

6.15

2.75

u/ml

4.35

595

1300

Sleep disorders (combined)

1368

4541

1.59

50.48

1.1

4.20

4.45

u/ml

0.16

648

2244

1314

4255

1.61

50.14

1.1

1.0

4.92

3.82

u/ml

1.15

672

1952

Urticaria and erythema

557

2833

2.00

49.83

1.1

4.11

4.74

u/ml

0.42

329

1380

Non-allergic asthma (mode)

211

689

3.08

49.07

1.1

1.0

4.80

2.84

u/ml

0.62

280

Chronic laryngitis and laryngotracheitis

153

414

3.76

48.89

1.1

1.0

3.10

2.09

u/ml

0.60

165

Non-allergic asthma (mode), excluding more controls

211

692

3.06

48.71

1.1

1.0

4.80

2.85

u/ml

0.62

284

Acute sinusitis

740

3855

1.80

47.56

1.1

3.90

4.16

u/ml

0.16

368

1799

Diseases of the eye and adnexa

1209

3781

1.61

46.73

1.1

4.96

4.52

u/ml

0.25

672

1714

D07AA Corticosteroids, weak (group I)

326

1383

2.41

46.52

1.1

13.51

4.35

u/ml

5.22

246

694

Diseases of the skin and subcutaneous tissue

1213

3805

1.61

46.47

1.1

1.0

6.05

3.11

u/ml

3.77

670

1636

Personal history of allergy to drugs, medicaments and biological substances

9.77

44.05

1.4

1.0

1.52

2.79

u/ml

0.31

Other and unspecified effects of external causes

458

2328

2.00

41.29

1.1

6.38

4.59

u/ml

1.07

288

1151

Other acute lower respiratory infections

618

3391

1.75

36.94

1.1

7.02

4.20

u/ml

2.03

374

1687

Asthma and opportunity respiratory infection

7.63

36.60

1.1

1.0

4.06

1.41

u/ml

0.48

Bronchiectasis

101

6.24

36.50

1.1

1.0

3.84

3.52

u/ml

0.03

Sleep apnoea

935

3827

1.59

36.33

1.1

4.48

3.82

u/ml

0.39

444

1760

Voice disturbances

296

1344

2.23

35.96

1.1

4.62

3.36

u/ml

0.24

144

586

Diarrhoea and gastroenteritis of presumed infectious origin

1190

5256

1.50

35.73

1.1

3.64

4.55

u/ml

1.29

570

2554

Early onset COPD, excluding more controls

139

435

3.22

35.43

1.1

1.0

6.14

2.34

u/ml

1.43

143

Migraine, single triptan purchase ok & required. ICD-code if available is included

1058

4733

1.53

34.33

1.1

4.77

4.31

u/ml

0.21

487

2328

Triptan medication for migraine, single purchase ok

1058

4733

1.53

34.33

1.1

4.77

4.31

u/ml

0.21

487

2328

Migraine

765

3866

1.62

33.15

1.1

5.35

4.27

u/ml

0.43

351

1887

COPD/asthma related infections

1198

4047

1.49

32.96

1.1

1.0

5.01

3.85

u/ml

1.16

608

1862

COPD/asthma/ILD related infections

1198

4047

1.49

32.96

1.1

1.0

5.01

3.85

u/ml

1.16

608

1862

Dermatitis

592

3482

1.71

32.60

1.1

1.0

4.09

2.90

u/ml

1.16

337

1497

Polypectomy (DHB20)

236

4.00

31.99

1.2

1.0

3.14

3.00

u/ml

0.03

105

Dentofacial anomalies [including malocclusion]

954

5062

1.53

31.89

1.1

5.00

4.44

u/ml

0.25

482

2428

Symptoms and signs involving speech and voice

321

1610

2.01

30.07

1.1

4.96

3.42

u/ml

0.34

158

719

Pain in joint

713

2835

1.61

29.49

1.1

5.01

4.11

u/ml

0.50

356

1401

Gastro-oesophageal reflux disease

675

3631

1.61

29.42

1.1

3.42

4.18

u/ml

0.30

308

1697

Headache

859

4538

1.52

28.58

1.1

4.09

4.25

u/ml

0.10

406

2195

Recurrent or chronic depression

536

2222

1.71

28.15

1.1

5.45

3.77

u/ml

0.95

248

1066

Any death

1656

0.25

28.07

1.0

3.92

3.06

u/ml

0.11

765

Other and unspecified urticaria

297

1493

2.02

27.88

1.1

3.23

4.63

u/ml

0.89

174

713

Acute bronchitis

416

2284

1.80

27.67

1.1

6.48

4.22

u/ml

0.98

239

1107

Episodal and paroxysmal disorders

1315

4758

1.41

27.66

1.1

5.07

4.48

u/ml

0.32

632

2362

Allergic contact dermatitis

194

830

2.38

27.40

1.1

1.0

6.03

2.32

u/ml

2.16

109

343

Dermatographic urticaria

127

465

2.81

25.02

1.1

4.27

3.33

u/ml

0.34

214

Malignant neoplasm

393

3954

0.58

23.72

1.0

1.1

3.12

4.00

u/ml

0.56

164

1835

Intestinal infectious diseases

1243

5166

1.38

23.46

1.1

3.63

4.59

u/ml

1.31

576

2512

Other and unspecified dermatitis

475

2894

1.65

23.41

1.1

1.0

3.95

3.00

u/ml

0.76

267

1278

Depression or dysthymia

686

2458

1.55

23.30

1.1

5.74

3.70

u/ml

0.96

328

1187

COPD

184

669

2.26

22.66

1.1

1.0

6.25

1.56

u/ml

2.45

106

247

Any event in cancer register

499

4661

0.63

22.53

1.0

1.1

3.03

4.17

u/ml

0.94

207

2186

Coxibs

288

775

1.97

22.43

1.1

6.55

4.61

u/ml

0.32

125

424

Abnormal findings on diagnostic imaging of lung

279

1412

1.90

22.39

1.1

1.0

4.01

3.14

u/ml

0.51

150

617

Special screening examination for infectious and parasitic diseases

441

1946

1.69

22.27

1.1

1.0

3.80

4.20

u/ml

0.21

214

870

Other chronic obstructive pulmonary disease

174

633

2.28

21.87

1.1

1.0

6.46

1.42

u/ml

2.60

102

231

Atopic conjunctivitis

284

3.20

21.82

1.1

7.01

3.53

u/ml

1.02

144

Solid cancers, helper endpoint

388

3813

0.60

21.55

1.0

1.1

2.72

3.93

u/ml

1.08

159

1759

Diabetes, insulin treatment (Kela reimbursement)

483

4607

0.63

21.42

1.1

3.34

4.06

u/ml

0.55

245

2144

Malignant neoplasm, wide definition for exclusion

448

4196

0.62

20.90

1.0

1.1

3.20

3.97

u/ml

0.49

186

1954

Temporomandibular joint disorders, including avohilmo

628

4139

1.51

20.78

1.1

3.84

4.58

u/ml

0.53

330

1985

Acetic acid derivatives and related substances

273

734

1.94

20.45

1.1

2.98

4.63

u/ml

1.37

124

396

Idiopathic urticaria

136

4.26

20.45

1.1

3.44

5.24

u/ml

0.34

Tonsillectomy and adenotomy

913

4534

1.41

20.33

1.1

4.42

4.50

u/ml

0.05

476

2242

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

475

4471

0.64

20.11

1.1

3.37

4.06

u/ml

0.51

241

2079

Eosinophilic disease (BM)

7.89

20.11

1.2

1.0

4.54

1.51

u/ml

0.47

Renal tubulo-interstitial diseases

402

4822

0.62

19.90

1.1

4.98

4.54

u/ml

0.19

208

2304

Diabetes medication

600

5275

0.67

19.64

1.1

3.60

4.16

u/ml

0.38

305

2457

Pain (limb, back, neck, head abdominally)

836

2938

1.43

19.13

1.1

4.94

4.31

u/ml

0.39

419

1475

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

514

1638

1.58

18.95

1.1

1.0

3.96

4.37

u/ml

0.23

250

813

Simple and mucopurulent chronic bronchitis

5.30

18.94

1.1

2.93

3.82

u/ml

0.11

Diabetes, varying definitions

610

5243

0.68

18.82

1.1

3.82

4.11

u/ml

0.17

308

2451

Diabetes mellitus

617

5275

0.68

18.80

1.1

3.77

4.24

u/ml

0.30

314

2467

Abnormalities of heart beat

325

1864

1.72

18.77

1.1

3.79

4.55

u/ml

0.37

162

875

Triptan medication for migraine, min. 3 purchases

812

4412

1.41

18.62

1.1

4.55

4.45

u/ml

0.03

358

2116

Conjunctivitis (acute, non atopic)

329

1938

1.71

18.42

1.1

8.55

4.74

u/ml

1.12

185

926

Medical observation and evaluation for suspected diseases and conditions

730

2582

1.45

18.14

1.1

1.0

4.94

4.47

u/ml

0.20

402

1151

All kidney diseases

572

5731

0.68

17.97

1.1

4.96

4.42

u/ml

0.30

294

2739

Irritable bowel syndrome

321

1899

1.71

17.96

1.1

3.54

4.21

u/ml

0.26

155

908

Caries of enamel

1011

5448

1.34

17.04

1.1

3.76

4.62

u/ml

1.02

522

2578

Pain in throat and chest

872

3803

1.38

17.02

1.1

4.57

4.52

u/ml

0.02

407

1784

Propionic acid derivatives

312

901

1.75

16.91

1.1

4.07

4.89

u/ml

0.43

157

510

Exposure to unspecified factor

1074

5829

1.33

16.91

1.1

5.03

4.37

u/ml

0.53

550

2819

Other special examinations and investigations of persons without complaint or reported diagnosis

727

2582

1.43

16.77

1.1

1.0

3.74

4.47

u/ml

0.71

378

1151

Anxiety disorders

1033

5413

1.34

16.56

1.1

4.10

4.42

u/ml

0.21

526

2569

Neurotic, stress-related and somatoform disorders

1029

5413

1.34

16.52

1.1

4.07

4.43

u/ml

0.24

524

2570

Neurological diseases

1081

4106

1.33

15.78

1.1

5.35

4.52

u/ml

0.46

534

2061

Schizophrenia

1147

0.22

15.61

1.0

1.1

4.80

3.48

u/ml

—

557

Anti-inflammatory and antirheumatic products, non-steroids

306

901

1.72

15.55

1.0

1.1

4.10

4.89

u/ml

0.40

155

510

Other bacterial diseases

585

5262

0.70

15.22

1.1

6.78

4.05

u/ml

2.57

300

2514

Disorders of lacrimal system

361

2297

1.58

14.96

1.1

4.60

4.08

u/ml

0.19

165

1049

Other headache syndromes

447

2989

1.50

14.88

1.1

4.31

4.07

u/ml

0.08

210

1396

Schizophrenia, schizotypal and delusional disorders

118

2452

0.48

14.75

1.1

2.35

4.20

u/ml

1.83

1181

Other bacterial diseases

468

4608

0.68

14.72

1.1

6.89

4.00

u/ml

2.23

241

2200

Schizophrenia or delusion

118

2448

0.48

14.69

1.1

2.35

4.21

u/ml

1.84

1179

Pain and other conditions associated with female genital organs and menstrual cycle

318

1820

1.62

14.57

1.1

2.29

5.66

u/ml

5.90

145

913

Abdominal and pelvic pain

1072

4124

1.31

14.31

1.1

3.92

4.61

u/ml

0.64

526

2036

Symptoms and signs involving the digestive system and abdomen

1074

4124

1.31

14.27

1.1

3.86

4.61

u/ml

0.71

523

2036

Other disorders of lacrimal gland

301

1862

1.63

14.25

1.1

4.20

3.69

u/ml

0.19

137

845

Migraine with aura

349

2240

1.57

14.21

1.1

5.27

4.24

u/ml

0.32

176

1092

Other (not insulin) diabetes medications

499

4262

0.69

14.12

1.1

3.66

4.03

u/ml

0.20

243

1910

Mycoses

883

5812

1.33

14.07

1.1

3.94

4.43

u/ml

0.38

399

2831

Eosinophilia

5.39

14.03

1.2

1.0

4.54

3.07

u/ml

0.19

Anxiety disorders, excluding more controls

922

4545

1.33

13.98

1.1

4.06

4.04

u/ml

0.01

474

2110

Type 2 diabetes

557

4573

0.71

13.70

1.1

3.70

3.98

u/ml

0.15

274

2058

Biguanides

468

4124

0.69

13.62

1.1

3.56

3.92

u/ml

0.18

229

1858

Codeine

1035

4332

1.30

13.49

1.1

4.04

4.33

u/ml

0.16

495

2052

Insulin medication

226

3181

0.59

13.46

1.1

2.95

4.15

u/ml

1.02

130

1532

Oxicams

167

486

1.96

13.41

1.0

1.1

0.92

3.82

u/ml

4.23

247

Other antidepressants

1033

4083

1.30

13.15

1.1

4.28

4.12

u/ml

0.10

497

1972

Diseases of the musculoskeletal system and connective tissue

783

2914

1.35

13.09

1.1

5.59

4.64

u/ml

0.40

393

1479

Heartburn

116

552

2.13

12.92

1.0

1.1

2.39

3.23

u/ml

0.31

267

Diseases of middle ear and mastoid

738

4508

1.35

12.90

1.1

3.75

4.78

u/ml

1.04

398

2244

Schizophrenia or delusion, excluding more controls

118

2309

0.50

12.79

1.1

2.35

3.64

u/ml

1.18

1099

Paracetamol or NSAID medication

221

630

1.78

12.78

1.1

4.28

5.13

u/ml

0.36

116

364

Other dorsopathies, not elsewhere classified

1120

4592

1.28

12.76

1.1

4.33

4.26

u/ml

0.03

552

2219

Bronchitis, not specified as acute or chronic

274

2.62

12.73

1.1

1.0

5.65

1.38

u/ml

1.66

113

Haemorrhage from respiratory passages

200

1033

1.75

12.47

1.1

1.0

5.45

3.61

u/ml

0.60

104

461

Codeine or tramadol medication

1142

4927

1.27

12.45

1.1

4.01

4.32

u/ml

0.18

536

2308

Opioids

1103

4497

1.28

12.38

1.1

4.16

4.35

u/ml

0.09

532

2157

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

432

2666

1.45

12.22

1.1

4.18

3.76

u/ml

0.23

234

1208

Type 2 diabetes, definitions combined, including avohilmo

521

4225

0.72

12.20

1.1

3.65

4.00

u/ml

0.18

248

1900

All anxiety disorders

808

4870

1.32

12.17

1.1

3.33

4.56

u/ml

1.67

419

2335

Certain infectious and parasitic diseases

806

3046

1.33

12.07

1.1

3.71

4.41

u/ml

0.58

391

1478

Low back pain

784

4272

1.32

12.03

1.1

4.07

4.13

u/ml

0.02

369

2030

Other viral diseases

521

3717

1.40

11.98

1.1

4.29

5.02

u/ml

0.45

277

1899

Dysphagia

163

899

1.82

11.80

1.1

1.0

4.47

2.95

u/ml

0.72

419

Dorsopathies

1161

4688

1.26

11.77

1.1

4.58

4.37

u/ml

0.11

571

2292

Cystitis

855

3902

1.31

11.72

1.1

4.61

4.54

u/ml

0.04

388

1891

Other joint disorders

1098

4585

1.27

11.57

1.1

4.71

4.54

u/ml

0.10

543

2245

Type 2 diabetes, definitions combined

512

4159

0.72

11.56

1.1

3.62

3.86

u/ml

0.12

247

1860

COPD (mode)

102

372

2.16

11.51

1.1

1.0

5.98

2.26

u/ml

1.17

129

Type 2 diabetes, strict (exclude DM1)

513

4163

0.72

11.51

1.1

3.61

3.89

u/ml

0.14

248

1861

Migraine with aura and triptan purchases

242

1504

1.63

11.48

1.1

5.63

4.19

u/ml

0.36

123

750

Early onset COPD

139

736

1.90

11.47

1.1

1.0

6.14

3.17

u/ml

1.04

327

Soft tissue disorders related to use, overuse and pressure

210

1256

1.68

11.47

1.0

1.1

3.12

3.35

u/ml

0.08

546

ILD, hospital admissions 1, main diag only

277

2.51

11.43

1.0

1.1

2.87

2.61

u/ml

0.07

133

Selective serotonin reuptake inhibitors

1012

4147

1.28

11.41

1.1

5.21

4.19

u/ml

0.55

475

2016

Neurological diseases, wide definition

504

1789

1.42

11.41

1.1

5.54

4.43

u/ml

0.32

253

964

Other and unspecified nonorganic psychotic disorders

1780

0.47

11.30

1.1

2.48

4.38

u/ml

1.37

878

Type 2 diabetes, wide definition

298

2884

0.66

11.15

1.1

3.31

3.57

u/ml

0.13

162

1254

Vocal cord dysfunction

161

808

1.80

11.03

1.2

1.0

7.14

3.92

u/ml

0.37

347

Kela-code for severe mental illness

159

2749

0.57

11.01

1.1

2.05

4.23

u/ml

3.29

1322

Other specific joint derangements/joint disorders

886

4465

1.29

10.99

1.1

4.87

4.52

u/ml

0.18

429

2177

Parasetamol

912

3597

1.29

10.97

1.1

4.17

4.53

u/ml

0.17

448

1773

Malignant neoplasm of breast, HER2-negative

150

1735

0.56

10.96

1.0

1.1

3.67

3.50

u/ml

0.06

746

Persons encountering health services for examination and investigation

688

2582

1.34

10.95

1.1

1.0

3.32

4.47

u/ml

1.32

349

1151

Other diseases of hard tissues of teeth

510

1885

1.40

10.89

1.1

3.01

5.12

u/ml

2.51

257

849

Malignant neoplasm of breast, including Hilmo

165

1838

0.58

10.89

1.0

1.1

3.49

3.40

u/ml

0.03

786

Malignant neoplasm of breast, HER2-negative, including Hilmo

165

1838

0.58

10.89

1.0

1.1

3.49

3.40

u/ml

0.03

786

Malignant neoplasm of breast

156

1771

0.57

10.77

1.0

1.1

3.62

3.49

u/ml

0.05

762

Acute bronchiolitis

141

696

1.87

10.53

1.1

11.65

5.39

u/ml

1.89

101

427

Anxiety (asthma-related co-morbidities)

780

4677

1.30

10.47

1.1

3.37

4.27

u/ml

1.07

404

2223

All chronic kidney diseases

175

2384

0.60

10.36

1.1

7.45

4.54

u/ml

0.89

1158

Other respiratory diseases principally affecting the interstitium

392

2.18

10.30

1.0

1.1

2.84

2.36

u/ml

0.17

186

Depression medications

542

1990

1.38

10.24

1.1

5.44

5.21

u/ml

0.06

273

1001

Soft tissue disorders

1154

4801

1.24

10.20

1.1

3.99

4.81

u/ml

0.81

570

2393

Insulin, combination of fast acting with intermediate-acting or long-acting

226

3224

0.64

10.20

1.1

2.95

4.09

u/ml

0.95

130

1543

Dorsalgia

1060

4549

1.25

10.18

1.1

4.53

4.15

u/ml

0.18

512

2192

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

253

2.28

10.18

1.0

2.88

3.61

u/ml

0.21

117

Mental and behavioural disorders due to alcohol, excluding acute intoxication

158

2665

0.59

10.16

1.1

5.01

3.98

u/ml

0.35

1252

Myalgia

252

1627

1.56

10.15

1.1

3.79

4.59

u/ml

0.29

129

769

Allergic urticaria

115

601

1.94

10.04

1.2

1.1

4.03

4.17

u/ml

0.04

289

Viral infections characterized by skin and mucous membrane lesions

868

5874

1.27

9.96

1.1

5.74

4.21

u/ml

1.34

420

2870

ILD, hospital admissions

322

2.28

9.87

1.0

1.1

2.87

2.61

u/ml

0.07

158

Other interstitial pulmonary diseases

322

2.28

9.87

1.0

1.1

2.87

2.61

u/ml

0.07

158

Interstitial lung disease endpoints

323

2.27

9.80

1.0

1.1

2.87

2.59

u/ml

0.08

159

Interstitial lung disease

323

2.27

9.80

1.0

1.1

2.87

2.59

u/ml

0.08

159

Other menopausal disorders

241

856

1.60

9.74

1.0

2.91

3.95

u/ml

0.52

102

363

Alcohol use disorder, ICD-based

146

2482

0.59

9.54

1.1

4.56

4.00

u/ml

0.18

1170

Mouth breathing

342

2381

1.44

9.47

1.1

3.72

3.98

u/ml

0.13

181

1147

Cerebrovascular diseases

198

2200

0.63

9.32

1.1

3.64

3.14

u/ml

0.22

984

Other viral diseases, not elsewhere classified

349

2445

1.43

9.18

1.1

4.62

5.10

u/ml

0.19

177

1240

Suppurative and unspecified otitis media

523

3478

1.34

9.17

1.1

4.16

4.93

u/ml

0.52

296

1795

Gastrointestinal diseases

810

3189

1.28

9.15

1.1

5.49

4.87

u/ml

0.25

397

1587

Periodontitis

512

4545

0.75

9.03

1.1

5.26

3.89

u/ml

0.56

243

2094

Examination and observation for other reasons

586

2566

1.33

9.01

1.1

1.0

3.46

4.44

u/ml

0.84

280

1142

Chronic periodontitis, including avohilmo

510

4535

0.75

8.97

1.0

1.1

5.26

3.89

u/ml

0.56

243

2090

Disorders of synovium and tendon

504

3304

1.34

8.94

1.0

1.1

3.30

4.29

u/ml

0.73

241

1542

Candidiasis

283

1928

1.48

8.90

1.1

3.89

4.65

u/ml

0.28

123

946

Alcohol dependence

1326

0.46

8.87

1.1

2.39

3.21

u/ml

0.53

612

Disease of hard tissues of teeth, NOS

476

1827

1.37

8.82

1.1

2.68

4.81

u/ml

2.74

231

808

Renal failure

1281

0.48

8.80

1.0

1.1

3.98

3.55

u/ml

0.10

603

Other chronic obstructive pulmonary disease, including avohilmo

241

1308

1.53

8.74

1.1

1.0

6.76

3.24

u/ml

1.76

138

577

Acute pharyngitis

220

1423

1.55

8.59

1.1

3.55

4.69

u/ml

0.65

107

749

Diseases of the ear and mastoid process

1242

5170

1.21

8.58

1.1

3.95

4.53

u/ml

0.58

620

2472

Alcohol use disorder, Swedish definition

228

3130

0.67

8.53

1.1

5.05

3.81

u/ml

0.58

128

1464

Unspecified mental disorder

212

3215

0.66

8.52

1.1

2.10

4.20

u/ml

4.02

117

1555

Mental and behavioural disorders due to psychoactive substance use

303

3977

0.70

8.40

1.1

6.98

3.91

u/ml

1.85

169

1889

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

223

1467

1.54

8.40

1.1

5.75

4.81

u/ml

0.25

109

704

Substance abuse

286

3844

0.70

8.40

1.1

6.75

3.98

u/ml

1.56

165

1829

290

3644

0.70

8.36

1.1

5.76

3.98

u/ml

0.95

161

1724

266

3476

0.69

8.29

1.1

5.92

4.04

u/ml

0.93

148

1663

Vasomotor rhinitis (mode)

309

2.20

8.26

1.1

2.85

3.31

u/ml

0.13

150

Insulin, intermediate and long-acting

197

2928

0.65

8.23

1.1

3.14

4.04

u/ml

0.59

114

1409

Allergic colitis

301

2.24

8.10

1.2

1.1

8.90

6.69

u/ml

0.32

184

Other and unspecified tonsillitis

476

3018

1.33

8.08

1.1

4.90

4.41

u/ml

0.23

246

1504

Other soft tissue disorders, not elsewhere classified

977

4680

1.23

8.07

1.1

4.38

4.75

u/ml

0.24

457

2321

Fenamates

120

454

1.80

8.01

1.1

1.79

4.25

u/ml

1.74

235

Persons encountering health services for specific procedures and health care

1112

5533

1.21

7.90

1.1

4.78

4.40

u/ml

0.26

638

2597

Substance abuse, excluding more controls

286

3450

0.70

7.87

1.1

6.75

3.92

u/ml

1.62

165

1610

Other anxiety disorders

609

4133

1.28

7.84

1.1

3.68

4.68

u/ml

0.85

324

2016

Stroke, including SAH

137

1636

0.61

7.79

1.1

3.44

2.94

u/ml

0.18

746

STROKE

220

2219

0.67

7.72

1.1

2.87

3.42

u/ml

0.31

104

966

Symptoms and signs involving the skin and subcutaneous tissue

620

4779

1.27

7.69

1.1

4.20

4.17

u/ml

0.01

306

2250

Restless leg syndrome

108

604

1.80

7.69

1.1

4.28

2.98

u/ml

0.31

279

Lichen simplex chronicus and prurigo

204

2.43

7.67

1.1

1.0

3.75

1.99

u/ml

0.51

Later onset COPD, excluding more controls

3.08

7.67

1.0

9.37

0.45

u/ml

0.87

Diseases of oesophagus, stomach and duodenum

998

4917

1.22

7.66

1.1

3.65

4.23

u/ml

0.33

474

2326

Arthropathies

1100

4625

1.21

7.63

1.1

4.36

4.55

u/ml

0.11

546

2274

Pruritus

519

1.87

7.63

1.1

1.0

1.37

1.73

u/ml

0.29

211

Exposure to other specified factors

774

5745

1.24

7.59

1.1

5.16

4.35

u/ml

0.53

413

2772

Acute tubulo-interstitial nephritis

295

3559

0.71

7.59

1.1

5.07

4.45

u/ml

0.23

147

1732

Unspecified chronic bronchitis

4.12

7.54

1.2

1.0

11.26

0.86

u/ml

—

COPD, hospital admissions

173

926

1.58

7.49

1.1

1.0

6.52

2.77

u/ml

1.59

101

408

Occupational exposure to risk-factors

125

2.85

7.47

1.1

1.0

3.28

3.00

u/ml

0.04

Mental and behavioural disorders due to alcohol

233

3248

0.69

7.47

1.1

6.23

3.97

u/ml

1.06

130

1550

Injuries to the wrist and hand

1005

5775

1.21

7.38

1.1

5.08

4.17

u/ml

0.69

530

2767

Depression

978

5483

1.21

7.37

1.1

5.71

4.06

u/ml

0.97

491

2608

COPD, early/later onset

174

934

1.57

7.35

1.1

1.0

6.46

2.79

u/ml

1.56

102

411

Non-allergic asthma

305

2.12

7.28

1.1

1.0

1.81

2.22

u/ml

0.14

117

Other diseases of urinary system

951

4405

1.22

7.24

1.1

3.90

4.41

u/ml

0.44

449

2142

Enthesopathies of lower limb, excluding foot

197

1310

1.51

7.09

1.1

3.07

3.36

u/ml

0.13

594

Other diseases of lip and oral mucosa

326

2378

1.38

7.09

1.1

3.63

4.32

u/ml

0.37

175

1103

Exfoliative dermatitis

7.20

7.06

1.1

1.0

22.65

1.98

u/ml

—

Erysipelas

308

3228

0.73

7.03

1.1

6.88

3.47

u/ml

2.32

171

1487

Dermatophytosis

536

4196

1.28

7.02

1.1

4.03

4.21

u/ml

0.09

242

2028

Organic, including symptomatic, mental disorders

862

0.49

7.02

1.0

1.20

2.53

u/ml

1.62

400

Somatoform disorder

167

1076

1.56

6.98

1.1

2.57

4.22

u/ml

1.06

491

Heart failure, not strict

253

2434

0.70

6.93

1.1

4.18

3.69

u/ml

0.20

132

1107

Acute suppurative otitis media

416

2949

1.33

6.92

1.1

4.03

5.04

u/ml

0.78

236

1547

Autoimmune diseases excluding thyroid diseases

784

5225

0.82

6.82

1.1

3.75

4.72

u/ml

0.97

389

2571

Functional dyspepsia

215

1468

1.47

6.81

1.1

3.56

3.47

u/ml

0.03

673

Psychiatric diseases

966

4015

1.21

6.74

1.1

5.09

4.31

u/ml

0.40

475

1926

Otalgia

527

1.81

6.74

1.2

1.1

4.97

u/ml

0.00

272

Autoimmune diseases excluding thyroid diseases, strict definition

770

5145

0.82

6.65

1.1

3.80

4.75

u/ml

0.94

382

2543

Malignant neoplasm of breast, ER-positive, including Hilmo

106

1370

0.59

6.63

1.0

1.1

2.50

3.47

u/ml

0.59

577

Trochanteric bursitis

100

574

1.75

6.58

1.0

1.20

3.09

u/ml

2.39

249

Polyarthropathies

394

3380

0.76

6.58

1.1

4.10

4.14

u/ml

0.02

185

1579

Metabolic disorders

556

4270

0.79

6.54

1.1

3.68

4.23

u/ml

0.40

285

1975

Peritonsillar abscess

186

1245

1.50

6.53

1.1

1.0

3.47

3.54

u/ml

0.02

547

Dislocation, sprain and strain of joints and ligaments of knee

641

4767

1.24

6.50

1.1

5.47

4.07

u/ml

0.82

325

2228

Herpesviral [herpes simplex] infections

268

1924

1.40

6.49

1.1

6.83

4.01

u/ml

1.41

134

916

Other inflammation of eyelid

111

660

1.69

6.45

1.0

1.1

8.73

3.10

u/ml

1.34

306

Inflammatory diseases of female pelvic organs

655

3891

1.24

6.39

1.1

3.99

4.60

u/ml

0.37

304

1813

Nummular dermatitis

248

2.16

6.38

1.1

1.0

5.04

2.04

u/ml

0.57

Stroke, excluding SAH

123

1438

0.62

6.33

1.1

3.47

2.94

u/ml

0.18

648

Malignant neoplasm of breast, HER-positive

103

1338

0.60

6.32

1.0

1.1

2.50

3.42

u/ml

0.55

563

Other contact dermatitis

400

1.89

6.31

1.1

1.0

8.43

2.00

u/ml

1.57

158

Disorders of eyelid, lacrimal system and orbit

693

4286

1.23

6.28

1.1

4.95

3.99

u/ml

0.63

328

2021

Schizoaffective disorder

565

0.31

6.27

1.0

1.1

4.84

3.45

u/ml

0.20

269

Cervicocranial syndrome

531

1.77

6.27

1.1

1.67

3.28

u/ml

1.26

250

Infective dermatitis

451

1.83

6.25

1.1

4.33

1.93

u/ml

1.01

177

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

489

1.80

6.20

1.1

10.21

4.12

u/ml

1.16

231

Emphysema

3.13

6.16

1.2

1.0

1.86

1.43

u/ml

0.20

Mood [affective] disorders

1005

5496

1.19

6.15

1.1

5.22

4.06

u/ml

0.70

499

2617

Migraine without aura

282

2063

1.38

6.14

1.1

5.56

4.54

u/ml

0.16

128

1029

Other general symptoms and signs

423

1.86

6.09

1.1

1.82

5.98

u/ml

2.78

227

Acute and transient psychotic disorders

804

0.43

6.09

1.1

3.44

3.80

u/ml

0.06

381

Inflammatory diseases of prostate (prostatitis)

376

1.90

6.09

1.0

1.1

0.79

4.13

u/ml

3.36

189

Sub-endpoint used in defining T1D endpoints

136

2062

0.65

6.07

1.1

3.47

4.09

u/ml

0.29

1045

Dyshidrosis [pompholyx]

3.06

6.02

1.1

1.0

4.48

3.43

u/ml

0.19

Selective deficiency of immunoglobulin G [IgG] subclasses

7.54

6.00

1.1

16.27

1.65

u/ml

—

Other and unspecified vaccines and biological substances

4.21

6.00

1.2

1.1

15.30

4.89

u/ml

0.75

Female infertility, cervical, vaginal, other or unspecified origin

335

1627

1.35

5.99

1.1

6.51

5.60

u/ml

0.16

156

780

Mood disorders

1004

5497

1.18

5.96

1.1

5.22

4.06

u/ml

0.70

499

2617

Cerebrovascular diseases (FINNGEN)

139

1508

0.65

5.92

1.1

1.0

3.94

3.66

u/ml

0.09

652

Type 1 diabetes

136

2080

0.65

5.92

1.1

3.47

4.38

u/ml

0.47

1049

Disturbances of skin sensation

280

2059

1.37

5.90

1.1

3.89

4.19

u/ml

0.10

133

960

ILD, hospital admission 2, with pulmonary infections

172

2.34

5.89

1.1

3.52

2.33

u/ml

0.25

Any gastric operation

979

4137

1.19

5.88

1.1

4.36

4.75

u/ml

0.26

470

2071

GASTRO-related operations

979

4137

1.19

5.88

1.1

4.36

4.75

u/ml

0.26

470

2071

Migraine without aura and triptan purchases

228

1625

1.41

5.85

1.1

6.21

4.28

u/ml

0.25

815

Disorders of skin appendages

501

3986

1.26

5.84

1.1

5.67

4.24

u/ml

0.49

266

1953

Condition for Implicit Sepsis (Organ dysfunction codes)

477

4238

0.79

5.78

1.1

4.84

4.10

u/ml

0.39

244

2035

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

679

0.41

5.73

1.0

1.1

1.56

2.81

u/ml

—

305

Lower back pain or/and sciatica

981

5432

1.18

5.72

1.1

4.57

4.11

u/ml

0.22

460

2586

Hypertrophy of breast in women and men

195

1358

1.45

5.67

1.1

6.22

3.82

u/ml

0.39

613

Internal derangement of knee

323

2431

1.33

5.64

1.1

3.95

4.08

u/ml

0.05

151

1115

Allergic contact dermatitis due to drugs in contact with skin

2.98

5.61

1.0

12.56

2.73

u/ml

0.88

Follow-up examination after treatment for conditions other than malignant neoplasms

411

2111

1.29

5.60

1.1

1.0

5.34

4.21

u/ml

0.49

188

921

Excessive attrition of teeth

572

4647

1.24

5.60

1.1

3.20

4.63

u/ml

1.94

301

2181

Dipeptidyl peptidase 4 (DPP-4) inhibitors

126

1558

0.65

5.60

1.0

1.49

2.88

u/ml

2.12

684

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

585

3759

1.24

5.60

1.0

1.1

3.96

4.36

u/ml

0.22

251

1716

Intestinal infectious diseases

913

5867

1.18

5.54

1.1

4.60

4.49

u/ml

0.05

471

2839

Dermatitis due to substances taken internally

264

2.03

5.49

1.1

1.0

11.16

2.04

u/ml

1.89

112

Other enthesopathies

240

1745

1.38

5.45

1.1

3.28

3.93

u/ml

0.25

108

766

Chronic gastritis

119

754

1.58

5.42

1.1

1.0

1.96

3.17

u/ml

0.58

331

Oesophagitis

167

2.30

5.38

1.1

1.0

1.56

1.86

u/ml

0.15

Benign neoplasm: Liver/bile ducts

131

2.49

5.33

1.0

1.37

2.94

u/ml

0.98

Chondrocostal junction syndrome [Tietze]

168

2.30

5.33

1.0

1.1

4.95

6.01

u/ml

0.12

Other degenerative diseases of the nervous system

812

0.54

5.31

1.1

1.0

1.35

2.68

u/ml

1.15

354

Other diseases of oesophagus

281

1.97

5.29

1.1

1.0

3.75

2.95

u/ml

0.17

136

Ischaemic Stroke, excluding all haemorrhages

110

1286

0.64

5.29

1.1

1.0

3.22

2.88

u/ml

0.11

577

Disorders of lipoprotein metabolism and other lipidaemias

365

2905

0.78

5.23

1.0

1.1

3.71

3.62

u/ml

0.04

190

1282

Pain in thoracic spine

137

906

1.52

5.21

1.1

4.81

3.09

u/ml

0.46

407

Generalized anxiety disorder

229

1669

1.38

5.20

1.1

3.29

4.77

u/ml

1.04

129

835

Excessive, frequent and irregular menstruation

448

1940

1.27

5.18

1.1

3.62

5.55

u/ml

1.64

218

978

Endometriosis of pelvic peritoneum

180

1199

1.44

5.16

1.1

1.45

4.90

u/ml

5.24

565

Other noninfective gastroenteritis and colitis

220

1592

1.39

5.16

1.1

4.75

4.66

u/ml

0.03

126

812

General symptoms and signs

1115

4814

1.16

5.14

1.1

4.66

4.29

u/ml

0.19

540

2339

COPD, hospital admission 2, with asthma infections

111

598

1.60

5.13

1.1

1.0

5.20

2.91

u/ml

0.73

279

Female infertility

361

1693

1.30

5.11

1.1

6.78

5.53

u/ml

0.24

165

823

Ovarian cyst

388

1743

1.29

5.10

1.1

2.62

5.52

u/ml

3.83

195

851

Benign neoplasm: Liver

122

2.51

5.08

1.0

1.46

3.10

u/ml

0.95

Cervicalgia

150

1016

1.48

5.07

1.1

1.0

2.77

3.18

u/ml

0.12

453

Acute appendicitis, no complications

560

4569

1.22

5.07

1.1

3.53

4.03

u/ml

0.32

261

2129

Septicaemia

121

1715

0.66

5.03

1.0

1.1

9.80

3.67

u/ml

1.75

830

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

186

2.19

5.02

1.0

2.31

5.67

u/ml

0.93

Type 1 diabetes, wide definition, subgroup 1

121

1825

0.66

5.00

1.1

3.63

4.07

u/ml

0.18

931

Noninflammatory disorders of female genital tract

501

2020

1.25

4.98

1.1

4.66

5.51

u/ml

0.24

234

1028

Other neurological diseases

279

2881

0.76

4.90

1.1

3.51

3.93

u/ml

0.20

149

1317

Malignant neoplasm of digestive organs

886

0.57

4.89

1.0

4.80

2.96

u/ml

0.46

417

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

303

2324

1.31

4.88

1.1

3.61

4.04

u/ml

0.21

169

1131

Type 1 diabetes, wide definition

127

1887

0.67

4.88

1.1

4.29

4.28

u/ml

0.01

962

Hypertrophy of breast

177

1249

1.43

4.87

1.1

6.29

4.02

u/ml

0.31

556

Visual disturbances

375

2956

1.27

4.86

1.1

4.98

4.35

u/ml

0.15

208

1438

Hypermobility syndrome

490

1.70

4.85

1.1

2.29

3.91

u/ml

0.81

225

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1072

5036

1.16

4.84

1.1

4.63

4.08

u/ml

0.32

565

2399

Subjective visual disturbances

198

1429

1.39

4.77

1.1

3.05

3.96

u/ml

0.44

111

667

Accidents

853

3630

1.18

4.75

1.1

5.76

3.92

u/ml

1.08

426

1696

Mood disorders, excluding more controls

892

4555

1.17

4.71

1.1

5.56

3.98

u/ml

0.93

444

2115

Other viral diseases

352

2759

1.28

4.70

1.1

5.14

5.06

u/ml

0.03

190

1422

Olecranon bursitis

184

2.14

4.69

1.1

6.22

3.05

u/ml

0.41

Insulin, fast-acting

165

2321

0.71

4.68

1.1

3.08

4.16

u/ml

0.73

1149

Other extrapyramidal and movement disorders in other diseases

145

993

1.47

4.68

1.1

5.01

3.11

u/ml

0.50

460

Insulin, fast-acting or short human

165

2319

0.71

4.66

1.1

3.08

4.14

u/ml

0.72

1148

Pure hypercholesterolaemia

288

2447

0.77

4.65

1.1

3.60

3.44

u/ml

0.07

158

1064

Recurrent aphthous stomatitis , including avohilmo

128

858

1.50

4.62

1.1

4.42

3.91

u/ml

0.11

430

Diseases of appendix

691

5251

1.19

4.62

1.1

3.83

4.10

u/ml

0.16

318

2447

General examination and investigation of persons without complaint and reported diagnosis

599

2582

1.21

4.61

1.1

1.0

4.25

4.47

u/ml

0.10

317

1151

5.51

4.61

1.1

1.0

0.89

3.47

u/ml

—

Non-invasive ventilation

223

1471

1.36

4.60

1.1

3.04

4.43

u/ml

0.93

141

684

Acute renal failure

582

0.43

4.58

1.0

1.1

1.57

2.70

u/ml

0.65

279

Lichen simplex chronicus

116

2.44

4.57

1.1

1.0

3.78

1.62

u/ml

0.31

Other disorders of penis

483

1.67

4.52

1.1

6.65

4.18

u/ml

0.38

279

Peripheral artery disease

760

0.55

4.49

1.1

1.0

2.74

2.59

u/ml

0.03

339

Adenomyosis (Endometriosis of uterus)

101

647

1.57

4.49

1.0

3.46

4.88

u/ml

0.34

283

Appendicitis, broad definition

686

5244

1.19

4.47

1.1

3.86

4.09

u/ml

0.14

316

2443

Viral warts

236

1772

1.34

4.47

1.1

4.61

4.40

u/ml

0.05

103

902

Acute laryngitis and tracheitis

179

1267

1.40

4.45

1.1

5.42

5.00

u/ml

0.12

107

680

Deep bite

164

1017

1.43

4.45

1.1

6.47

5.47

u/ml

0.19

584

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

640

0.46

4.43

1.1

9.58

3.93

u/ml

0.60

315

Other external causes of accidental injury

847

3630

1.17

4.37

1.1

5.95

3.92

u/ml

1.21

427

1696

Visual disturbances and blindness

391

3139

1.25

4.36

1.1

5.04

4.37

u/ml

0.17

218

1528

Transplanted organ and tissue status

538

0.42

4.32

1.0

1.1

1.41

4.83

u/ml

2.94

276

All-cause Heart Failure

100

1077

0.65

4.27

1.1

1.0

4.22

3.08

u/ml

0.26

503

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

705

5391

0.85

4.27

1.1

3.26

4.54

u/ml

1.53

343

2587

Flat foot [pes planus] (acquired)

430

1.69

4.27

1.1

1.0

2.03

3.36

u/ml

0.80

185

COPD, hospital admissions 1, only main diagnosis

112

633

1.52

4.25

1.1

5.53

2.94

u/ml

0.82

292

Heart failure, strict

103

1100

0.66

4.24

1.1

1.0

4.22

3.09

u/ml

0.26

518

Disorders of the thyroid gland

851

4771

1.16

4.24

1.1

3.14

4.59

u/ml

2.00

383

2289

Spinal osteochondrosis

3.34

4.22

1.1

3.38

1.58

u/ml

—

Seborrhoeic dermatitis

364

1.74

4.21

1.1

1.0

2.47

1.82

u/ml

0.37

155

Diseases of male genital organs

397

1600

1.26

4.21

1.1

3.31

4.34

u/ml

0.66

194

862

Persons encountering health services in other circumstances

388

3113

1.24

4.20

1.1

5.85

4.26

u/ml

0.79

181

1548

Diseases of salivary glands

256

1963

1.31

4.19

1.1

2.68

4.33

u/ml

1.13

123

918

ILD-related respiratory insufficiency

3.44

4.19

1.1

1.0

4.02

1.83

u/ml

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

123

825

1.49

4.18

1.2

1.1

6.11

4.67

u/ml

0.36

451

Fibromyalgia

612

1.57

4.17

1.1

1.0

2.51

3.75

u/ml

0.77

267

Heart failure,strict

101

1078

0.66

4.15

1.1

1.0

4.40

3.26

u/ml

0.25

501

Infections with a predominantly sexual mode of transmission

526

4081

1.21

4.13

1.1

4.32

4.66

u/ml

0.15

245

2031

Persons encountering health services in other circumstances, wide

1115

5036

1.14

4.12

1.1

5.05

4.08

u/ml

0.64

558

2399

Provisional assignment of new diseases of uncertain etiology

467

3841

1.22

4.12

1.1

3.90

4.49

u/ml

0.33

251

1879

780

4046

1.17

4.11

1.1

1.0

5.07

3.84

u/ml

0.89

430

1861

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

780

4046

1.17

4.11

1.1

1.0

5.07

3.84

u/ml

0.89

430

1861

Drug-induced adrenocortical insufficiency

2.68

4.10

1.2

1.0

1.75

2.54

u/ml

0.32

Liquid cancers, helper endpoint

102

1333

0.67

4.08

1.1

4.09

3.69

u/ml

0.07

645

COPD related to multimorbidity

119

678

1.48

4.08

1.1

1.0

7.95

2.58

u/ml

1.63

298

Gluteal tendinitis

155

2.15

4.07

1.0

1.1

1.94

1.60

u/ml

0.14

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

645

5237

0.85

4.07

1.1

3.72

4.28

u/ml

0.35

330

2488

Bacterial Sepsis

128

1569

0.70

4.06

1.0

1.1

6.15

3.64

u/ml

0.63

739

Codes for special purposes

467

3848

1.21

4.05

1.1

3.90

4.49

u/ml

0.33

251

1883

Exclusions for E4_PCOS_CONSORTIUM

589

4376

0.84

4.04

1.1

4.07

4.58

u/ml

0.28

250

2109

Erysipelas

198

2339

0.75

4.03

1.1

7.03

3.11

u/ml

2.00

119

1060

Nonalcoholic fatty liver disease

523

1.60

4.02

1.0

1.1

1.42

3.32

u/ml

2.06

236

Acute appendicitis

649

5157

1.18

4.02

1.1

3.73

4.06

u/ml

0.20

301

2403

Unspecified acute lower respiratory infection

125

860

1.46

4.01

1.1

1.0

7.01

3.12

u/ml

1.83

412

Implicit Sepsis

450

3987

0.82

3.98

1.1

4.91

4.18

u/ml

0.36

228

1912

Diseases of arteries, arterioles and capillaries

191

1894

0.74

3.98

1.0

3.70

3.00

u/ml

0.24

862

Prurigo nodularis

3.05

3.98

1.0

3.78

1.29

u/ml

—

Transport accidents

467

3317

1.21

3.98

1.1

4.90

3.89

u/ml

0.39

236

1561

Hyperkinetic disorders, excluding more controls

214

1546

1.34

3.97

1.1

7.32

5.14

u/ml

0.56

117

834

Implicit Sepsis

364

3397

0.81

3.96

1.1

5.53

4.04

u/ml

0.78

197

1616

Other diseases of stomach and duodenum

170

2.07

3.96

1.1

1.0

4.67

2.17

u/ml

0.64

Other otitis externa (chronic)

334

1.75

3.96

1.1

1.0

1.92

3.54

u/ml

1.02

169

Spondylolisthesis/Spondylolysis

118

805

1.47

3.95

1.0

2.40

3.03

u/ml

0.35

358

Benign neoplasm: Colon, unspecified

612

1.54

3.93

1.1

1.0

2.80

2.77

u/ml

0.01

273

ILD, hospital admissions 3, with pneumonia sepsis

144

2.16

3.92

1.1

1.0

1.59

2.75

u/ml

0.40

Diseases of external ear

255

1974

1.30

3.92

1.1

4.02

4.70

u/ml

0.27

135

952

Dental pulpitis, including avohilmo

972

5520

1.15

3.92

1.1

4.52

4.27

u/ml

0.14

479

2622

Valvular heart disease excluding rheumatic fever

143

1446

0.71

3.91

1.0

1.1

2.34

4.18

u/ml

1.70

684

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

199

1.99

3.90

1.1

8.21

4.78

u/ml

0.27

103

L04AD Calcineurin inhibitors

715

0.53

3.89

1.0

1.1

9.00

4.70

u/ml

0.44

364

Chronic periodontitis, complicated

197

2590

0.75

3.88

1.0

1.1

8.11

3.48

u/ml

0.88

1147

Abnormal findings in secretions and smears from cervix uteri vagina vulva

551

3496

1.19

3.88

1.1

4.02

4.48

u/ml

0.24

241

1585

Otitis externa

194

1449

1.35

3.86

1.1

3.68

3.94

u/ml

0.09

100

699

Hypertensive diseases

552

3704

0.84

3.84

1.1

4.02

4.00

u/ml

0.01

266

1680

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

513

0.45

3.84

1.0

1.1

6.93

2.75

u/ml

—

232

Other septicaemia

106

1491

0.68

3.80

1.0

1.1

10.21

3.80

u/ml

1.61

722

Other disorders of patella

170

1248

1.37

3.80

1.1

3.69

3.26

u/ml

0.11

562

Type 1 diabetes, strict (exclude DM2)

1120

0.63

3.79

1.1

2.55

4.56

u/ml

1.67

584

External causes of morbidity and mortality

722

3097

1.17

3.78

1.1

5.92

3.90

u/ml

1.01

361

1472

Nonsuppurative otitis media

321

2220

1.26

3.78

1.1

3.56

5.49

u/ml

1.81

185

1190

Condition for Implicit Sepsis (Organ dysfunction codes)

590

4790

0.85

3.78

1.1

5.29

4.23

u/ml

0.48

296

2309

Substance use, excluding alcohol

107

1557

0.68

3.77

1.1

9.46

3.66

u/ml

1.54

749

Iron deficiency

252

1.86

3.76

1.1

0.50

6.35

u/ml

4.44

122

Bacterial infection, other or unspecified

224

2461

0.77

3.76

1.1

6.07

3.69

u/ml

0.91

105

1176

Hypertension

552

3695

0.84

3.76

1.1

4.02

4.01

u/ml

0.00

266

1675

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

3.06

3.71

1.3

1.0

2.29

1.99

u/ml

—

Diseases of oral cavity, salivary glands and jaws

446

1885

1.22

3.71

1.1

2.38

5.12

u/ml

5.09

215

849

Other acute skin changes due to ultraviolet radiation

109

2.32

3.70

1.1

1.0

1.91

3.54

u/ml

0.55

Bleeding

394

3414

0.82

3.70

1.1

4.89

4.23

u/ml

0.31

195

1610

Cervical disc disorders

218

1667

1.31

3.69

1.1

1.0

4.38

3.10

u/ml

0.60

103

706

Other disorders of adrenal gland

261

1.82

3.66

1.1

1.81

4.97

u/ml

2.41

134

Diaphragmatic hernia

172

1272

1.36

3.66

1.1

2.03

3.23

u/ml

0.79

552

Postmenopausal atrophic vaginitis

146

571

1.42

3.65

1.1

1.0

1.86

4.80

u/ml

2.17

234

Hypothyreosis and Thyroxine purchase for inclusion criteria

817

4659

1.15

3.65

1.1

3.01

4.56

u/ml

2.16

357

2225

Non-rheumatic valve diseases

140

1401

0.72

3.64

1.0

1.1

2.36

3.98

u/ml

1.38

655

Hypothyroidism, strict autoimmune

692

3910

1.17

3.64

1.1

3.27

4.67

u/ml

1.50

313

1861

Dysplasia of cervi uteri

270

1533

1.28

3.63

1.1

3.79

5.38

u/ml

0.63

116

725

Viral and other specified intestinal infections

371

2924

1.23

3.63

1.1

5.85

5.32

u/ml

0.15

202

1557

Other respiratory disorders and diseases

529

1.55

3.60

1.1

5.11

3.77

u/ml

0.32

262

Other diseases of the respiratory system

529

1.55

3.60

1.1

5.11

3.77

u/ml

0.32

262

Rosacea

642

1.51

3.60

1.1

5.36

3.01

u/ml

0.78

277

109

683

1.47

3.59

1.1

1.0

2.55

2.50

u/ml

0.02

312

Other disorders of cornea

405

1.64

3.59

1.1

13.72

2.60

u/ml

0.69

175

Hypothyroidism, other/unspecified

793

4531

1.15

3.58

1.1

3.06

4.61

u/ml

2.08

349

2166

Injuries to the ankle and foot

754

5821

1.15

3.57

1.1

6.20

4.26

u/ml

0.96

390

2818

Tracheo-bronchomalasia

4.43

3.57

1.1

1.0

3.87

3.82

u/ml

—

Other and unspecified rosacea

437

1.61

3.56

1.1

4.30

2.68

u/ml

0.40

186

Striking against or struck by other objects

337

2730

1.24

3.56

1.1

5.74

4.61

u/ml

0.29

155

1424

Disorders of tooth development and eruption

189

1150

1.34

3.55

1.1

2.21

6.15

u/ml

5.83

565

Other noninflammatory disorders of vagina

430

1.62

3.54

1.0

1.65

4.53

u/ml

1.71

183

Alzheimer disease, including avohilmo

252

0.36

3.54

1.1

1.0

0.04

1.92

u/ml

—

119

Keratitis

289

2305

1.26

3.53

1.1

8.28

3.98

u/ml

1.11

148

1076

Sulfonylureas

482

0.51

3.53

1.0

4.16

2.47

u/ml

0.28

216

Type 1 diabetes, strict definition, subgroup 1

976

0.62

3.51

1.1

2.67

4.65

u/ml

1.34

521

Type 1 diabetes, definitions combined

1120

0.64

3.47

1.1

3.94

4.49

u/ml

0.16

582

Retinal breaks without detachment

551

1.53

3.45

1.1

1.53

2.86

u/ml

1.61

242

Explicit Sepsis

163

2034

0.75

3.43

1.1

7.59

4.23

u/ml

1.05

979

Suicide or other Intentional self-harm

149

2014

0.74

3.42

1.1

4.82

4.30

u/ml

0.16

978

Peroneal tendinitis

2.55

3.40

1.0

0.47

2.75

u/ml

—

Blepharochalasis

113

789

1.44

3.40

1.1

1.0

5.67

2.52

u/ml

0.73

333

Heart failure and antihypertensive medication

698

0.64

3.40

1.1

5.86

3.08

u/ml

0.51

318

Dementia, including avohilmo

475

0.55

3.40

1.0

0.67

2.00

u/ml

1.24

225

Mental and behavioural disorders due to cannabinoids

315

0.34

3.39

1.1

10.79

4.32

u/ml

—

164

Anomalies of dental arch relationship, including avohilmo

255

1816

1.27

3.38

1.1

5.27

5.20

u/ml

0.01

143

956

Any dementia, excluding more controls

347

0.48

3.38

1.0

0.15

2.08

u/ml

3.57

162

Chronic kidney disease

808

0.59

3.37

1.0

1.1

5.13

3.41

u/ml

0.34

396

Struck by thrown, projected or falling objec

313

1.71

3.37

1.1

1.0

3.83

4.16

u/ml

0.07

153

Other and unspecified drugs and medicaments

428

1.60

3.37

1.1

8.81

3.66

u/ml

0.73

195

Lichen planus

420

1.60

3.36

1.1

1.04

2.70

u/ml

2.16

183

Dialysis, with operation codes

525

0.49

3.35

1.0

1.1

1.02

3.90

u/ml

3.89

269

Short Achilles tendon (acquired)

121

2.18

3.34

1.0

3.03

3.60

u/ml

0.08

Atypical facial pain

247

1.80

3.33

1.1

2.29

2.99

u/ml

0.31

119

Hard cardiovascular diseases

446

3173

0.84

3.33

1.1

3.96

4.01

u/ml

0.02

200

1449

Other disorders of bone

178

1346

1.33

3.33

1.1

3.09

3.92

u/ml

0.37

635

Ocular pain

557

1.52

3.32

1.1

3.66

3.41

u/ml

0.05

259

Dislocation, sprain and strain of joints and ligaments at neck level

172

1296

1.34

3.31

1.1

3.36

4.50

u/ml

0.54

622

Disorders of sclera, cornea, iris and ciliary body

441

3700

1.19

3.31

1.1

6.14

3.94

u/ml

0.76

226

1776

Stomatitis and related lesions

177

1339

1.33

3.30

1.1

5.75

3.88

u/ml

0.58

654

Use of disulfiram, acamprosate or naltrexone

521

0.50

3.30

1.0

1.1

3.25

2.92

u/ml

0.10

242

Seropositive rheumatoid arthritis, strict definition

652

0.55

3.28

1.1

1.37

3.13

u/ml

1.30

286

Any dementia

346

0.48

3.27

1.0

0.15

1.91

u/ml

3.20

163

Oxycodone

1222

0.69

3.27

1.1

1.0

1.47

3.48

u/ml

3.74

545

Other nutritional deficiencies

623

5065

1.16

3.26

1.1

4.83

4.31

u/ml

0.21

315

2359

Degenerative diseases of the nervous system

314

0.44

3.25

1.1

0.53

2.25

u/ml

—

150

Panic disorder

195

1501

1.31

3.24

1.1

4.43

4.51

u/ml

0.02

108

743

Other disorders of urethra and urinary system

574

3548

1.17

3.24

1.1

4.46

4.21

u/ml

0.12

275

1689

Other intervertebral disc disorders

683

3561

1.16

3.23

1.1

3.77

3.67

u/ml

0.05

320

1642

Reimbursement for rheumatic diseases

302

3694

0.81

3.23

1.0

1.1

2.65

4.36

u/ml

1.91

142

1747

Appendectomy

619

5114

1.16

3.22

1.1

4.01

4.07

u/ml

0.03

289

2397

Other congenital malformations of skin

295

1.72

3.22

1.1

16.98

6.05

u/ml

0.62

160

Injury, poisoning and certain other consequences of external causes

601

2580

1.17

3.21

1.1

4.95

3.67

u/ml

0.92

293

1224

Extrapyramidal and movement disorders

189

1450

1.31

3.18

1.1

4.65

3.29

u/ml

0.43

659

COPD-related respiratory insufficiency

185

1.90

3.18

1.1

1.0

3.70

2.26

u/ml

0.34

Tinnitus

148

1097

1.35

3.17

1.1

1.0

2.03

3.61

u/ml

1.45

491

Polyarteritis nodosa and related conditions

3.00

3.15

1.1

1.0

0.95

2.22

u/ml

—

Ganglion

191

1473

1.30

3.12

1.0

1.1

4.17

4.43

u/ml

0.06

679

Endometriosis

337

1615

1.23

3.12

1.1

2.41

5.28

u/ml

3.08

159

775

Postviral fatigue syndrome

2.52

3.10

1.2

1.0

0.65

4.11

u/ml

—

Menorrhagia

304

1363

1.24

3.10

1.1

3.30

4.70

u/ml

0.87

146

629

Idiopathic pulmonary fibrosis

2.29

3.10

1.0

4.85

1.38

u/ml

0.47

Disorders of choroid and retina

345

2966

0.83

3.09

1.1

2.42

3.70

u/ml

1.63

174

1352

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

515

2788

1.18

3.09

1.1

4.47

4.99

u/ml

0.23

256

1316

Diarrhoea and gastroenteritis of presumed infectious origin

670

5261

1.15

3.08

1.1

3.53

4.55

u/ml

1.19

350

2563

Injury of muscle and tendon at shoulder and upper arm level

175

1336

1.31

3.07

1.1

1.0

2.87

3.26

u/ml

0.17

587

Glaucoma suspect

155

1163

1.34

3.07

1.0

1.1

2.88

3.10

u/ml

0.07

521

Subacute thyroiditis

181

1.90

3.07

1.0

5.10

2.89

u/ml

0.19

Other symptoms and signs involving the nervous and musculoskeletal systems

334

2752

1.22

3.07

1.1

3.83

4.58

u/ml

0.46

186

1316

Other disorders of eyelid

182

1329

1.31

3.06

1.1

4.83

2.75

u/ml

0.87

593

Type 1 diabetes, strict definition

1015

0.65

3.06

1.1

4.05

4.63

u/ml

0.15

542

Symptoms and signs involving the nervous and musculoskeletal systems

434

3666

1.19

3.03

1.1

4.12

4.35

u/ml

0.12

233

1770

Other abnormal products of conception

443

2474

1.19

3.02

1.1

5.23

4.58

u/ml

0.27

198

1123

Lichen ruber planus, wide definition including periferal and oral lichen planus

122

886

1.38

3.00

1.1

2.41

3.08

u/ml

0.18

385

Disturbance of activity and attention

210

1619

1.28

2.99

1.1

7.32

5.19

u/ml

0.52

114

917

Lichen planus, including avohilmo

103

727

1.42

2.98

1.1

2.76

2.66

u/ml

0.02

310

malignant neoplasm of male genital organs

474

0.60

2.98

1.0

1.1

1.42

2.71

u/ml

0.81

231

Alzheimer disease

208

0.35

2.98

1.0

0.04

0.89

u/ml

—

Irregular menses

558

3801

1.16

2.96

1.1

3.17

4.73

u/ml

1.63

256

1760

Fracture of femur

572

0.57

2.93

1.0

1.1

4.85

3.27

u/ml

0.17

278

Myotonic disorders

3.53

2.93

1.2

1.0

2.55

1.46

u/ml

—

Hypothyroidism, levothyroxine purchases

386

1820

1.20

2.93

1.1

3.65

5.29

u/ml

1.18

182

915

Hypothyroidism and >3 levothyroxin purchases

386

1820

1.20

2.93

1.1

3.65

5.29

u/ml

1.18

182

915

Viral pneumonia

664

1.44

2.92

1.1

5.49

3.64

u/ml

0.52

325

Presence of cardiac and vascular implants and grafts

870

0.68

2.92

1.0

3.03

3.14

u/ml

0.02

410

Combinations of oral blood glucose lowering drugs

950

0.65

2.92

1.0

4.52

3.05

u/ml

0.18

415

Nephropathy related operations

512

0.52

2.92

1.0

1.1

0.96

3.85

u/ml

4.01

262

Acute lymphadenitis

453

1.54

2.91

1.1

3.85

4.17

u/ml

0.09

224

Coronary artery bypass grafting

314

0.47

2.91

1.0

3.51

3.27

u/ml

0.04

142

Chondropathies

138

1029

1.35

2.90

1.0

1.1

3.02

3.40

u/ml

0.13

482

Other/unspecified synovitis and tenosynovitis

591

1.46

2.89

1.0

1.1

2.04

3.29

u/ml

0.87

272

Adrenocortical insufficiency

185

1.86

2.89

1.2

1.0

1.56

2.75

u/ml

0.86

Oedema, not elsewhere classified

194

1495

1.28

2.89

1.1

3.00

3.52

u/ml

0.26

695

Implicit bacterial Sepsis

100

1240

0.71

2.88

1.1

4.95

3.17

u/ml

0.43

569

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

282

1.68

2.87

1.0

1.1

3.40

3.85

u/ml

0.08

135

Malignant neoplasm of skin

139

1270

0.75

2.87

1.0

1.1

1.85

2.73

u/ml

0.58

574

Any operation in hilmo

190

1.63

2.87

1.1

1.0

4.01

4.22

u/ml

0.04

Mental and behavioural disorders due to opioids

332

0.42

2.87

1.0

1.1

2.14

3.87

u/ml

—

167

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

109

1496

0.72

2.85

1.1

5.16

4.35

u/ml

0.20

726

Mental retardation, wide definition

410

0.48

2.84

1.2

1.1

3.97

6.21

u/ml

—

247

Hallux rigidus

399

1.56

2.84

1.0

1.1

6.33

2.78

u/ml

0.68

163

Benign neoplasm of other and ill-defined parts of digestive system

618

1.45

2.84

1.1

4.09

3.02

u/ml

0.30

275

Other disorders of white blood cells

208

1.79

2.83

1.2

1.0

9.78

3.31

u/ml

0.54

100

Keratoconus

137

2.00

2.82

1.1

25.48

2.19

u/ml

0.65

Embedded and impacted teeth

415

2901

1.19

2.82

1.1

5.86

4.77

u/ml

0.31

228

1527

Hyperkinetic disorders

220

1718

1.26

2.82

1.1

7.08

5.18

u/ml

0.49

122

968

Injuries to the knee and lower leg

1122

5614

1.11

2.81

1.1

4.88

4.32

u/ml

0.38

555

2703

Other demyelinating diseases of the central nervous system

300

0.40

2.79

1.1

1.0

3.61

2.88

u/ml

—

136

Other viral hepatitis

503

0.53

2.79

1.1

3.75

3.55

u/ml

0.03

238

Hypothyroidism (congenital or acquired)

389

1843

1.20

2.79

1.1

3.58

5.23

u/ml

1.23

187

929

Presence of other devices

692

1.41

2.79

1.1

1.0

2.71

3.68

u/ml

0.31

312

Sequelae of cerebrovascular disease

781

0.65

2.79

1.0

1.1

5.63

2.69

u/ml

0.55

356

Deforming dorsopathies

217

1728

1.26

2.79

1.0

1.1

4.23

4.28

u/ml

0.02

105

826

Other diseases of intestines

1081

5537

1.11

2.78

1.1

3.67

4.70

u/ml

1.17

496

2742

Polyp of the female genital tract

237

1086

1.26

2.77

1.1

2.22

4.28

u/ml

1.83

108

486

Metatarsalgia

499

1.49

2.76

1.1

2.71

3.47

u/ml

0.23

221

Persons encountering health services in circumstances related to reproduction

622

3658

1.15

2.75

1.1

4.39

4.78

u/ml

0.24

299

1841

Factors influencing health status and contact with health services

270

1095

1.24

2.74

1.1

1.0

3.70

4.17

u/ml

0.20

142

461

Bacterial infection, other or unspecified

194

2128

0.79

2.74

1.1

6.33

3.54

u/ml

0.91

1016

Bruxism

125

2.04

2.73

1.1

1.0

1.30

2.40

u/ml

0.81

Dementia

427

0.58

2.73

1.0

0.67

2.06

u/ml

1.27

202

Dental operations

450

1964

1.18

2.72

1.0

1.1

3.09

4.80

u/ml

1.75

210

902

Chronic conjunctivitis

146

1.94

2.72

1.0

1.1

8.17

4.39

u/ml

0.39

Other enthesopathy of foot (+metatarsalgia)

550

1.46

2.71

1.1

2.76

3.62

u/ml

0.28

247

Atrial fibrillation and flutter

144

1227

0.76

2.70

1.0

3.72

3.51

u/ml

0.06

528

Other obstetric conditions, not elsewhere classified

516

2834

1.16

2.69

1.1

4.51

4.97

u/ml

0.20

255

1329

Unspecific neurodegenerative disorder

334

0.53

2.68

1.0

1.06

1.95

u/ml

—

160

Faecal incontinence

257

1.68

2.67

1.0

0.95

3.22

u/ml

1.76

113

Lateral epicondylitis

102

736

1.39

2.66

1.1

3.52

3.29

u/ml

0.05

321

Other deformities of toe(s)

2.14

2.65

1.0

1.43

3.75

u/ml

1.03

Inhalation and ingestion of food causing obstruction of respiratory tract

2.99

2.64

1.4

1.1

3.37

4.85

u/ml

—

Noninfective enteritis and colitis

400

3399

1.18

2.64

1.1

4.11

4.75

u/ml

0.34

201

1696

Unspecified privation

570

1.45

2.64

1.1

4.50

3.46

u/ml

0.27

274

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

352

2639

1.19

2.61

1.1

5.87

5.39

u/ml

0.14

187

1456

L02BG Aromatase inhibitors

1148

0.70

2.61

1.0

2.41

3.50

u/ml

0.62

482

Mental retardation

396

0.50

2.60

1.2

1.1

3.97

6.33

u/ml

—

241

Injury of muscle and tendon at lower leg level

103

748

1.38

2.59

1.0

1.1

2.42

2.99

u/ml

0.31

348

Demyelinating diseases of the central nervous system

666

0.61

2.58

1.0

1.1

1.74

3.00

u/ml

0.70

312

Redundant prepuce, phimosis and paraphimosis

158

1211

1.30

2.58

1.0

1.1

5.26

4.32

u/ml

0.26

656

Congenital malformations, deformations and chromosomal abnormalities

688

5619

1.13

2.54

1.1

5.74

4.44

u/ml

0.58

354

2738

Deep bite that required surgery

2.31

2.54

1.0

1.1

11.16

2.66

u/ml

—

Dislocation, sprain and strain of joint and ligaments of hip

101

2.10

2.53

1.1

1.0

6.66

1.88

u/ml

0.41

Viral hepatitis

538

0.57

2.53

1.1

3.75

3.58

u/ml

0.03

253

Toxic effect of contact with venomous animals

239

1.69

2.52

1.0

5.21

3.56

u/ml

0.27

120

Intermittent heterotropia

586

0.59

2.52

1.1

15.62

6.15

u/ml

0.36

336

Insulin, fast-acting (human)

1129

0.71

2.52

1.1

3.00

3.86

u/ml

0.33

549

Continuous positive airway pressure

135

862

1.32

2.52

1.1

3.82

4.54

u/ml

0.24

416

Haemorrhage in early pregnancy

297

2409

1.20

2.51

1.1

1.0

4.14

4.58

u/ml

0.14

124

1101

Medicines for HER+ breast cancer

133

1648

0.76

2.51

1.1

2.07

3.65

u/ml

1.66

697

Disorders of breast

432

3372

1.17

2.49

1.1

4.11

4.35

u/ml

0.06

183

1537

Mental and behavioural disorders due to use of other stimulants, including caffeine

270

0.40

2.49

1.1

2.36

3.97

u/ml

—

142

Status post-ami

362

0.55

2.48

1.0

6.76

2.99

u/ml

0.36

160

Pain in limb

743

4425

1.12

2.46

1.1

4.41

4.71

u/ml

0.16

341

2172

Endometriosis of rectovaginal septum and vagina

398

1.52

2.46

1.1

0.92

4.11

u/ml

2.85

168

Anogenital herpesviral [herpes simplex] infection

141

1085

1.31

2.45

1.1

3.36

4.70

u/ml

0.35

540

Other retinal disorders

225

2151

0.81

2.44

1.1

2.48

3.66

u/ml

1.10

111

1019

Carpal tunnel syndrome

424

3215

1.16

2.43

1.1

2.93

3.79

u/ml

0.75

191

1431

Contracture of joint

2.94

2.43

1.0

10.06

4.64

u/ml

—

Pre-eclampsia or poor fetal growth

253

3046

0.82

2.42

1.0

1.1

3.20

4.73

u/ml

1.17

118

1386

Hypothyroidism, strict autoimmune, 3 medication purchases required

723

4346

1.12

2.41

1.1

3.17

4.57

u/ml

1.61

324

2057

Vulvovaginal ulceration/inflammation in other diseases

532

1.44

2.41

1.2

1.0

5.14

3.57

u/ml

0.25

248

Pleural plaque

2.29

2.41

1.1

5.00

1.15

u/ml

—

Atherosclerosis, excluding cerebral and coronary sclerosis

608

0.65

2.41

1.1

1.0

2.47

2.49

u/ml

0.00

280

Use of anticholinesterases

266

0.47

2.39

1.1

1.0

0.05

1.72

u/ml

—

126

N06DA Anticholinesterases

266

0.47

2.39

1.1

1.0

0.05

1.72

u/ml

—

126

Other congenital malformations of skin

583

1.42

2.38

1.1

11.88

4.58

u/ml

0.63

286

Patellar tendinitis

111

2.01

2.38

1.1

5.04

4.24

u/ml

0.10

Hypoplasia of dental enamel, prenatal

0.00

2.37

0.0

1.2

—

10.56

—

Other disorders starting during childhood or adolecense, excluding more controls

664

1.39

2.37

1.1

2.29

6.29

u/ml

4.44

397

All influenza

186

1487

1.25

2.36

1.1

4.06

4.37

u/ml

0.12

101

750

MS-disease / Multiple Sclerosis

575

0.60

2.34

1.0

1.1

2.17

3.04

u/ml

0.34

278

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

176

1.77

2.34

1.0

9.65

3.18

u/ml

0.79

Uterine polyps

428

1.48

2.32

1.0

3.23

4.62

u/ml

0.26

179

Malaise and fatigue

359

2462

1.18

2.31

1.1

2.64

4.33

u/ml

2.45

186

1213

Disorders of gallbladder, biliary tract and pancreas

600

4275

0.88

2.30

1.1

3.71

4.00

u/ml

0.16

257

1956

Certain infectious and parasitic diseases

999

4535

1.10

2.30

1.1

4.84

4.29

u/ml

0.42

496

2193

Poisoning by drugs, medicaments and biological substances

168

2105

0.80

2.30

1.1

5.57

4.41

u/ml

0.39

1029

Chronic viral hepatitis

433

0.55

2.29

1.1

3.76

3.32

u/ml

0.07

205

Asymmetry of jaw

120

1.95

2.29

1.1

9.19

4.16

u/ml

0.35

Umbilical hernia

177

1414

1.26

2.28

1.0

1.1

4.58

3.31

u/ml

0.41

643

Other systemic involvement of connective tissue (FG)

162

1264

1.27

2.28

1.1

2.61

3.53

u/ml

0.38

562

Heart failure and coronary heart disease

656

0.69

2.28

1.1

1.0

3.81

3.03

u/ml

0.14

302

Respiratory tuberculosis, not confirmed

2.56

2.27

1.0

1.77

3.14

u/ml

—

Other and unspecified disorders of vitreous body

175

1377

1.26

2.27

1.0

1.92

3.20

u/ml

0.77

595

Malignant neoplasm of respiratory system and intrathoracic organs

318

0.52

2.26

1.0

1.1

0.88

3.07

u/ml

—

154

Fissure and fistula of anal and rectal regions

168

1336

1.26

2.26

1.1

4.55

3.65

u/ml

0.24

629

Leiomyoma of uterus

384

2533

0.86

2.25

1.0

1.1

3.81

3.63

u/ml

0.07

156

1085

Separation of retinal layers (serosa)

171

1.77

2.25

1.1

2.34

3.13

u/ml

0.24

Other disorders of eye and adnexa

123

941

1.31

2.25

1.1

4.84

4.10

u/ml

0.15

444

Rheumatism, unspecified

589

1.40

2.25

1.0

2.40

2.72

u/ml

0.08

250

Budesonide

108

811

1.34

2.25

1.1

1.0

1.49

2.88

u/ml

1.68

356

Pedestrian injured in collision with pedal cycle

142

1.85

2.24

1.0

3.97

2.93

u/ml

0.11

Benign neoplasm: Ascending colon

310

1.55

2.23

1.1

1.51

1.99

u/ml

0.33

144

Hypertensive diseases (excluding secondary)

453

3022

0.87

2.22

1.1

3.99

4.24

u/ml

0.11

225

1386

Contraceptive management

444

2704

1.15

2.22

1.1

3.01

4.56

u/ml

1.48

194

1282

Benign neoplasm: Scapula and long bones of upper limb

2.73

2.22

1.0

1.1

15.74

1.74

u/ml

—

Genitourinary diseases

619

2746

1.13

2.22

1.1

3.95

5.03

u/ml

0.99

300

1462

Diagnoses used for exclusion with ILD

127

978

1.30

2.21

1.1

3.72

2.97

u/ml

0.22

451

Finngen Rheumatological endpoints

803

5065

0.90

2.20

1.1

3.33

4.56

u/ml

1.72

395

2393

Haemangioma and lymphangioma, any site

500

1.43

2.19

1.1

12.21

4.37

u/ml

0.40

242

Haemangioma, any site

442

1.46

2.19

1.1

3.41

4.69

u/ml

0.32

220

Major coronary heart disease event excluding revascularizations

160

1341

0.79

2.19

1.1

1.0

4.87

3.01

u/ml

0.66

595

Trigger finger

677

1.36

2.19

1.1

1.0

2.49

3.47

u/ml

0.39

296

Inflammatory disease of uterus

152

1201

1.27

2.19

1.1

3.89

5.07

u/ml

0.32

557

Noninfectious colitis NAS

109

824

1.33

2.18

1.1

2.51

3.78

u/ml

0.67

407

Fitting and adjustment of other devices

135

946

1.29

2.18

1.1

1.0

3.03

3.02

u/ml

0.00

411

Poisoning by medicine

151

1899

0.79

2.16

1.1

5.87

4.56

u/ml

0.39

933

Diseases of arteries, arterioles and capillaries (FINNGEN)

834

0.74

2.15

1.1

1.0

2.81

2.91

u/ml

0.03

362

Postpartum care and examination

163

1290

0.80

2.14

1.1

5.08

5.74

u/ml

0.17

623

Other systemic involvement of connective tissue

162

1292

1.26

2.14

1.1

2.61

3.62

u/ml

0.43

586

Infections of the skin and subcutaneous tissue

518

4527

1.14

2.14

1.1

5.31

4.29

u/ml

0.65

274

2242

Rotator cuff syndrome

371

2288

1.16

2.14

1.0

1.1

2.50

3.58

u/ml

0.92

173

995

Convergence insufficiency and excess

2.04

2.13

1.3

1.0

3.05

4.00

u/ml

0.15

Lumbar disc prolapse

485

3266

1.14

2.11

1.1

4.33

3.50

u/ml

0.49

236

1499

Herpesviral [herpes simplex] infections

691

1.35

2.10

1.1

12.12

2.80

u/ml

3.15

322

Other/unspecified dorsalgia

272

2272

1.19

2.10

1.1

4.16

3.98

u/ml

0.07

150

1062

Hypertension, essential

536

3430

0.88

2.09

1.1

4.12

3.57

u/ml

0.31

254

1509

Post-traumatic stress disorder

118

910

1.31

2.08

1.1

6.68

4.75

u/ml

0.27

469

Mental retardation, excluding more controls

357

0.54

2.07

1.2

1.1

3.97

6.80

u/ml

—

217

Abrasion of teeth

245

2049

1.20

2.07

1.1

2.66

3.95

u/ml

1.08

126

915

Foreign body in alimentary tract

261

1.58

2.07

1.1

1.0

4.21

4.72

u/ml

0.08

140

Candidiasis

101

762

1.33

2.06

1.1

5.90

3.59

u/ml

0.40

360

Other symptoms and signs involving the circulatory and respiratory systems

253

1.59

2.06

1.1

1.0

1.90

3.12

u/ml

0.48

118

Certain disorders involving the immune mechanism

132

1034

1.28

2.05

1.1

5.09

3.91

u/ml

0.25

481

Unspecified threat to breathing

2.27

2.03

1.1

2.73

5.09

u/ml

—

Polyuria

106

807

1.32

2.03

1.1

1.29

2.88

u/ml

1.77

381

Localized swelling, mass and lump of skin and subcutaneous tissue

216

1790

1.21

2.02

1.1

3.49

4.07

u/ml

0.25

108

849

Otitis media, unspecified

157

1160

1.25

2.00

1.2

1.1

6.16

5.45

u/ml

0.20

103

650

Malignant neoplasm of bronchus and lung, including Hilmo

317

0.55

2.00

1.1

7.51

2.89

u/ml

—

151

Endometriosis ASRM stages 1,2

182

1486

1.23

1.99

1.1

1.43

4.55

u/ml

4.11

684

Other and unspecified polyneuropathies, also in other diseases

535

1.39

1.99

1.1

6.87

2.33

u/ml

0.95

247

Mental and behavioural disorders due to sedatives or hypnotics

464

0.60

1.99

1.1

7.04

3.50

u/ml

0.48

216

Ischaemic heart disease, wide definition

293

2130

0.85

1.98

1.1

3.96

3.17

u/ml

0.37

135

941

Complications predominantly related to the puerperium

273

2317

1.18

1.98

1.1

3.57

4.35

u/ml

0.33

125

1071

Other and unspecified nail disorders

2.05

1.96

1.2

1.0

0.55

2.88

u/ml

—

Other immunodeficiencies

2.23

1.96

1.1

0.94

3.67

u/ml

—

Urethritis and urethral syndrome

2.00

1.96

1.3

1.0

1.77

3.62

u/ml

—

Acute alcohol intoxication, ICD10

101

1316

0.77

1.96

1.1

9.90

3.80

u/ml

1.55

636

Other and unspecified corneal deformities and disorders

149

1.76

1.95

1.0

4.32

2.29

u/ml

0.47

Other benign neoplasms of uterus

1.99

1.95

1.1

1.0

8.58

1.75

u/ml

—

Implicit bacterial Sepsis

126

1380

0.79

1.94

1.1

4.33

3.32

u/ml

0.26

639

Alcoholic liver disease

296

0.50

1.94

1.1

7.66

2.27

u/ml

—

141

Other symptoms and signs involving the digestive system and abdomen

108

831

1.30

1.94

1.1

1.0

2.18

4.06

u/ml

1.10

401

Periapical abscess

257

3030

0.85

1.93

1.1

6.21

4.24

u/ml

0.88

139

1410

Other bacterial intestinal infections

141

1123

1.26

1.93

1.1

5.19

4.14

u/ml

0.12

535

Streptococcal septicaemia

334

0.54

1.92

1.0

1.1

6.23

4.14

u/ml

—

176

Chronic apical periodontitis

879

5478

0.91

1.89

1.1

4.11

4.33

u/ml

0.15

422

2608

Other diseases of liver

120

940

1.28

1.89

1.1

2.01

3.69

u/ml

1.86

426

Excessive earwax

323

2720

1.16

1.89

1.1

2.78

4.32

u/ml

1.81

172

1303

Monoplegia

2.34

1.89

1.0

1.39

4.72

u/ml

—

Disorders of muscles

524

1.38

1.88

1.1

1.0

1.53

3.61

u/ml

2.02

236

Suppurative otitis media, unspecified

166

1.70

1.88

1.0

1.1

12.47

5.39

u/ml

0.44

Other hammer toe(s) (acquired)

389

1.43

1.88

1.1

1.0

2.12

2.70

u/ml

0.23

157

Measles

2.12

1.88

1.1

1.0

10.08

3.13

u/ml

—

Dissection of aorta

0.00

1.87

0.0

1.0

—

3.23

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

403

1.40

1.87

1.1

1.0

5.91

2.24

u/ml

0.79

191

Disorders of orbit

205

1.62

1.86

1.1

1.0

2.58

2.41

u/ml

0.04

Atrial septal defect

339

0.55

1.85

1.1

1.87

7.87

u/ml

—

206

LeFortI or BSSO operation

326

1.49

1.85

1.1

4.98

4.10

u/ml

0.12

153

Impacted teeth

310

2378

1.16

1.85

1.1

5.16

5.33

u/ml

0.06

174

1279

Viral haemorrhagic fevers, not elsewhere classified/unspecified

114

890

1.28

1.84

1.1

5.30

4.33

u/ml

0.19

441

Oter anti-inflammatory and antirheumatic agents, non-steroids

328

1.36

1.84

1.0

1.1

1.58

2.86

u/ml

0.94

157

All influenza (not pneumonia)

121

953

1.27

1.83

1.1

3.90

4.31

u/ml

0.14

473

Coronary atherosclerosis

204

1550

0.83

1.83

1.0

4.98

3.16

u/ml

0.77

680

Implicit viral Sepsis

170

1391

1.22

1.83

1.1

6.16

3.88

u/ml

0.71

668

Single spontaneous delivery

275

1707

0.85

1.83

1.1

5.04

4.65

u/ml

0.13

146

867

Actinic keratosis

518

1.36

1.83

1.0

1.1

3.11

2.31

u/ml

0.20

241

Disorders of thyroid, IBD co-morbidities

177

1018

1.23

1.83

1.1

3.10

3.43

u/ml

0.12

497

Transient ischemic attack

127

1292

0.79

1.82

1.0

1.86

2.79

u/ml

0.67

572

Malignant neoplasm of breast, ER-negative, including Hilmo

850

0.73

1.82

1.0

1.1

4.83

2.67

u/ml

0.53

368

Other abnormal uterine and vaginal bleeding

153

884

1.24

1.81

1.1

5.40

5.14

u/ml

0.05

410

Other viral diseases, not elsewhere classified

192

1590

1.21

1.80

1.1

6.25

4.71

u/ml

0.45

815

Nonorganic sleeping disorders, excluding more controls

197

1640

1.21

1.80

1.1

2.22

4.37

u/ml

1.62

101

796

Perforation of tympanic membrane

546

1.36

1.80

1.1

3.74

3.81

u/ml

0.01

263

Endometriosis of ovary

138

1080

1.25

1.80

1.1

2.16

4.29

u/ml

2.07

492

Acute alcohol intoxication

118

1489

0.79

1.79

1.1

9.49

3.81

u/ml

1.66

704

Maternal care for other known or suspected fetal problems

278

2052

0.85

1.79

1.1

4.28

5.34

u/ml

0.39

123

983

Open wound of wrist and hand

390

3350

1.14

1.78

1.1

6.31

4.06

u/ml

1.16

198

1638

Hypertensive Heart Disease

374

0.63

1.78

1.0

0.38

3.05

u/ml

3.16

163

Major anomalies of jaw size

169

1.67

1.78

1.2

1.0

3.89

4.62

u/ml

0.11

Other arthrosis

324

1941

1.16

1.78

1.1

2.58

3.26

u/ml

0.43

160

821

Thyroiditis, ILD-related definition

104

808

1.29

1.77

1.1

1.0

2.64

3.32

u/ml

0.21

373

Other disorders of breast

104

808

1.29

1.77

1.1

1.44

3.49

u/ml

2.41

360

Covid-19 confirmed case

236

2000

1.18

1.76

1.1

4.37

4.49

u/ml

0.03

124

977

Stenosis and insufficiency of lacrimal passages

362

1.44

1.76

1.1

1.0

9.58

2.72

u/ml

0.89

169

Habitual aborter

201

1.61

1.76

1.1

2.05

2.94

u/ml

0.31

Chronic suppurative otitis media, including avohilmo

480

1.38

1.76

1.1

5.13

3.88

u/ml

0.17

254

Contact with machinery

429

1.40

1.76

1.1

2.00

3.10

u/ml

0.74

208

Concussion

486

3534

1.12

1.75

1.1

5.83

4.35

u/ml

0.63

258

1781

Type1 diabetes, definitions combined, early onset

856

0.73

1.74

1.1

3.37

5.00

u/ml

0.53

462

Malignant neoplasm of breast, HER-negative

732

0.71

1.74

1.0

5.66

2.80

u/ml

0.61

320

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

132

1.75

1.74

1.1

1.0

0.50

2.82

u/ml

—

Unspecified event, undetermined intent

155

1.70

1.74

1.1

5.43

3.68

u/ml

0.20

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

484

0.64

1.73

1.1

3.56

3.06

u/ml

0.06

228

Rheumatoid arthritis, including avohilmo

148

1814

0.81

1.73

1.1

2.84

3.30

u/ml

0.16

811

Antihypertensive medication - note that there are other indications

852

4133

1.09

1.73

1.1

4.82

4.67

u/ml

0.07

414

2076

Other complications of labour and delivery, not elsewhere classified

128

1459

0.80

1.73

1.0

1.1

5.53

5.09

u/ml

0.07

700

Generalized skin eruption due to drugs and medicaments

194

1.61

1.72

1.1

5.13

4.62

u/ml

0.11

Tetralogy of Fallot, a congenital heart defect.

0.00

1.72

0.0

1.1

—

7.28

—

Malignant neoplasm of prostate

378

0.68

1.72

1.0

1.1

1.62

3.01

u/ml

0.67

181

Explicit bacterial Sepsis

458

0.63

1.72

1.0

1.1

11.57

4.23

u/ml

0.47

233

Other complications of surgical and medical care, not elsewhere classified

525

1.36

1.71

1.2

1.0

3.13

3.88

u/ml

0.33

240

malignant neoplasm of female genital organs

491

0.65

1.71

1.0

1.1

9.44

2.89

u/ml

0.55

216

Injuries to the neck

209

1760

1.19

1.70

1.1

3.27

4.67

u/ml

0.93

109

855

Outcome of delivery

181

1346

0.83

1.70

1.0

1.1

2.05

5.73

u/ml

4.14

639

Acne

156

1277

1.23

1.70

1.1

7.65

4.53

u/ml

0.39

696

Infections with a predominantly sexual mode of transmission

352

3082

1.14

1.70

1.1

3.72

4.42

u/ml

0.32

160

1502

Benign neoplasm: Skin of eyelid, including canthus

534

1.35

1.70

1.1

5.53

3.08

u/ml

0.61

235

Focal epilepsy, mode (most common among epilepsy diagnosis)

1073

0.76

1.69

1.1

2.00

3.94

u/ml

1.69

540

Skin changes due to chronic exposure to nonionizing radiation

572

1.32

1.68

1.0

2.86

2.36

u/ml

0.13

266

Disorders of refraction and accommodation

275

2363

1.16

1.68

1.1

7.60

4.76

u/ml

0.47

131

1224

Shoulder lesions

530

2877

1.12

1.67

1.1

2.45

3.83

u/ml

1.57

240

1293

Coxarthrosis [arthrosis of hip](FG)

189

1590

0.84

1.67

1.1

1.84

3.29

u/ml

1.39

670

Hypertensive heart and/or renal disease

440

0.68

1.67

1.1

1.0

0.56

3.01

u/ml

3.15

192

Other reaction to severe stress, and adjustment disorders

392

3467

1.13

1.67

1.1

4.71

4.50

u/ml

0.08

195

1654

Complications associated with artificial fertilization

165

1.66

1.67

1.1

9.77

3.09

u/ml

0.53

Fracture at wrist and hand level

289

2498

1.16

1.66

1.1

7.88

3.90

u/ml

1.71

159

1235

Open wound of hip and thigh

212

1.57

1.66

1.1

3.87

4.03

u/ml

0.02

108

Postdysenteric arthropathy

2.48

1.65

1.2

1.0

3.45

5.09

u/ml

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

142

1.70

1.65

1.1

1.0

2.87

3.81

u/ml

0.18

Foreign body entering into or through eye or natural orifice

486

1.37

1.65

1.0

4.31

4.14

u/ml

0.03

243

Rheumatoid arthritis

129

1430

0.81

1.64

1.1

3.03

3.24

u/ml

0.06

612

Perineal laceration during delivery

182

1817

0.83

1.64

1.1

3.72

4.98

u/ml

0.52

863

Other spirochaetal diseases

188

1574

1.20

1.64

1.1

3.81

3.72

u/ml

0.02

733

Focal epilepsy

100

1269

0.79

1.64

1.1

3.49

4.13

u/ml

0.14

633

Retinal detachments and breaks

140

1139

1.23

1.63

1.1

2.91

3.06

u/ml

0.05

497

Pityriasis lichenoides chronica

3.66

1.63

1.0

1.1

7.31

2.94

u/ml

—

Inflammation of lacrimal passages (acute and unspecified)

2.16

1.62

1.2

1.0

1.78

3.64

u/ml

—

Immunodeficiencies

270

1.49

1.62

1.1

6.29

5.00

u/ml

0.11

134

Impetigo

412

1.40

1.61

1.2

1.1

5.06

4.77

u/ml

0.05

220

Other, unspecified and serous retinal detachments

1.88

1.61

1.0

9.74

2.64

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1042

0.77

1.60

1.1

2.52

3.24

u/ml

0.17

451

Ulcer of vagina/vulva

159

1.65

1.60

1.2

1.0

4.68

5.24

u/ml

—

Pre-eclampsia

138

1685

0.82

1.60

1.1

2.62

4.26

u/ml

0.98

775

Sacrococcygeal disorders, not elsewhere classified

159

1.65

1.60

1.1

2.07

2.26

u/ml

0.06

Melanocytic naevi

239

2049

1.17

1.59

1.1

2.77

4.47

u/ml

1.57

126

978

Erosion of teeth , including avohilmo

251

2161

1.16

1.59

1.1

3.72

4.65

u/ml

0.43

129

1051

Seropositive rheumatoid arthritis

1081

0.77

1.59

1.0

1.1

2.42

3.07

u/ml

0.16

464

Myocardial infarction, strict

106

951

0.79

1.58

1.1

1.0

4.65

3.01

u/ml

0.45

415

Pre-eclampsia or eclampsia

145

1760

0.82

1.58

1.0

1.1

2.51

4.30

u/ml

1.18

808

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

241

2800

0.86

1.58

1.1

4.33

4.31

u/ml

0.01

115

1357

Other predominantly sexually transmitted diseases, not elsewhere classified

262

2265

1.16

1.58

1.1

5.01

4.54

u/ml

0.13

125

1132

Special screening examination for neoplasms

167

1.62

1.58

1.0

0.72

1.45

u/ml

—

Ischemic heart diseases

432

2910

0.89

1.58

1.1

3.65

4.11

u/ml

0.24

191

1328

Tic and related disorders

137

1.71

1.58

1.0

1.1

4.22

7.56

u/ml

0.79

Use of biperiden

222

0.49

1.58

1.0

1.18

2.46

u/ml

—

103

Myocardial infarction

119

1040

0.80

1.57

1.1

1.0

5.21

2.90

u/ml

0.78

453

Benign neoplasm of middle ear and respiratory system

247

1.50

1.57

1.1

1.0

5.48

3.84

u/ml

0.30

116

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

421

3740

1.12

1.56

1.1

7.04

4.48

u/ml

0.78

205

1880

Congenital malformations, deformations and chromosomal abnormalities

624

5411

1.10

1.56

1.1

6.04

4.47

u/ml

0.66

322

2664

Superficial injury of hip and thigh

603

1.31

1.56

1.1

11.47

3.28

u/ml

0.78

287

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

208

0.48

1.56

1.0

1.1

6.39

2.50

u/ml

—

Atrial septal defect, secundum type

271

0.55

1.56

1.1

1.95

7.85

u/ml

—

166

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

1.55

0.0

1.1

—

8.15

—

Obesity

563

4924

1.10

1.55

1.1

5.02

4.32

u/ml

0.27

283

2278

Guttate psoriasis

2.06

1.55

1.1

1.0

1.39

2.14

u/ml

—

Other spirochaetal diseases

192

1621

1.19

1.55

1.1

3.72

3.76

u/ml

0.01

759

Other congenital malformations

105

834

1.27

1.54

1.1

10.51

5.00

u/ml

0.54

440

Arthropod-borne viral fevers and viral haemorrhagic fevers

122

985

1.24

1.54

1.1

4.99

4.19

u/ml

0.17

489

Mycoses

175

1467

1.20

1.53

1.1

5.34

3.84

u/ml

0.41

697

Other specified/unspecified soft tissue disorders

153

1.64

1.53

1.0

4.98

2.94

u/ml

—

Alopecia areata

169

1.61

1.53

1.0

14.93

5.40

u/ml

0.68

Hydatidiform mole

1.85

1.53

1.0

10.36

3.27

u/ml

—

Sequelae of injuries, of poisoning and of other consequences of external causes

171

1431

1.20

1.53

1.1

4.56

3.54

u/ml

0.31

668

Alzheimer disease, excluding more controls

137

0.48

1.52

1.0

0.04

1.80

u/ml

—

Postmenopausal bleeding

115

488

1.26

1.52

1.0

3.06

4.36

u/ml

0.47

203

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

364

3222

1.13

1.52

1.1

6.29

3.99

u/ml

0.50

179

1473

Haemorrhoids and perianal venous thrombosis

158

1310

1.21

1.52

1.0

1.1

3.26

3.32

u/ml

0.01

614

Gingivitis and periodontal diseases

884

4209

1.08

1.51

1.1

3.59

4.44

u/ml

0.51

450

1961

Thyroiditis

417

1.37

1.51

1.1

6.77

3.79

u/ml

0.35

194

Other skin changes

721

1.28

1.51

1.1

1.0

6.42

3.30

u/ml

0.62

340

Sequelae of injuries of upper limb

529

1.33

1.50

1.1

3.34

3.01

u/ml

0.09

246

Chondromalacia

131

1.69

1.50

1.1

1.0

0.83

3.30

u/ml

—

Fracture of lumbar spine and pelvis

723

0.73

1.50

1.1

2.53

2.87

u/ml

0.12

333

Hydronephrosis

454

0.66

1.49

1.1

5.95

3.41

u/ml

0.27

216

Other and unspecified follicular disorders

226

1.52

1.49

1.1

1.0

2.61

3.59

u/ml

0.27

111

Other congenital malformations of circulatory system

116

1.74

1.49

1.2

1.0

4.36

4.56

u/ml

—

Supervision of high-risk pregnancy

220

1545

0.85

1.49

1.1

2.72

5.67

u/ml

2.89

727

Other maternal disorders predominantly related to pregnancy

598

3409

1.10

1.49

1.1

4.39

4.73

u/ml

0.15

265

1587

Gonarthrosis [arthrosis of knee](FG)

389

2542

0.89

1.49

1.1

3.07

3.38

u/ml

0.18

183

1069

Obesity and other hyperalimentation

563

4930

1.10

1.48

1.1

5.02

4.32

u/ml

0.27

283

2283

Immunodeficiency with predominantly antibody defects

147

1.65

1.48

1.1

1.0

10.30

4.66

u/ml

0.35

Malignant neoplasm of prostate, including Hilmo

405

0.72

1.48

1.0

1.1

1.24

2.92

u/ml

1.16

193

Disorders of vestibular function (Vertigo)

242

2057

1.16

1.47

1.1

4.50

3.26

u/ml

0.44

111

925

Mixed conductive and sensorineural hearing loss

351

1.40

1.47

1.1

5.62

2.35

u/ml

0.61

170

Convulsions, not elsewhere classified

154

1819

0.83

1.46

1.1

5.62

4.96

u/ml

0.15

965

False labour

419

2335

1.12

1.46

1.1

4.12

5.27

u/ml

0.59

194

1094

Other superficial mycoses

104

832

1.26

1.46

1.1

4.55

3.55

u/ml

0.29

408

Care involving dialysis

305

0.59

1.46

1.0

1.1

1.37

4.00

u/ml

2.36

157

Congenital malformations of the respiratory system

140

1.66

1.46

1.2

1.1

4.57

8.15

u/ml

0.50

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.90

1.46

1.1

7.08

3.29

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

1049

0.78

1.46

1.0

1.1

2.47

3.23

u/ml

0.19

454

Seropositive rheumatoid arthritis, wide

1071

0.78

1.45

1.0

1.1

2.42

3.27

u/ml

0.22

464

Benign paroxysmal vertigo

143

1183

1.21

1.45

1.0

1.1

3.71

3.24

u/ml

0.10

524

Heart failure and bmi 25plus

612

0.76

1.45

1.1

1.0

2.49

3.32

u/ml

0.20

272

Other abnormal auditory perceptions

2.06

1.45

1.3

1.0

8.29

2.26

u/ml

—

Benign neoplasm: Transverse colon

244

1.48

1.44

1.1

1.0

0.76

2.56

u/ml

2.63

113

Other and unspecified spinal muscular atrophies

3.16

1.44

1.0

1.1

3.32

0.53

u/ml

—

Acute nasopharyngitis (common cold)

739

1.27

1.44

1.1

4.04

3.33

u/ml

0.20

354

Benign neoplasm of eye and adnexa

361

1.39

1.44

1.0

1.1

1.69

3.21

u/ml

0.75

165

Polyarthrosis

518

1.31

1.44

1.1

1.0

1.17

2.67

u/ml

1.53

204

L04AC Interleukin inhibitors

401

0.64

1.44

1.0

5.14

3.47

u/ml

0.20

190

Systemic connective tissue disorders

202

1726

1.17

1.43

1.1

2.22

3.64

u/ml

0.96

100

790

Congenital malformations of cardiac septa

638

0.72

1.43

1.1

6.65

5.90

u/ml

0.13

370

Disorders of other endocrine glands

354

3095

1.13

1.43

1.1

3.29

4.83

u/ml

1.39

183

1560

Other bursopathies

499

1.33

1.42

1.1

2.06

3.65

u/ml

0.98

221

Varicose veins of other sites

295

1.43

1.42

1.0

1.1

1.81

2.98

u/ml

0.72

149

Abnormal findings on diagnostic imaging of central nervous system

262

1.46

1.41

1.0

1.1

3.41

4.28

u/ml

0.18

123

Acute pancreatitis

830

0.76

1.41

1.1

1.0

3.20

u/ml

0.00

378

Basal cell carcinoma, including avohilmo

119

1005

0.81

1.41

1.1

1.0

0.43

2.92

u/ml

9.18

457

Fracture of shoulder and upper arm

170

2006

0.84

1.41

1.1

3.55

4.32

u/ml

0.30

1000

Benign intracranial hypertension

1.81

1.41

1.1

7.26

5.55

u/ml

—

Other disorders of fluid, electrolyte and acid-base balance

1015

0.79

1.40

1.1

2.65

3.68

u/ml

0.36

460

Other disorders of male genital organs

189

1.54

1.40

1.0

1.1

0.56

3.02

u/ml

2.83

107

Enlarged lymph nodes

114

926

1.23

1.40

1.1

10.55

3.52

u/ml

0.81

456

Atrial fibrillation and flutter with reimbursement

702

0.79

1.40

1.0

3.50

2.92

u/ml

0.18

292

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

342

3004

1.13

1.40

1.1

5.27

4.76

u/ml

0.15

185

1501

Adenocarcinoma and papilloma adenocarcinoma of rectum

199

0.50

1.40

1.0

1.1

6.39

2.59

u/ml

—

Cervicobrachial syndrome

150

1253

1.20

1.39

1.1

1.83

3.19

u/ml

1.34

551

Meniscus derangement

370

2219

1.12

1.39

1.1

3.09

3.39

u/ml

0.17

176

956

Nausea and vomiting

187

1560

1.18

1.39

1.1

2.19

5.39

u/ml

3.92

100

810

CR(E)ST syndrome

2.10

1.39

1.1

1.0

0.27

1.88

u/ml

—

Colonic or urogenital fistula

170

1437

1.19

1.39

1.1

4.51

3.43

u/ml

0.31

677

Aplastic and other anaemias

134

1505

0.83

1.38

1.1

3.15

3.74

u/ml

0.28

710

Delivery

286

1720

0.88

1.38

1.1

4.41

4.70

u/ml

0.11

151

874

Cellulitis

159

1337

1.19

1.38

1.1

4.42

3.79

u/ml

0.17

652

Hernia of abdominal wall

262

2291

1.15

1.38

1.0

1.1

4.56

3.76

u/ml

0.30

139

1035

Focal epilepsy, strict definition

1106

0.79

1.38

1.1

2.09

3.99

u/ml

1.73

558

Panniculitis affecting regions of neck and back

166

1.58

1.37

1.1

1.0

10.64

2.25

u/ml

—

Melanoma in situ

1.81

1.37

1.0

0.94

2.21

u/ml

—

Persistent delusional disorders

336

0.62

1.37

1.0

5.51

2.76

u/ml

0.46

157

Other congenital malformations

140

1165

1.21

1.37

1.1

8.44

4.52

u/ml

0.49

594

Parkinson's disease, including avohilmo

249

0.56

1.36

1.0

0.78

2.31

u/ml

—

117

Later onset COPD

189

1.48

1.36

1.0

8.22

1.46

u/ml

0.71

L04AA Selective immunosuppressants

120

1457

0.82

1.36

1.1

4.60

4.26

u/ml

0.08

688

Alzheimer’s disease, strict definition

163

0.50

1.36

1.0

0.04

0.96

u/ml

—

Unspecified fall

357

3140

1.12

1.36

1.1

5.55

4.68

u/ml

0.41

194

1570

Glaucoma-related operations

1.84

1.35

1.0

0.76

2.03

u/ml

—

Gout, idiopatic and unspecified

537

0.71

1.34

1.1

1.0

3.16

2.47

u/ml

0.13

249

Parkinson's disease

235

0.55

1.34

1.0

0.88

2.22

u/ml

—

112

Congenital malformations of the respiratory system

128

1.66

1.34

1.2

1.1

4.85

7.54

u/ml

0.33

Autoimmune diseases

968

5278

0.93

1.34

1.1

3.58

4.71

u/ml

1.46

478

2601

Other/unspecified enthesopathies, not elsewhere classified

324

1.39

1.33

1.2

1.1

3.97

3.19

u/ml

0.13

148

Spontaneous abortion

451

2747

1.11

1.33

1.1

3.24

4.44

u/ml

0.97

205

1260

Mixed disorders of conduct and emotions

319

0.62

1.32

1.1

5.81

5.42

u/ml

—

181

Other diseases of peritoneum

160

1.57

1.32

1.0

4.75

2.35

u/ml

—

Problems related to lifestyle

785

0.76

1.31

1.1

12.91

3.75

u/ml

0.55

380

Sarcoidosis

612

1.28

1.31

1.1

4.87

2.52

u/ml

0.48

269

Fall on same level

998

5827

0.93

1.31

1.1

5.79

4.25

u/ml

1.02

511

2820

Immunodeficiency associated with other major defects

2.87

1.30

1.0

1.2

0.64

9.39

u/ml

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

137

1.61

1.29

1.0

8.03

3.39

u/ml

0.68

Disorders of lens

266

1889

0.88

1.29

1.0

1.1

4.20

3.04

u/ml

0.67

132

818

Non-ischemic cardiomyopathy

632

0.76

1.28

1.1

1.0

3.72

2.63

u/ml

0.18

298

Viral conjunctivitis

260

1.43

1.28

1.1

1.0

4.08

4.62

u/ml

0.07

129

Autonomic disorders

1.73

1.28

1.0

0.37

3.93

u/ml

2.04

Osteopathies and chondropathies

358

2989

1.12

1.27

1.1

3.69

4.40

u/ml

0.35

182

1417

Other shoulder lesions

553

1.29

1.27

1.1

4.74

3.09

u/ml

0.33

256

Viral infections characterized by skin and mucous membrane lesions

324

2889

1.12

1.27

1.1

7.86

4.26

u/ml

1.99

162

1428

Benign neoplasm: Choroid

170

1.54

1.26

1.0

0.23

2.44

u/ml

4.05

Crowding of teeth, including avohilmo

155

1086

1.19

1.25

1.1

6.00

5.75

u/ml

0.07

108

629

Certain conditions originating in the perinatal period

147

1101

1.19

1.25

1.1

7.59

6.06

u/ml

0.41

666

Impingement syndrome of shoulder

121

1003

1.21

1.25

1.1

1.0

2.87

3.09

u/ml

0.09

432

Tic and related disorders

147

1.59

1.25

1.0

1.1

4.22

5.53

u/ml

0.29

Chronic suppurative otitis media

380

1.35

1.25

1.1

5.81

4.69

u/ml

0.12

192

severe traumatic brain injury, does not include concussion

689

0.75

1.25

1.1

5.52

3.09

u/ml

0.61

330

Acute pancreatitis (for exclusion)

813

0.77

1.25

1.1

3.20

3.18

u/ml

0.00

371

Bilateral sagittal split ramus osteotomy operation

270

1.42

1.24

1.2

1.1

6.19

3.57

u/ml

0.34

128

Other congenital malformations of tongue, mouth and pharynx

244

1.45

1.24

1.1

3.46

6.62

u/ml

1.12

165

Syncope and collapse

274

2073

1.13

1.24

1.1

6.00

4.03

u/ml

0.84

138

1008

Other malignant neoplasms of skin (=non-melanoma skin cancer)

119

984

0.83

1.24

1.1

1.0

1.64

2.85

u/ml

0.84

446

Acute generalized exanthematous pustulosis

220

1.46

1.24

1.1

1.0

5.13

5.30

u/ml

0.03

101

Lyme disease

180

1547

1.17

1.23

1.1

3.44

3.56

u/ml

0.03

714

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

207

1798

1.15

1.23

1.1

2.93

3.66

u/ml

0.58

110

852

Unspecified/other endometriosis

104

852

1.23

1.1

2.37

4.90

u/ml

1.27

399

Other acquired deformities of musculoskeletal system and connective tissue

204

1.48

1.22

1.1

15.07

2.64

u/ml

0.92

Digestive system disorders of fetus and newborn

0.00

1.22

0.0

1.2

—

8.59

—

Trigeminal neuralgia

254

1.42

1.22

1.1

0.93

3.13

u/ml

2.17

112

Helminthiases

1.81

1.22

1.1

1.0

4.74

4.03

u/ml

—

Benign neoplasm: Skin of ear and external auricular canal

1.73

1.21

1.0

1.93

3.52

u/ml

—

Biological medication for rheuma

121

1447

0.83

1.21

1.0

1.1

3.23

4.12

u/ml

0.37

695

Other disorders of Eustachian tube

140

1.58

1.20

1.1

1.0

5.14

4.95

u/ml

0.02

Pregnancy, childbirth and the puerperium

216

1295

0.87

1.20

1.1

5.67

4.82

u/ml

0.28

111

666

Juvenile osteochondrosis

272

1.41

1.20

1.1

3.88

5.26

u/ml

0.32

129

Benign neoplasm: Colon

199

1649

1.15

1.19

1.1

1.0

2.22

3.17

u/ml

0.61

731

Other disorders starting during childhood or adolescence

776

1.23

1.19

1.1

3.15

6.04

u/ml

1.62

463

Other congenital malformations of the digestive system

450

1.31

1.19

1.1

5.44

5.92

u/ml

0.09

259

Delivery, wide proxy

246

1485

0.88

1.19

1.1

4.95

u/ml

0.00

127

764

Angina pectoris

155

1212

0.85

1.19

1.1

1.0

1.83

2.66

u/ml

0.49

512

Nonorganic sleeping disorders

197

1712

1.15

1.19

1.1

2.22

5.01

u/ml

2.19

101

838

Synovial cyst of popliteal space [Baker]

222

1.45

1.18

1.2

1.0

1.87

2.93

u/ml

0.40

102

Spirochaetal infections, other/unspecified

181

1563

1.16

1.18

1.1

3.44

3.70

u/ml

0.07

723

Unknown and unspecified causes of morbidity

358

1.35

1.18

1.0

6.47

2.59

u/ml

0.46

165

Exposure to other and unspecified animate mechanical forces

248

1.42

1.18

1.1

12.97

4.82

u/ml

0.29

123

Infectious mononucleosis

121

1012

1.20

1.17

1.1

3.50

4.45

u/ml

0.36

525

Disorders of iron metabolism

1.95

1.17

1.1

1.0

2.36

3.03

u/ml

—

Congenital hypothyroidism without goiter

0.00

1.17

0.0

1.1

—

3.75

—

Leukaemia of unspecified cell type

0.00

1.16

0.0

1.0

—

1.82

—

Extracorporeal dialysis

211

0.57

1.16

1.0

1.1

1.21

3.31

u/ml

—

101

Alcoholic gastritis

0.00

1.16

0.0

1.0

—

1.74

—

Inflammatory disorders of breast

544

1.28

1.16

1.1

3.25

3.58

u/ml

0.06

249

Secondary uncertain malignant neoplasm

357

0.67

1.15

1.1

4.27

3.79

u/ml

0.04

176

Other predominantly sexually transmitted diseases, not elsewhere classified

195

1698

1.15

1.1

4.56

4.59

u/ml

0.01

827

Other infective otitis externa

291

1.38

1.15

1.1

8.78

3.88

u/ml

0.84

141

Cysts of oral region, not elsewhere classified

274

1.39

1.15

1.1

1.0

5.17

3.92

u/ml

0.14

135

Benign neoplasm: Small intestine

1.73

1.15

1.1

1.0

4.73

1.95

u/ml

—

Burn and corrosion confined to eye and adnexa

134

1.58

1.15

1.0

2.27

3.12

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

137

1097

0.85

1.14

1.1

1.0

1.61

2.82

u/ml

0.96

494

Superficial injury of wrist and hand

200

1746

1.15

1.14

1.1

3.29

4.46

u/ml

0.53

101

880

Diseases of inner ear

286

2468

1.12

1.14

1.1

3.83

3.64

u/ml

0.06

133

1109

Symptoms and signs involving cognition, perception, emotional state and behaviour

691

5066

0.93

1.14

1.1

3.31

4.36

u/ml

0.71

356

2375

Glomerular diseases

857

0.79

1.14

1.1

6.67

4.22

u/ml

0.37

421

Other and specified injuries of hip and thigh

1.86

1.13

1.1

1.0

1.64

4.60

u/ml

—

Parkinson's disease, strict definition

197

0.56

1.13

1.0

0.62

2.10

u/ml

—

Viral pneumonia (unknown virus, not influenza)

361

1.34

1.13

1.1

8.20

3.45

u/ml

0.89

175

Necrosis of pulp, including avohilmo

438

4777

0.91

1.13

1.1

5.67

4.06

u/ml

0.85

214

2233

Single delivery by caesarean section

208

1364

0.87

1.13

1.1

3.82

5.17

u/ml

0.49

681

Intestinal adhesions without obstruction

233

1.42

1.12

1.0

1.1

4.80

2.96

u/ml

0.20

118

Other and unspecified injuries of ankle and foot

336

1.35

1.12

1.1

11.17

3.44

u/ml

0.41

172

Coxarthrosis

181

1378

0.87

1.12

1.1

1.32

3.06

u/ml

4.04

571

Other postsurgical states

318

0.66

1.12

1.0

1.1

1.27

5.10

u/ml

—

167

Other noninflammatory disorders of vulva and perineum

600

1.25

1.12

1.1

3.80

4.26

u/ml

0.09

280

Volume depletion

270

0.63

1.11

1.1

11.99

4.12

u/ml

—

133

Oral lichen planus, including avohilmo , including avohilmo

242

1.41

1.11

1.1

1.05

2.26

u/ml

1.40

107

Invasive ventilation

306

0.65

1.11

1.1

9.12

4.92

u/ml

—

163

5-aminosalicylic acid

168

1451

1.16

1.11

1.1

2.05

4.15

u/ml

1.99

668

Other gastritis (incl. Duodenitis)

798

1.22

1.11

1.1

1.0

3.80

3.43

u/ml

0.10

362

Testicular dysfunction

184

1.48

1.11

1.0

1.1

0.60

3.68

u/ml

2.89

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1.79

1.11

1.1

0.85

1.27

u/ml

—

Poor fetal growth

121

1432

0.84

1.10

1.0

1.1

4.24

4.50

u/ml

0.07

672

Other specified disorders of external ear

1.67

1.10

1.0

2.84

1.97

u/ml

—

Use of pramipexole

772

1.22

1.10

1.1

2.33

2.81

u/ml

0.20

345

Generalized epilepsy, strict definition

193

1.46

1.10

1.0

1.1

1.37

7.54

u/ml

3.51

111

160

1.51

1.10

1.1

1.0

23.52

3.21

u/ml

0.83

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

446

0.72

1.10

1.1

3.56

2.29

u/ml

0.23

207

Malignant neoplasm of rectum

207

0.58

1.09

1.2

1.1

5.97

2.46

u/ml

—

Myopia

137

1167

1.18

1.09

1.1

6.11

4.51

u/ml

0.13

579

Tramadol

605

3439

1.08

1.09

1.1

3.02

4.07

u/ml

1.04

298

1587

Major coronary heart disease event

419

2772

0.91

1.09

1.1

3.96

4.11

u/ml

0.06

185

1264

Ulcer of lower limb, not elsewhere classified

340

0.68

1.09

1.2

1.1

6.71

2.51

u/ml

0.56

158

Unstable angina pectoris

647

0.79

1.09

1.0

1.33

2.65

u/ml

0.90

280

Scar conditions and fibrosis of skin

243

0.61

1.08

1.0

9.82

3.25

u/ml

—

111

Septal defects

602

0.76

1.08

1.1

6.65

6.00

u/ml

0.11

344

Peripheral artery operations in Hilmo

231

0.60

1.08

1.1

1.0

0.32

2.24

u/ml

—

112

Osteomyelitis

219

1.42

1.07

1.1

2.58

3.36

u/ml

0.27

103

Female infertility, tubal origin

339

1.33

1.06

1.1

4.56

3.17

u/ml

0.29

138

Other puerperal infections

107

895

1.20

1.06

1.1

6.01

3.98

u/ml

0.40

428

Viral conjunctivitis

137

1.55

1.06

1.1

1.0

6.49

3.65

u/ml

—

Infections of genitourinary tract in pregnancy

759

0.79

1.06

1.1

5.71

5.36

u/ml

0.05

371

Superficial injury of lower leg

204

1795

1.14

1.06

1.1

6.33

4.61

u/ml

0.38

884

Speech and linguistic disorders, excluding more controls

115

911

1.19

1.06

1.1

6.12

5.55

u/ml

0.11

535

Abnormal involuntary movements

668

1.23

1.05

1.1

5.00

3.42

u/ml

0.44

307

452

0.73

1.05

1.1

6.76

6.28

u/ml

0.04

294

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

791

1.21

1.05

1.1

3.15

5.35

u/ml

1.16

470

Long labour

289

2222

1.12

1.05

1.1

5.67

4.54

u/ml

0.18

139

1021

Nontraumatic intracranial haemmorrhage

488

0.74

1.05

1.1

3.50

2.34

u/ml

0.23

226

Non-small cell lung cancer, including Hilmo

239

0.63

1.05

1.1

1.74

2.22

u/ml

—

119

Gout, unspecified

419

0.72

1.05

1.1

3.58

2.08

u/ml

0.23

198

Testicular hypofunction

162

1.49

1.04

1.0

1.1

0.34

3.10

u/ml

—

Feeding problems of newborn

1.71

1.04

1.1

5.09

6.20

u/ml

—

Pyogenic arthritis

237

1.40

1.04

1.2

1.1

1.27

2.54

u/ml

1.08

118

Other and unspecified nerve root and plexus disorders, also in other diseases

129

1099

1.18

1.04

1.0

1.1

3.40

3.04

u/ml

0.12

499

Helminthiases

315

1.34

1.03

1.1

4.49

5.05

u/ml

0.08

155

Postpartum hemorraghe, parous women as controls

298

2285

1.11

1.03

1.1

3.99

4.52

u/ml

0.19

126

1025

Colorectal adenocarcinoma

405

0.71

1.03

1.0

1.1

4.94

2.69

u/ml

0.44

194

All dysplastic lesions of the vagina

138

1.53

1.03

1.0

0.70

3.02

u/ml

—

Sacroiliitis, not elsewhere classified

376

1.31

1.03

1.0

1.1

2.02

3.66

u/ml

1.01

183

Care involving use of rehabilitation procedures

467

3952

1.09

1.03

1.1

4.81

4.22

u/ml

0.24

264

1832

Other appendicitis

464

1.28

1.03

1.1

4.67

2.79

u/ml

0.49

209

Emergency coronary revascularization (for ACS)

408

2713

0.91

1.03

1.1

3.66

4.17

u/ml

0.27

179

1241

Other disorders of veins

245

2172

1.12

1.03

1.1

4.09

3.92

u/ml

0.05

111

952

Disorders of vitreous body

208

1773

1.13

1.02

1.0

1.1

1.89

3.31

u/ml

1.12

765

Tic disorders

147

1.52

1.02

1.0

1.1

3.90

7.27

u/ml

0.81

Viral hepatitis, IBD co-morbidity

404

0.71

1.01

1.1

1.0

3.75

3.01

u/ml

0.13

202

Persons with potential health hazards related to communicable diseases

454

4143

1.09

1.01

1.1

4.90

4.86

u/ml

0.02

230

2122

Burns and corrosions confined to eye and internal organs

155

1.49

1.01

1.1

1.87

3.33

u/ml

0.41

Other disorders of binocular vision

1.67

1.01

1.1

1.0

3.05

4.39

u/ml

—

Benign lipomatous neoplasm

156

1352

1.16

1.01

1.0

1.1

6.27

3.35

u/ml

0.30

620

Maternal care for other conditions predominantly related to pregnancy

260

2285

1.12

1.01

1.1

2.60

4.94

u/ml

1.67

119

1063

Obsessive-compulsive disorder

745

1.21

1.01

1.1

5.15

5.06

u/ml

0.02

384

Puerperal sepsis

699

1.22

1.01

1.1

1.0

3.74

3.45

u/ml

0.07

300

Basal cell carcinoma

111

910

0.84

1.00

1.1

1.0

0.44

2.86

u/ml

7.75

413

Nontoxic goitre/thyroid nodule

137

1177

1.17

1.00

1.0

1.1

1.04

3.23

u/ml

5.32

517

ILD medications: immunosuppressive drugs

468

4008

1.09

1.00

1.0

4.98

3.79

u/ml

0.65

224

1835

Benign neoplasm of bone and articular cartilage

502

1.26

1.00

1.0

3.81

3.76

u/ml

0.01

234

Cramp and spasm

248

1.38

1.00

1.1

1.0

6.30

4.39

u/ml

0.32

122

Other diseases of gallbladder

123

1.55

0.99

1.1

1.0

1.13

2.57

u/ml

—

Other and unspecified disorders of skin and subcutaneous tissue

248

1.38

0.99

1.1

1.0

1.07

3.76

u/ml

1.82

112

Disorders of ocular muscles, binocular movement, accommodation and refraction

444

4053

1.09

0.99

1.1

5.80

4.64

u/ml

0.28

217

2033

Gonarthrosis,primary

390

2627

0.91

0.99

1.1

2.76

3.34

u/ml

0.54

180

1105

Effects of foreign body entering through natural orifice

192

1692

1.14

0.99

1.1

3.70

4.43

u/ml

0.36

101

858

Mixed disorders of conduct and emotions, excluding more controls

296

0.67

0.99

1.1

5.81

5.40

u/ml

—

165

Severe mental retardation

0.00

0.98

0.0

1.2

—

4.92

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

1058

0.83

0.98

1.1

1.97

3.51

u/ml

1.35

511

Diabetes insipidus

0.00

0.98

0.0

1.0

—

1.79

—

Intentional self-harm by jumping from a high place

0.00

0.98

0.0

1.0

—

1.01

—

Radiculopathy

575

1.24

0.98

1.1

1.69

2.29

u/ml

0.38

252

Injury of muscle and tendon at hip and thigh level

486

1.26

0.97

1.1

3.11

3.06

u/ml

0.01

218

Complications of medical and surgical care

509

4335

1.08

0.97

1.1

6.62

3.90

u/ml

0.89

246

1988

Divergent concomitant strabismus

503

0.75

0.97

1.1

4.05

4.96

u/ml

0.23

228

Other sleep disorders

576

1.24

0.97

1.1

1.47

3.31

u/ml

2.23

271

Malignant neoplasm of bone and articular cartilage

0.00

0.97

0.0

1.0

—

2.19

—

Brain glioblastoma

0.00

0.96

0.0

1.0

—

4.36

—

Dental caries, including avohilmo

574

2726

1.08

0.96

1.0

1.1

2.96

4.49

u/ml

1.94

287

1252

Parkinson's disease, excluding more controls

199

0.61

0.96

1.0

0.88

1.69

u/ml

—

Other heart diseases

447

3165

0.92

0.96

1.1

4.13

4.61

u/ml

0.26

227

1517

Cardiomyopathy (excluding other)

388

0.72

0.96

1.2

1.0

4.02

2.65

u/ml

0.19

182

Coeliac disease

777

1.20

0.95

1.0

1.1

6.23

4.01

u/ml

0.54

381

Coronary revascularization (ANGIO or CABG)

398

2656

0.92

0.95

1.1

3.76

4.17

u/ml

0.20

174

1214

Valvular operations

399

0.73

0.95

1.0

1.1

2.16

3.87

u/ml

0.72

201

Other and unspecified visual disturbances

479

1.26

0.94

1.2

1.1

1.09

3.32

u/ml

2.56

220

Sequelae of other external causes

242

1.37

0.94

1.2

1.0

5.76

3.47

u/ml

0.30

115

Zoster [herpes zoster]

259

2294

1.11

0.94

1.1

5.02

3.85

u/ml

0.43

126

1064

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

126

1419

0.86

0.94

1.1

8.46

4.93

u/ml

0.91

763

Viral Sepsis

108

916

1.18

0.94

1.1

8.58

3.87

u/ml

1.18

456

Congenital malformations of the urinary system

443

0.74

0.94

1.0

1.1

15.30

5.35

u/ml

0.86

239

Tuberculosis

1.62

0.93

1.1

1.0

2.08

2.36

u/ml

—

Postpartum haemorrhage due to anatomy

133

1149

1.16

0.93

1.1

5.14

4.63

u/ml

0.09

534

Other/unspecified rheumatoid arthritis

363

0.71

0.93

1.2

1.1

1.17

2.45

u/ml

1.11

164

Retention of urine

856

0.83

0.93

1.1

2.48

3.04

u/ml

0.18

407

405

0.73

0.93

1.1

7.01

6.60

u/ml

0.03

263

Fall on same level involving ice and snow

403

3709

1.09

0.93

1.1

4.67

4.12

u/ml

0.19

205

1768

Percutaneous Coronary Intervention

398

2654

0.92

1.1

3.76

4.17

u/ml

0.20

174

1214

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

610

4179

0.93

0.92

1.1

3.36

3.70

u/ml

0.21

282

1891

Diseases of pulp and periapical tissues, including avohilmo

905

4958

0.94

0.92

1.1

4.27

4.36

u/ml

0.05

460

2408

Pedal cyclist injured in noncollision transport accidents

765

0.81

0.91

1.1

1.99

3.83

u/ml

1.78

368

Medical abortion

593

2999

1.07

0.91

1.1

5.93

4.59

u/ml

0.58

274

1403

Personal history of malignant neoplasm

326

0.70

0.91

1.0

1.1

7.87

3.48

u/ml

0.33

140

Foreign body in ear

102

1.58

0.91

1.1

1.0

13.39

7.03

u/ml

—

Polyneuropathies and other disorders of the peripheral nervous system

699

1.20

0.91

1.1

6.09

2.49

u/ml

0.83

329

Respiratory tuberculosis

1.63

0.91

1.0

2.08

2.40

u/ml

—

Respiratory tuberculosis, confirmed and not-confirmed

1.63

0.91

1.0

2.08

2.40

u/ml

—

Congenital malformations of the urinary system

417

0.74

0.90

1.0

1.1

15.30

5.55

u/ml

0.84

229

Amblyopia ex anopsia

323

1.31

0.90

1.1

17.71

6.46

u/ml

0.40

185

Striae atrophicae

1.71

0.89

1.2

1.0

0.26

2.61

u/ml

—

Other erythematous conditions

135

1.49

0.89

1.1

0.89

5.35

u/ml

—

Mixed hyperlipidaemia

104

0.48

0.89

1.0

1.1

—

2.58

—

Crossbite

100

784

1.18

0.89

1.1

4.46

5.50

u/ml

0.32

461

Implicit viral Sepsis

107

913

1.17

0.88

1.1

7.91

3.86

u/ml

0.98

455

Speech therapy

135

1173

1.15

0.88

1.1

2.76

3.56

u/ml

0.26

543

Melanocytic naevi of other and unspecified parts of face

324

1.30

0.88

1.0

1.1

1.82

4.38

u/ml

1.30

154

Alcohol abuse, main dg, excluding more controls

1012

0.84

0.88

1.1

10.32

3.86

u/ml

1.56

488

Disorders of lacrimal system and orbit in diseases classified elsewhere

111

1.54

0.88

1.1

1.0

0.35

2.20

u/ml

—

Other disorders of choroid

2.01

0.87

1.3

1.0

1.99

3.07

u/ml

—

Sciatica+with lumbago

357

3018

1.09

0.86

1.1

5.81

3.59

u/ml

1.24

176

1363

Use of hypnotics and sedatives

778

4731

0.94

0.86

1.1

3.33

4.17

u/ml

0.74

349

2198

Artrosis, including avohilmo

649

3330

1.07

0.86

1.1

3.55

3.83

u/ml

0.18

296

1500

Other heart diseases, wide

793

5131

0.94

0.86

1.1

3.71

4.28

u/ml

0.50

402

2431

Disorders of vitreous body and globe

213

1833

1.12

0.86

1.0

1.1

1.95

3.40

u/ml

1.21

800

Cardiac murmurs and other cardiac sounds

687

1.20

0.86

1.1

5.08

4.74

u/ml

0.06

359

Pilonidal cyst

780

0.82

0.86

1.1

3.40

3.87

u/ml

0.17

372

Adhesive capsulitis of shoulder

649

1.20

0.86

1.1

1.0

1.83

2.94

u/ml

0.52

275

Campylobacter enteritis

120

1.51

0.85

1.1

1.0

2.80

4.39

u/ml

—

Other epidermal thickening

187

1.40

0.85

1.1

1.0

4.79

3.31

u/ml

0.24

Neuromuscular dysfunction of bladder

326

1.29

0.85

1.1

5.04

2.67

u/ml

0.41

151

Other local infections of skin and subcutaneous tissue

532

1.23

0.84

1.0

1.1

8.82

3.77

u/ml

1.33

257

Other sexually transmitted chlamydial diseases

149

1310

1.14

0.84

1.1

2.68

5.15

u/ml

1.59

701

Covid-19 suspected case

215

1932

1.12

0.84

1.0

1.1

3.50

4.83

u/ml

0.68

116

937

Tumor necrosis factor alpha inhibitors

114

1319

0.86

0.84

1.0

1.1

3.09

3.92

u/ml

0.32

632

Cardiomyopathies, Primary/intrinsic

367

0.73

0.84

1.2

1.0

4.02

2.69

u/ml

0.19

174

Other perinatal digestive system disorders

0.00

0.84

0.0

1.2

—

10.65

—

Cholelithiasis, broad definition with cholecystitis

516

3720

0.93

0.84

1.1

3.70

u/ml

0.00

220

1674

Vascular disorders of the intestines

1.56

0.84

1.1

1.0

0.64

2.26

u/ml

—

Other and unspecified injuries of lower leg

533

1.22

0.84

1.1

3.01

3.86

u/ml

0.27

259

Procreative management

360

2764

1.09

0.84

1.1

5.89

5.13

u/ml

0.18

203

1417

Palmar fascial fibromatosis [Dupuytren]

309

1.30

0.83

1.0

1.1

0.49

3.03

u/ml

3.09

143

Other inflammation of vagina/vulva

301

1.30

0.83

1.0

2.10

4.46

u/ml

1.03

135

Other disorders of conjunctiva

416

1.25

0.83

1.0

1.1

3.52

2.44

u/ml

0.28

183

Other and unspecified epidermal thickening

121

1.50

0.83

1.1

1.0

6.70

4.17

u/ml

0.29

Disorders of eyelid in diseases classified elsewhere

146

1.45

0.82

1.2

1.0

9.47

3.26

u/ml

0.86

Melanocytic naevi, other sites/unspecified

471

1.24

0.82

1.0

1.1

2.89

3.45

u/ml

0.13

215

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

382

3486

1.08

0.82

1.1

6.17

3.89

u/ml

0.51

184

1595

Monoamine oxidase A inhibitors

489

1.23

0.82

1.1

1.0

2.09

2.54

u/ml

0.13

221

Disorders of adult personality and behaviour

249

2740

0.91

0.81

1.1

3.43

4.34

u/ml

0.55

137

1338

Other disorders of binocular movement

172

1.41

0.81

1.2

1.1

3.63

4.49

u/ml

0.15

Systemic sclerosis (FG)

1.61

0.81

1.1

1.0

0.27

3.36

u/ml

—

Congenital absence, atresia and stenosis of large intestine

0.00

0.81

0.0

1.1

—

6.47

—

Oral leukoplakia, including avohilmo

1.61

0.81

1.1

1.0

3.83

2.49

u/ml

—

Non-selective monoamine reuptake inhibitors

193

1665

1.12

0.81

1.1

1.0

2.62

3.28

u/ml

0.33

106

728

Other/unspecified enthesopathies of lower limb, excluding foot

409

1.25

0.81

1.1

2.52

2.72

u/ml

0.06

193

Otitis externa, unspecified

737

1.18

0.80

1.1

1.97

3.56

u/ml

1.46

360

Alcohol abuse, main dg

1002

0.85

0.80

1.1

10.32

3.83

u/ml

1.57

480

Congenital malformations of heart and great arteries

1054

0.85

0.80

1.1

7.10

5.27

u/ml

0.36

578

Mumps

122

1.48

0.80

1.1

1.0

3.93

3.33

u/ml

—

Congenital mitral valve regurgitation

0.00

0.80

0.0

1.1

—

3.69

—

Scleritis and episcleritis

347

1.27

0.80

1.0

1.1

2.18

2.45

u/ml

0.11

157

Anisometropia and aniseikonia

164

1.41

0.80

1.0

3.19

6.39

u/ml

—

Any mental disorder

978

4658

1.05

0.80

1.1

5.00

4.22

u/ml

0.42

494

2193

Other specified/unspecified bacterial intestinal infections

250

1.32

0.80

1.1

1.0

17.51

3.04

u/ml

0.56

122

Sequelae of infectious and parasitic diseases

347

1.27

0.80

1.2

1.0

2.06

2.74

u/ml

0.30

152

Torticollis

106

1.52

0.79

1.1

1.26

4.98

u/ml

—

Alcohol induced polyneuropathy

0.00

0.79

0.0

1.0

—

2.97

—

Cardiovascular diseases

851

4339

1.06

0.79

1.1

3.28

4.97

u/ml

2.44

426

2181

Supervision of normal pregnancy

261

1637

0.91

0.79

1.1

4.41

5.42

u/ml

0.42

114

781

HSIL lesion of the vagina

1.64

0.79

1.0

0.83

2.57

u/ml

—

Other and unspecified local infections of skin and subcutaneous tissue

510

1.22

0.78

1.0

1.1

9.31

3.68

u/ml

1.45

245

Benzodiazepine use

756

5493

0.95

0.78

1.1

3.43

4.42

u/ml

1.05

357

2590

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

385

2624

0.93

0.78

1.1

2.60

4.13

u/ml

1.66

175

1164

Adhesive middle ear disease

1.60

0.78

1.0

1.42

7.03

u/ml

—

Other coagulation defects

474

0.78

1.1

1.09

4.17

u/ml

2.63

224

Other benign neoplasms of connective and other soft tissue

463

0.78

1.1

3.66

3.39

u/ml

0.03

210

Spondylosis

274

2039

1.10

0.78

1.1

1.0

4.34

3.18

u/ml

0.46

115

878

Symptoms and signs involving emotional state

208

1.35

0.78

1.1

3.35

4.47

u/ml

0.34

Family history of malignant neoplasm

814

0.83

0.78

1.1

1.28

3.53

u/ml

2.65

362

Statin medication

587

3511

0.94

0.77

1.1

3.60

3.83

u/ml

0.13

269

1645

Pneumonia due to Streptococcus pneumoniae

165

1.40

0.77

1.0

23.28

2.48

u/ml

0.52

Mixed and other personality disorders

639

0.81

0.77

1.1

4.62

3.25

u/ml

0.25

300

Familial hypercholesterolemia, with ischemic heart disease

123

1.47

0.77

1.0

4.34

2.68

u/ml

—

Other disorders of skin and subcutaneous tissue

366

3509

0.93

0.77

1.1

2.76

4.16

u/ml

1.44

186

1639

Ménière disease

287

1.29

0.77

1.1

5.41

2.63

u/ml

0.27

130

Parkinson's disease, strict definition, excluding more controls

166

0.63

0.76

1.0

0.62

1.87

u/ml

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

594

0.81

0.76

1.0

1.1

1.83

4.44

u/ml

1.73

307

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.76

0.0

1.1

—

2.88

—

Other congenital malformations of the digestive system

392

1.25

0.76

1.1

6.52

6.31

u/ml

0.03

230

Anoxic brain damage

0.00

0.76

0.0

1.0

—

2.78

—

Nail disorders

485

1.22

0.76

1.1

1.0

2.21

3.54

u/ml

0.74

233

Muscle strain

183

1.37

0.76

1.1

1.0

1.16

3.50

u/ml

1.11

L04AX Other immunosuppressants

373

4016

0.93

0.76

1.0

1.1

4.58

4.43

u/ml

0.05

177

1956

Follow-up examination after treatment for malignant neoplasms

233

0.69

0.76

1.0

0.40

1.43

u/ml

—

Anogenital herpesviral [herpes simplex] infection

586

1.20

0.76

1.1

1.0

1.77

3.53

u/ml

1.43

279

Hyperplasia of prostate

117

576

1.15

0.76

1.0

0.73

3.22

u/ml

4.87

267

Other and unspecified mononeuropathies, also in other diseases

1.52

0.75

1.1

1.0

1.83

2.81

u/ml

—

Hypoplasia of dental enamel , including avohilmo

499

0.79

0.75

1.0

1.1

2.01

6.72

u/ml

4.31

312

Nontoxic diffuse goitre

1.54

0.75

1.0

1.31

2.51

u/ml

—

Other specified disorders of muscle

124

1.46

0.75

1.1

1.0

2.17

4.17

u/ml

—

Used for control exclusion in common control thyroid runs

954

5055

0.95

0.75

1.1

3.69

4.78

u/ml

1.26

465

2517

Paralytic ileus

1.54

0.75

1.1

1.0

2.54

2.36

u/ml

—

Pericarditis

124

1.46

0.75

1.2

1.0

8.23

3.79

u/ml

0.44

Other peripheral vertigo

297

1.28

0.75

1.1

4.93

2.42

u/ml

0.37

132

Labour and delivery complicated by umbilical cord complications

403

0.77

0.74

1.0

3.63

2.95

u/ml

0.09

166

Polyarthritis, unspecified

141

1.42

0.74

1.1

2.62

3.07

u/ml

0.14

Lesion of plantar nerve

201

1.35

0.74

1.1

1.0

2.86

2.44

u/ml

0.07

Malignant neoplasm of corpus uteri, including Hilmo

220

0.68

0.74

1.1

1.0

2.83

2.77

u/ml

—

Other disorders of the musculoskeletal system and connective tissue

578

1.20

0.74

1.1

7.71

2.46

u/ml

0.98

256

Cardiac arrhythmias

567

3911

0.94

0.73

1.1

3.39

4.27

u/ml

0.80

284

1841

Other and unspecified erythematous conditions

125

1.45

0.73

1.1

0.79

5.74

u/ml

—

Anxious personality disorder

171

0.64

0.72

1.0

0.68

4.53

u/ml

—

Presbycusis

1.50

0.72

1.0

4.80

0.71

u/ml

—

Drug-induced cataract

1.53

0.72

1.1

1.0

8.36

3.85

u/ml

—

Dilated cardiomyopathy

311

0.74

0.72

1.2

1.0

4.70

2.76

u/ml

0.24

149

Oesophageal obstruction

1.61

0.72

1.2

1.0

9.11

1.50

u/ml

—

Femoral hernia

1.53

0.72

1.0

1.58

2.56

u/ml

—

Endometriosis diagnosis and infertility diagnosis occurring together

979

0.86

0.72

1.1

1.63

3.64

u/ml

1.55

430

Glomerular disorders in diseases classified elsewhere

479

0.79

0.72

1.1

7.18

3.34

u/ml

0.41

235

Glucosamine medication

122

854

1.14

0.72

1.0

2.36

2.66

u/ml

0.14

367

Sleep terrors [night terrors]

1.98

0.72

1.4

1.0

0.49

6.11

u/ml

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

123

1351

0.88

0.72

1.1

8.58

5.05

u/ml

0.89

737

Injury of other and unspecified intrathoracic organs

253

0.71

0.72

1.0

1.1

2.76

2.86

u/ml

—

127

Disorders of mineral metabolism

335

1.26

0.71

1.1

1.42

3.20

u/ml

1.62

158

Azathioprine

1000

0.86

0.71

1.0

1.1

2.46

3.83

u/ml

0.64

478

Heterophoria

636

1.18

0.71

1.1

4.05

4.76

u/ml

0.18

336

Eustachian salpingitis and obstruction

738

1.17

0.71

1.1

3.68

3.92

u/ml

0.06

361

Graves ophthalmopathy

109

1.48

0.71

1.0

0.35

2.78

u/ml

—

Benign neoplasm: Other and unspecified parts of mouth

109

1.47

0.71

1.0

0.31

2.33

u/ml

—

Falls/tendency to fall

1081

5182

1.05

0.71

1.1

5.15

4.25

u/ml

0.54

557

2480

Other abnormal immunological findings in serum

126

1.44

0.70

1.0

1.1

3.28

4.95

u/ml

—

Cutaneous abscess, furuncle and carbuncle

166

1847

0.90

0.70

1.1

4.86

4.56

u/ml

0.07

908

Other and/or unspecified nontoxic goitre

300

1.27

0.70

1.0

0.94

2.42

u/ml

1.27

125

Other anaemias

129

1385

0.88

0.70

1.1

3.13

3.67

u/ml

0.24

652

Varicose veins

263

2163

0.92

0.70

1.0

1.1

2.42

3.18

u/ml

0.54

105

931

Other female pelvic inflammatory diseases

106

925

1.15

0.70

1.1

1.0

3.55

4.46

u/ml

0.20

411

Traumatic subdural haemorrhage

253

0.72

0.70

1.1

8.87

1.72

u/ml

—

118

Primary_lymphoid and hematopoietic malignant neoplasms

783

0.84

0.70

1.1

4.52

3.72

u/ml

0.11

384

Pain associated with micturition

582

1.19

0.70

1.0

1.1

7.48

4.03

u/ml

0.95

282

Placental disorders

1.55

0.70

1.0

4.61

5.27

u/ml

—

Pedal cyclist injured in collision with motor vehicle

195

1.34

0.69

1.1

1.0

3.80

4.69

u/ml

0.15

Other and unspecified anaemias

128

1377

0.88

0.69

1.1

3.13

3.69

u/ml

0.25

648

Supplementary factors related to causes of morbidity and mortality classified elsewhere

235

2149

1.09

0.69

1.1

4.92

4.47

u/ml

0.16

147

1072

Cholelithiasis

497

3643

0.94

0.69

1.1

3.61

3.71

u/ml

0.04

212

1641

Pustular psoriasis

193

0.67

0.69

1.0

1.1

3.57

3.12

u/ml

—

Neuralgia and neuritis, unspecified

230

1.31

0.69

1.0

1.1

6.20

2.78

u/ml

0.28

106

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

241

2618

0.92

0.69

1.1

4.33

4.25

u/ml

0.03

115

1249

Presence of other functional implants

184

1413

0.90

0.69

1.1

1.0

2.80

3.18

u/ml

0.18

629

Calculus of kidney and ureter

140

1246

1.12

0.69

1.1

3.89

3.13

u/ml

0.32

574

Fever of other and unknown origin

429

3575

1.07

0.69

1.1

6.55

4.28

u/ml

0.89

213

1778

Abnormal findings on diagnostic imaging of other body structures

546

1.19

0.69

1.1

5.62

2.60

u/ml

0.65

244

Sexual dysfunction

1.57

0.69

1.0

1.95

2.45

u/ml

—

Colorectal cancer

530

0.81

0.68

1.0

5.26

2.92

u/ml

0.50

243

Other congenital malformations of tongue, mouth and pharynx

195

1.34

0.68

1.2

1.1

4.66

5.93

u/ml

0.26

137

Chronic iridocyclitis

239

0.71

0.68

1.0

1.1

2.57

3.58

u/ml

—

121

Focal brain injury

239

0.71

0.68

1.1

0.49

2.96

u/ml

—

113

Cholecystectomy

436

3523

1.07

0.68

1.1

4.18

3.63

u/ml

0.25

185

1578

Macular hole

1.56

0.68

1.0

0.52

1.07

u/ml

—

Ulcerative colitis (strict definition, require KELA)

110

1251

0.88

0.68

1.1

2.02

3.57

u/ml

1.51

607

Papilloedema, unspecified

127

1.43

0.68

1.0

1.1

12.33

7.23

u/ml

—

Complications of procedures, not elsewhere classified

605

4738

1.06

0.68

1.1

4.98

4.10

u/ml

0.26

285

2193

Collagenous colitis

419

1.22

0.68

1.1

1.54

4.13

u/ml

1.79

200

Fracture of skull and facial bones

124

1399

0.89

0.68

1.1

5.28

3.55

u/ml

0.41

685

Type of accident

216

1971

1.10

0.67

1.1

4.33

4.40

u/ml

0.03

133

971

Other functional intestinal disorders

298

2557

1.08

0.67

1.1

3.56

4.70

u/ml

0.68

148

1288

Viral pneumonia (known virus, not influenza)

102

1.48

0.67

1.1

3.32

5.82

u/ml

—

Second line medication for Crohn's disease

392

4189

0.93

0.67

1.1

4.40

4.32

u/ml

0.03

185

2031

Injuries to the head

920

5910

0.96

0.67

1.1

5.43

4.25

u/ml

0.83

455

2871

Symptoms and signs involving the urinary system

418

3398

0.94

0.67

1.1

3.58

4.19

u/ml

0.36

193

1623

Ankyloglossia

258

1.29

0.67

1.1

3.46

6.51

u/ml

1.07

169

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.64

0.67

1.0

—

2.00

—

Medial epicondylitis

179

1.35

0.67

1.1

1.0

1.08

2.84

u/ml

1.23

Cerebral cysts

393

1.23

0.67

1.2

1.1

4.72

4.10

u/ml

0.10

184

Personality disorders

231

2518

0.92

0.66

1.1

3.03

4.40

u/ml

1.00

129

1223

Delayed milestone in childhood

314

0.76

0.66

1.1

10.29

7.99

u/ml

0.16

218

Other specific arthropathies, wide

1.52

0.66

1.1

1.0

17.48

3.35

u/ml

—

Intestinal malabsorption

232

1.30

0.66

1.0

1.1

2.44

3.53

u/ml

0.28

115

Retinal detachment with retinal break

357

1.23

0.66

1.0

1.1

4.52

2.12

u/ml

0.45

164

Carcinoma in situ of breast, intraductal

294

0.75

0.66

1.0

4.95

2.58

u/ml

—

119

Transient synovitis

1.63

0.66

1.0

6.18

6.80

u/ml

—

Fall on and from ladder

241

1.29

0.65

1.1

1.21

3.25

u/ml

1.26

115

Diabetic nephropathy, excluding more controls

353

0.79

0.65

1.1

7.61

2.76

u/ml

0.64

171

Congenital malformations of breast

180

1.34

0.65

1.1

0.58

5.58

u/ml

2.94

Exclusions for E4_PCOS_BROAD

141

1260

1.12

0.65

1.1

3.30

4.26

u/ml

0.31

632

Tuberculosis, IBD comorbidity

128

1.41

0.65

1.0

3.41

2.33

u/ml

—

Gout, FINNGEN

613

0.83

0.65

1.1

1.0

4.43

2.50

u/ml

0.43

278

Glomerulonephritis

472

0.80

0.65

1.1

5.18

4.09

u/ml

0.12

239

Malignant melanoma of skin, including Hilmo

428

0.79

0.65

1.0

1.1

1.70

2.23

u/ml

0.15

198

Acne vulgaris

116

1026

1.13

0.65

1.1

9.11

4.56

u/ml

0.48

552

Foreign body in respiratory tract

295

1.26

0.65

1.1

1.0

2.99

4.90

u/ml

0.51

157

Inguinal hernia

337

2420

0.93

0.65

1.0

1.1

2.49

3.92

u/ml

1.38

165

1167

Spirochaetal infections, other/unspecified

349

1.24

0.65

1.0

1.1

5.65

3.25

u/ml

0.25

162

Injury of eye and orbit

118

1045

1.13

0.65

1.1

5.69

3.85

u/ml

0.37

511

Malignant neoplasm of bladder

1.61

0.65

1.0

1.1

0.53

1.52

u/ml

—

Pregnancy with abortive outcome

619

3060

1.06

0.64

1.1

4.50

4.53

u/ml

0.01

277

1442

Etanercept

460

0.80

0.64

1.0

1.1

3.97

3.67

u/ml

0.04

213

Benign neoplasm of other and unspecified sites

120

1.42

0.64

1.0

5.59

4.17

u/ml

—

Vitreous haemorrhage

338

0.77

0.64

1.0

1.1

0.37

2.16

u/ml

4.00

171

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

251

1.28

0.64

1.1

1.0

7.72

4.76

u/ml

0.22

127

Specific personality disorders

202

2210

0.91

0.64

1.1

2.76

4.55

u/ml

1.87

112

1068

Noise effects on inner ear

146

1.37

0.64

1.1

0.21

2.87

u/ml

3.39

Other disorders originating in the perinatal period

173

1.35

0.63

1.0

1.1

13.25

7.26

u/ml

0.49

118

Superficial injury of thorax

756

1.15

0.63

1.2

1.1

4.21

3.15

u/ml

0.29

356

Molar incisor enamel hypoplasia

525

0.82

0.63

1.0

1.1

2.31

6.72

u/ml

3.65

331

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

433

1.21

0.63

1.1

6.99

4.25

u/ml

0.37

242

Other misadventures during surgical and medical care

1.53

0.63

1.2

1.1

0.57

3.04

u/ml

—

Emotionally unstable personality disorder

117

1315

0.89

0.62

1.1

3.15

4.53

u/ml

0.84

649

Bacterial pneumonia (organism specified)

228

1899

1.09

0.62

1.1

5.34

3.97

u/ml

0.32

136

890

Ingrowing nail

315

1.24

0.62

1.1

1.0

3.02

4.13

u/ml

0.37

153

Premature rupture of membranes

284

1883

1.08

0.62

1.0

1.1

5.55

5.24

u/ml

0.07

129

893

Gout

538

0.83

0.62

1.1

1.0

4.43

2.11

u/ml

0.55

226

Wide developmental disorders

477

0.81

0.61

1.1

3.57

5.95

u/ml

0.55

287

Coagulation defects, purpura and other haemorrhagic conditions

101

1145

0.88

0.61

1.1

0.91

3.76

u/ml

7.23

558

Pleural effusion

313

0.77

0.61

1.0

1.1

6.84

2.20

u/ml

—

145

Contact with other sharp object(s)

555

0.83

0.61

1.0

1.1

6.10

4.25

u/ml

0.26

272

Dronedarone medication

1.67

0.61

1.0

—

0.78

—

Other benign neoplasms of skin

185

1686

1.10

0.61

1.1

4.06

3.24

u/ml

0.36

764

Acute peritonitis

199

0.70

0.61

1.0

1.1

0.42

3.91

u/ml

—

Complications of anaesthesia during pregnancy

0.00

0.61

0.0

1.1

—

2.90

—

Supernumerary ureter

0.00

0.61

0.0

1.1

—

2.69

—

Gout, strict definition

335

0.78

0.61

1.1

4.12

2.46

u/ml

0.20

157

Subarachnoid haemorrhage

290

0.76

0.61

1.1

5.87

2.62

u/ml

—

135

Bitten or struck by other mammals

103

909

1.14

0.61

1.1

8.94

3.89

u/ml

0.67

425

Deep endometriosis

619

1.17

0.61

1.1

1.29

3.09

u/ml

1.86

281

Reactive arthropathies

471

1.19

0.61

1.0

1.1

4.35

2.68

u/ml

0.38

210

Lupus nephritis

0.00

0.61

0.0

1.0

—

1.99

—

Viral infections of the central nervous system

462

1.19

0.61

1.1

1.0

5.22

4.17

u/ml

0.16

212

Inguinal hernia, bilateral

262

1.26

0.60

1.0

1.1

1.50

2.56

u/ml

0.79

124

Renal tubulo-interstitial disorders in diseases classified elsewhere

0.00

0.60

0.0

1.1

—

2.80

—

Contact with and exposure to communicable diseases

393

3678

1.07

0.60

1.1

5.09

4.91

u/ml

0.06

191

1883

Rash and other nonspecific skin eruption

490

1.19

0.60

1.1

4.49

3.63

u/ml

0.14

242

Open wound of ankle and foot

657

1.16

0.60

1.1

3.20

3.89

u/ml

0.22

325

Adult respiratory distress syndrome

0.00

0.60

0.0

1.0

—

2.48

—

Benign neoplasm: Conjunctiva

122

1.40

0.60

1.0

3.77

3.41

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

657

1.16

0.60

1.0

1.1

1.80

2.77

u/ml

0.93

292

Osteosarcoma, including Hilmo

0.00

0.60

0.0

1.0

—

2.53

—

Tubulo-interstitial nephritis, not specified as acute or chronic

300

0.76

0.60

1.0

1.1

5.40

3.62

u/ml

0.24

140

Vestibular neuronitis

326

1.23

0.59

1.0

1.1

4.56

2.78

u/ml

0.36

147

Residual foreign body in soft tissue

290

1.25

0.59

1.0

5.60

4.48

u/ml

0.08

145

Spinal stenosis

183

1266

1.10

0.59

1.1

1.0

2.29

2.77

u/ml

0.29

531

Other and unspecified mononeuropathies of lower limb

1.45

0.59

1.0

1.38

2.96

u/ml

—

Tuberculosis, wide

131

1.38

0.59

1.0

3.41

2.29

u/ml

—

Intracerebral haemorrhage

243

0.74

0.59

1.1

1.0

4.12

2.06

u/ml

—

113

Fibroblastic disorders

808

1.14

0.59

1.0

0.94

2.98

u/ml

4.65

353

Reactive arthropathies, FINNGEN

409

1.20

0.58

1.0

1.1

2.06

2.84

u/ml

0.32

182

Other mental disorders due to brain damage and dysfunction and to physical disease

254

0.75

0.58

1.1

1.0

1.78

2.70

u/ml

—

118

Episcleritis

300

1.24

0.58

1.1

2.44

2.32

u/ml

0.04

132

Prepatellar bursitis

184

1.31

0.58

1.0

4.07

2.97

u/ml

0.28

Fentanyl

219

0.73

0.58

1.1

1.0

2.27

2.89

u/ml

—

100

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

108

1212

0.89

0.57

1.1

2.02

3.62

u/ml

1.57

590

Sicca syndrome [Sjögren]

364

1.21

0.57

1.0

4.86

3.34

u/ml

0.14

161

Ventricular septal defect, a heart condition

274

0.76

0.57

1.1

7.13

6.98

u/ml

0.02

175

Hydrocephalus

196

0.71

0.57

1.0

3.78

2.78

u/ml

—

100

Event of undetermined intent

447

1.19

0.57

1.1

5.56

3.55

u/ml

0.43

216

Glaucoma

199

1571

1.09

0.57

1.0

1.1

2.64

3.25

u/ml

0.28

707

Disorders of synovium and tendon in diseases classified elsewhere

1.49

0.57

1.0

4.72

2.86

u/ml

—

Pulmonary heart disease

107

951

1.13

0.57

1.1

2.52

3.10

u/ml

0.22

429

Pulmonary embolism

107

951

1.13

0.57

1.1

2.52

3.10

u/ml

0.22

429

Diabetic maculopathy

360

1.21

0.57

1.0

1.1

2.62

3.46

u/ml

0.39

175

ILD medications: azathioprine

978

0.88

0.57

1.0

1.1

2.46

4.12

u/ml

0.82

468

Hidradenitis suppurativa

297

0.77

0.56

1.2

1.1

17.10

4.33

u/ml

0.64

141

Diseases of tongue

229

1.27

0.56

1.1

14.21

5.09

u/ml

0.55

Bursitis of shoulder

1.43

0.56

1.0

0.90

2.96

u/ml

—

Symptoms and signs concerning food and fluid intake

539

1.17

0.56

1.1

2.70

4.38

u/ml

0.57

287

Total colectomy operation

218

0.73

0.56

1.0

1.1

0.91

3.08

u/ml

—

104

Total colectomy

218

0.73

0.56

1.0

1.1

0.91

3.08

u/ml

—

104

Pedestrian injured in transport accident

356

1.21

0.56

1.1

1.0

3.64

3.51

u/ml

0.02

178

Left ventricular outflow tract obstruction, narrow definition

330

0.78

0.56

1.0

1.1

1.66

5.99

u/ml

—

176

Complications of the puerperium, not elsewhere classified

407

0.81

0.56

1.1

1.0

2.17

3.35

u/ml

0.38

180

Viral agents as the cause of diseases classified to other chapters

150

1.34

0.56

1.1

9.66

6.36

u/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

213

2282

0.92

0.56

1.1

4.69

4.24

u/ml

0.14

112

1115

Primary open-angle glaucoma

522

1.17

0.56

1.0

1.22

2.43

u/ml

1.38

240

Dizziness and giddiness

507

3813

1.05

0.56

1.1

3.37

4.39

u/ml

0.48

258

1775

Pedal cyclist injured in transport accident

150

1650

0.91

0.56

1.1

3.04

4.87

u/ml

1.24

818

Other sexually transmitted chlamydial diseases

794

1.14

0.55

1.1

3.44

4.38

u/ml

0.24

403

Peripheral arterial reconstruction

229

0.74

0.55

1.2

1.0

4.22

2.18

u/ml

—

104

Malignant neoplasm of rectum, including Hilmo

274

0.77

0.55

1.1

3.89

2.44

u/ml

—

128

Other keratitis

728

1.14

0.55

1.1

9.95

3.36

u/ml

1.58

342

Diffuse brain injury

183

0.71

0.55

1.1

1.0

2.45

4.03

u/ml

—

Unspecified urinary incontinence

302

1.23

0.55

1.1

3.63

3.93

u/ml

0.04

149

Disturbances of smell and taste

159

1.32

0.55

1.0

4.15

2.88

u/ml

0.20

Fracture of lower leg, including ankle

335

3530

0.94

0.55

1.1

4.14

4.09

u/ml

0.02

174

1673

Speech and linguistic disorders

124

1071

1.11

0.55

1.1

6.33

5.64

u/ml

0.15

632

Inguinal or femoral hernia, bilateral

266

1.24

0.55

1.0

1.1

1.50

2.57

u/ml

0.81

127

Other and unspecified myopathies

251

0.76

0.55

1.0

12.24

3.00

u/ml

0.50

118

Injuries to the elbow and forearm

531

4903

0.95

0.54

1.1

4.75

4.66

u/ml

0.04

275

2417

Achilles tendinitis

477

1.18

0.54

1.1

3.06

2.19

u/ml

0.18

219

Primary hyperparathyroidism

312

1.22

0.54

1.0

3.81

2.32

u/ml

0.25

136

Convergent concomitant strabismus

492

0.83

0.54

1.0

1.1

2.69

4.86

u/ml

1.17

246

Contact with nonpowered hand tool

213

1.27

0.54

1.2

1.0

2.03

3.27

u/ml

0.49

101

Malignant melanoma of skin

306

0.78

0.54

1.0

1.1

2.69

2.60

u/ml

—

144

Emotional disorders starting during childhood or adolecense, excluding more controls

630

1.15

0.54

1.1

4.99

5.52

u/ml

0.13

379

Nontoxic multinodular goitre

683

1.14

0.53

1.1

1.0

0.89

2.90

u/ml

3.27

286

Other/unspecified disorders of vestibular function

125

1.36

0.53

1.1

1.0

0.94

3.49

u/ml

—

Other specified/unspecified hearing loss

249

1.25

0.53

1.1

1.0

1.42

3.67

u/ml

0.92

127

Psoriasis

142

1562

0.91

0.53

1.0

1.1

4.02

3.66

u/ml

0.12

703

Diseases of pulp and periapical tissues and dental caries

506

2460

1.05

0.53

1.0

1.1

3.41

4.42

u/ml

0.87

249

1126

DVT of lower extremities

675

0.86

0.53

1.1

2.93

3.16

u/ml

0.05

291

Benign neoplasm of other and unspecified female genital organs

169

1.31

0.53

1.1

1.0

4.22

2.84

u/ml

—

HSIL lesion of the cervix uteri, vagina or vulva

209

1933

1.08

0.53

1.1

4.40

4.15

u/ml

0.06

893

Tooth agenesis EXCLUDE clefts and syndromes

479

1.17

0.53

1.1

4.92

5.64

u/ml

0.13

267

Spermatocele

169

1.30

0.53

1.0

4.12

2.83

u/ml

—

Fracture of forearm

364

3534

0.94

0.53

1.1

5.16

4.60

u/ml

0.23

188

1711

Neonatal jaundice from other and unspecified causes

272

0.77

0.52

1.2

1.1

11.26

7.74

u/ml

0.22

179

Mandibular retrognathia

627

1.15

0.52

1.1

14.58

4.34

u/ml

0.86

326

Secondary and unspecified malignant neoplasm of lymph nodes

271

0.77

0.52

1.1

4.50

3.49

u/ml

—

131

Leisure time condition

126

1140

1.11

0.51

1.1

2.88

4.09

u/ml

0.62

556

Corns and callosities

248

0.76

0.51

1.1

1.0

2.16

2.80

u/ml

0.31

113

Hypertrichosis

197

1.28

0.51

1.0

2.43

5.33

u/ml

0.96

Astigmatism

489

1.17

0.51

1.0

1.1

15.62

5.42

u/ml

0.43

280

Other and unspecified injuries of wrist and hand

269

1.23

0.51

1.1

2.52

4.21

u/ml

0.74

133

Pustulosis palmaris et plantaris

180

0.72

0.51

1.0

1.1

3.57

3.32

u/ml

—

Allergic purpura

188

1.28

0.51

1.1

1.0

0.95

3.90

u/ml

—

Arthropathic psoriasis

586

0.85

0.51

1.0

1.1

2.69

2.98

u/ml

0.07

259

Convalescence

260

1.23

0.51

1.1

1.0

5.07

3.13

u/ml

0.30

113

Injuries involving multiple body regions

225

0.75

0.51

1.1

0.42

4.08

u/ml

—

116

Benign neoplasm of mouth and pharynx

425

1.18

0.51

1.1

3.99

2.59

u/ml

0.22

195

Caries of dentine, including avohilmo

634

3097

1.05

0.51

1.0

1.1

2.92

4.55

u/ml

2.39

326

1453

Systemic sclerosis, icd10

1.42

0.50

1.1

1.0

0.27

3.16

u/ml

—

Systemic sclerosis

1.42

0.50

1.1

1.0

0.27

3.25

u/ml

—

Congenital malformations of breast

162

1.31

0.50

1.1

0.41

4.59

u/ml

—

Delayed puberty

101

1.40

0.50

1.1

9.40

6.16

u/ml

—

Congenital malformations of aortic and mitral valves

269

0.78

0.50

1.0

1.1

1.87

5.71

u/ml

—

143

Barrett oesophagus

118

1.36

0.50

1.1

0.87

2.69

u/ml

—

Viral meningitis

252

1.24

0.50

1.0

7.05

3.41

u/ml

0.44

122

Other diseases of anus and rectum

142

1293

1.10

0.49

1.1

4.17

3.54

u/ml

0.19

612

Prominent ears

110

1.38

0.49

1.0

10.68

5.82

u/ml

—

Other protozoal intestinal diseases

136

1.33

0.49

1.1

2.78

3.39

u/ml

—

Tongue abnormality

198

1.27

0.49

1.1

1.0

2.82

3.58

u/ml

0.14

Other or ill-defined heart diseases

234

1.24

0.49

1.1

1.0

5.03

4.13

u/ml

0.13

112

Crushed, pushed or stepped on by crowd or human stampede

689

1.14

0.49

1.1

3.98

4.68

u/ml

0.16

353

HSIL lesion of the cervix uteri

199

1845

1.08

0.49

1.1

4.60

4.15

u/ml

0.11

853

Other symptoms and signs involving general sensations and perceptions

167

0.72

0.49

1.2

1.1

1.01

4.34

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

307

1.21

0.49

1.1

1.72

2.15

u/ml

0.18

144

Oligomenorrhoea

280

1.22

0.49

1.0

1.1

2.42

4.08

u/ml

0.52

129

Thoracic aortic aneurysm

353

1.19

0.49

1.0

2.73

2.22

u/ml

0.19

174

Hernia

649

4533

0.96

0.48

1.0

1.1

3.34

4.24

u/ml

0.79

333

2114

Diabetic retinopathy, excluding more controls

525

0.89

0.48

1.0

1.1

4.99

3.45

u/ml

0.40

250

Other and unspecified iron deficiency

185

1710

1.08

0.48

1.1

3.71

4.57

u/ml

0.29

817

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

681

1.13

0.48

1.1

1.27

4.83

u/ml

2.29

306

Persons encountering health services for specific procedures, not carried out

540

1.15

0.48

1.1

4.14

3.72

u/ml

0.09

251

Chalazion

634

1.14

0.47

1.1

1.52

3.35

u/ml

1.89

292

KRA_PSY_EATING, excluding more controls

113

1018

1.11

0.47

1.1

4.74

4.83

u/ml

0.02

526

Scabies

147

1348

1.09

0.47

1.0

1.1

2.96

4.23

u/ml

0.71

689

Gingival hyperplasia

222

0.76

0.47

1.1

0.37

5.48

u/ml

4.49

124

Gastroduodenal ulcer

633

0.87

0.47

1.1

1.0

2.65

3.54

u/ml

0.26

290

Other disorders of bladder

336

1.19

0.47

1.2

1.1

5.09

2.37

u/ml

0.54

171

Dystonia

272

1.22

0.47

1.1

1.0

4.62

3.00

u/ml

0.36

127

Radial styloid tenosynovitis [de Quervain]

364

1.18

0.47

1.1

1.0

1.79

3.43

u/ml

0.76

167

Open bite

607

1.14

0.47

1.1

4.22

4.86

u/ml

0.15

328

Ovarian hyperstimulation (induction)

191

1.27

0.47

1.1

11.24

3.54

u/ml

0.52

Maternal care for known or suspected abnormality of pelvic organs

307

1969

1.06

0.46

1.1

3.10

5.19

u/ml

1.30

143

916

Neoplasms

860

4721

0.96

0.46

1.1

4.22

4.80

u/ml

0.27

411

2380

Obesity, other/unspecified

287

2702

1.06

0.46

1.1

5.66

4.23

u/ml

0.33

137

1271

Fall on and from stairs and steps

156

1436

1.09

0.46

1.1

3.24

3.94

u/ml

0.30

684

GI-bleeding

103

1140

0.90

0.46

1.1

4.51

4.24

u/ml

0.08

554

Acute appendicitis, with complications

993

0.90

0.46

1.1

5.06

3.23

u/ml

0.43

450

Other diseases of the digestive system

103

1140

0.90

0.46

1.1

3.76

4.18

u/ml

0.16

545

Pervasive developmental disorders excl. Autism + Asperger

207

0.76

0.46

1.0

1.1

1.52

6.47

u/ml

—

144

Malignant neoplasm of corpus uteri

165

0.73

0.46

1.1

1.0

3.32

3.02

u/ml

—

Other cataract

143

1180

0.92

0.46

1.0

5.50

3.02

u/ml

1.03

521

Anomalies of pupillary function

129

1.32

0.46

1.1

1.0

9.74

4.84

u/ml

—

Evidence of alcohol involvement determined by blood alcohol level

0.59

0.46

1.0

19.16

6.00

u/ml

—

Multiple delivery

632

0.87

0.45

1.1

1.0

0.47

2.91

u/ml

5.19

292

Hypotension

310

1.19

0.45

1.0

1.1

2.62

2.67

u/ml

0.01

147

Contusion of other and unspecified parts of foot

431

1.16

0.45

1.1

9.94

4.01

u/ml

0.39

225

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

228

1.23

0.45

1.1

1.0

2.24

1.94

u/ml

0.09

103

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

783

5531

0.96

0.45

1.1

4.90

4.34

u/ml

0.32

426

2635

Other maltreatment syndromes

231

0.78

0.45

1.0

1.1

4.47

2.65

u/ml

—

113

Benign neoplasm: Skin of trunk

192

1.25

0.45

1.1

1.0

2.32

3.42

u/ml

0.57

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

122

1335

0.91

0.44

1.0

1.1

2.18

3.62

u/ml

1.46

653

Adalimumab

768

0.88

0.44

1.1

1.31

3.82

u/ml

3.78

358

Certain zoonotic bacterial diseases

121

1.33

0.44

1.3

1.0

9.64

3.23

u/ml

0.42

Inflammatory disease of cervix uteri

247

1.22

0.44

1.2

1.0

1.07

2.11

u/ml

0.94

Premenstrual syndrome

1.38

0.44

1.0

1.1

2.24

4.03

u/ml

—

Other congenital malformations of ear

148

1.29

0.44

1.1

7.64

5.50

u/ml

—

Hirsutism in women

175

1.26

0.43

1.0

2.64

5.70

u/ml

0.93

Lesion of radial nerve

139

1.30

0.43

1.1

1.0

4.18

3.41

u/ml

—

Car occupant injured in other and unspecified transport accidents

166

1538

1.08

0.43

1.1

7.70

4.34

u/ml

0.48

760

Postprocedural disorders of nervous system

629

0.87

0.43

1.1

6.00

3.54

u/ml

0.43

296

Vertical strabismus

166

1.27

0.43

1.0

1.94

3.47

u/ml

0.51

Dislocation, sprain and strain of joints and ligaments of thorax

166

1.27

0.43

1.0

1.82

4.28

u/ml

—

Congenital malformations of great arteries

268

0.80

0.43

1.1

11.97

8.90

u/ml

0.21

174

Other and unspecified disease of Bartholin gland

104

1.35

0.43

1.3

1.0

8.93

2.29

u/ml

—

Other pleural conditions

174

0.75

0.43

1.2

1.0

10.68

2.05

u/ml

—

Primary open-angle glaucoma, strict

441

1.15

0.43

1.0

1.37

2.74

u/ml

1.31

202

Benign neoplasms

949

5066

1.03

0.43

1.1

3.80

4.55

u/ml

0.41

435

2500

Other facial nerve disorders

113

1.33

0.42

1.1

1.0

2.11

2.22

u/ml

—

Urolithiasis

143

1318

1.09

0.42

1.1

3.83

3.22

u/ml

0.25

609

Macular pucker

248

1.21

0.42

1.0

1.1

1.40

2.55

u/ml

0.69

113

Viral warts

688

1.12

0.42

1.1

4.32

3.39

u/ml

0.15

338

Diabetic maculopathy, excluding more controls

564

0.87

0.42

1.0

1.1

2.55

3.61

u/ml

0.83

273

Labour and delivery complicated by fetal stress [distress]

307

2123

0.95

0.42

1.1

6.14

4.69

u/ml

0.25

143

987

Pulmonary artery stenosis

0.00

0.42

0.0

1.2

—

2.65

—

Venous complications and haemorrhoids in pregnancy

184

0.76

0.42

1.1

1.02

4.04

u/ml

—

Injuries to the hip and thigh

235

1999

1.06

0.42

1.1

6.45

3.78

u/ml

0.68

124

957

Other specified and unspecified personality disorders

701

0.88

0.42

1.1

3.06

3.36

u/ml

0.08

332

Disorders of endocrine glands in diseases classified elsewhere

0.00

0.41

0.0

1.1

—

3.44

—

Marasmic kwashiorkor

0.00

0.41

0.0

1.0

—

0.43

—

Osteosarcoma

0.00

0.41

0.0

1.1

—

1.91

—

Hernia of abdominal wall, postoperative

841

1.11

0.41

1.0

5.06

3.66

u/ml

0.26

384

Polyglandular dysfunction

0.00

0.41

0.0

1.0

—

1.65

—

Multiple congenital exostoses

0.00

0.41

0.0

1.0

—

1.63

—

Spina bifida

0.00

0.41

0.0

1.0

—

2.55

—

Haemolytic-uraemic syndrome

0.00

0.41

0.0

1.1

—

8.08

—

Superficial frostbite

1.52

0.41

1.4

1.1

0.35

2.30

u/ml

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.41

0.0

1.1

—

1.74

—

Epileptic seizures related to drugs

0.00

0.41

0.0

1.0

—

2.19

—

Agranulocytosis

488

0.86

0.41

1.1

7.28

3.84

u/ml

0.28

224

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.41

0.0

1.0

—

1.68

—

Conotruncal defects

172

0.75

0.41

1.1

12.29

6.87

u/ml

—

108

Acquired absence of limb

0.00

0.41

0.0

1.1

—

1.08

—

Dislocation of lens

0.00

0.41

0.0

1.1

—

0.80

—

Benign neoplasm: Endocrine pancreas

0.00

0.41

0.0

1.1

—

0.79

—

Bacterial, viral and other infectious agents

614

1.13

0.41

1.1

4.41

4.20

u/ml

0.05

289

Family history of mental and behavioural disorders

0.00

0.41

0.0

1.0

—

2.45

—

Nightmares

0.00

0.41

0.0

1.0

—

8.22

—

Disseminated intravascular coagulation [defibrination syndrome]

0.00

0.41

0.0

1.1

—

3.85

—

Complications of surgical and medical care, not elsewhere classified

715

5068

0.97

0.41

1.1

4.73

4.21

u/ml

0.17

339

2370

Hypertrophic scar

398

1.16

0.41

1.0

1.1

1.83

3.98

u/ml

1.49

192

Tick-borne viral encephalitis

0.00

0.41

0.0

1.0

—

6.30

—

Dermatopolymyositis, unspecified

0.00

0.41

0.0

1.1

—

2.18

—

Antenatal screening

284

1686

0.94

0.40

1.1

4.82

5.41

u/ml

0.21

137

807

Small cell lung cancer

0.00

0.40

0.0

1.1

—

2.42

—

Small cell lung cancer, including Hilmo

0.00

0.40

0.0

1.1

—

2.42

—

Papulosquamous disorders

225

2115

1.06

0.40

1.1

3.23

3.45

u/ml

0.11

116

962

Intracranial injury

435

3936

1.05

0.40

1.1

6.18

4.21

u/ml

0.82

226

1993

Pulmonary heart disease, diseases of pulmonary circulation

114

1043

1.09

0.40

1.1

2.44

3.14

u/ml

0.30

475

Epilepsy

173

1850

0.93

0.40

1.1

3.82

4.46

u/ml

0.17

940

Diseases of liver

178

1660

1.07

0.40

1.1

2.41

3.53

u/ml

0.93

751

Retained placenta and membranes, without haemorrhage

805

1.11

0.40

1.1

4.88

3.40

u/ml

0.24

344

Use of antiglaucoma preparations and miotics

123

1.30

0.40

1.0

1.95

2.07

u/ml

—

Reduction defects of lower limb

0.00

0.40

0.0

1.0

—

1.22

—

Presbyopia

324

1.18

0.40

1.1

7.78

2.74

u/ml

0.52

136

Qualitative platelet defects

0.00

0.40

0.0

1.1

—

6.23

—

Contact with heat and hot substances

352

1.17

0.40

1.0

1.1

12.47

5.04

u/ml

0.82

180

Adrenogenital disorders

0.00

0.40

0.0

1.1

—

5.13

—

Other disorders of optic [2nd] nerve and visual pathways

352

1.17

0.40

1.1

8.03

5.08

u/ml

0.39

184

Unspecified jaundice

141

1.28

0.40

1.1

1.0

0.32

3.96

u/ml

—

Hypo-osmolality and hyponatraemia

452

0.86

0.40

1.1

1.21

4.11

u/ml

2.62

211

Epileptic seizures related to alcohol

0.00

0.40

0.0

1.1

—

4.62

—

Hypothyroidism, drug reimbursement

124

952

0.92

0.40

1.1

3.07

4.30

u/ml

0.58

453

Small cell lung cancer, helper endpoint

0.00

0.40

0.0

1.1

—

2.12

—

Maltreatment syndromes

475

0.86

0.40

1.1

1.0

10.65

3.69

u/ml

0.69

230

1023

0.91

0.39

1.1

8.42

3.83

u/ml

1.07

491

Benign neoplasm of other and unspecified endocrine glands

559

1.13

0.39

1.0

1.1

2.80

3.21

u/ml

0.12

253

Ventral hernia

105

959

1.10

0.39

1.0

1.1

3.66

3.43

u/ml

0.07

426

Chromosomal abnormalities, not elsewhere classified

269

0.81

0.39

1.3

1.1

4.90

6.25

u/ml

0.13

167

Benign neoplasm: Vulva

1.41

0.39

1.1

1.0

2.32

2.75

u/ml

—

Reduction defects of lower limb

0.00

0.39

0.0

1.0

—

1.22

—

Wilms' tumor, including Hilmo

0.00

0.39

0.0

1.3

—

4.86

—

Contusion of toe(s) without damage to nail

187

1.24

0.39

1.1

3.97

4.54

u/ml

—

Chronic myeloproliferative disease

0.00

0.39

0.0

1.1

—

2.88

—

Bacterial pneumonia, not elsewhere classified

202

1668

1.07

0.39

1.1

3.99

4.00

u/ml

0.00

122

774

Unspecified misadventure during surgical and medical care

196

1.23

0.39

1.1

1.0

3.37

3.11

u/ml

0.05

Toxic effects of substances chiefly nonmedicinal as to source

788

1.11

0.39

1.0

1.1

5.17

3.75

u/ml

0.36

393

Alcohol-induced chronic pancreatitis

237

0.80

0.39

1.0

1.1

1.85

2.25

u/ml

0.15

107

Seborrhoeic keratosis

645

1.12

0.39

1.1

1.0

0.69

2.84

u/ml

4.62

284

Corneal ulcer

131

1210

1.08

0.39

1.0

1.1

5.95

3.50

u/ml

0.76

567

Erythema nodosum

133

1.28

0.38

1.1

1.0

0.62

5.11

u/ml

3.10

Use of other anti-dementia drugs

160

0.78

0.38

1.1

1.0

1.74

1.18

u/ml

—

Use of memantine

160

0.78

0.38

1.1

1.0

1.74

1.18

u/ml

—

Bullous disorders

169

1.24

0.38

1.0

13.39

2.68

u/ml

0.85

Undescended testicle

147

0.74

0.38

1.0

1.1

4.10

4.16

u/ml

—

105

Embedded teeth, including avohilmo

113

1038

1.09

0.38

1.1

7.28

4.36

u/ml

0.26

552

Female genital prolapse

167

878

1.08

0.38

1.0

1.1

4.98

4.28

u/ml

0.14

384

Ectopic pregnancy

133

1230

1.08

0.38

1.1

2.94

3.85

u/ml

0.44

547

Multiple gestation

895

0.90

0.38

1.1

0.80

3.80

u/ml

3.05

417

Benign neoplasm: Tonsil

1.39

0.38

1.0

1.1

—

2.60

—

Twin gestation

853

0.90

0.38

1.1

0.75

3.81

u/ml

2.91

392

Psoriatic arthropathies, ICD10

537

0.87

0.38

1.0

1.1

2.67

2.83

u/ml

0.04

241

Ptosis of eyelid

298

1.18

0.38

1.1

3.16

2.35

u/ml

0.18

142

Juvenile arthritis (FINNGEN)

494

0.87

0.38

1.0

1.1

1.88

4.91

u/ml

1.96

260

Impacted cerumen

354

1.16

0.38

1.1

2.58

4.32

u/ml

0.62

186

Other disorders of kidney and ureter

441

0.86

0.38

1.1

5.54

2.93

u/ml

0.33

217

conjunctival haemorrhage

197

1.22

0.37

1.0

1.1

4.76

2.39

u/ml

0.30

Aortic valve malfunction, age under 60 years

483

0.87

0.37

1.0

1.1

2.02

3.21

u/ml

0.57

239

L02BA Anti-estrogens

768

0.90

0.37

1.0

1.1

1.95

2.83

u/ml

0.44

321

Maternal care related to the fetus and amniotic cavity and possible delivery problems

495

2791

1.04

0.37

1.1

4.58

4.82

u/ml

0.10

216

1314

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

308

1.17

0.37

1.1

4.54

2.63

u/ml

0.30

144

Sudden idiopathic hearing loss

336

1.16

0.37

1.0

1.1

8.70

2.55

u/ml

0.96

167

Hypogonadotropic hypogonadism

161

1.25

0.37

1.1

1.0

4.98

2.84

u/ml

—

Enterobiasis

216

1.21

0.37

1.2

1.1

5.47

5.22

u/ml

0.02

114

Nerve, nerve root and plexus disorders

806

4786

1.03

0.37

1.1

3.46

4.11

u/ml

0.61

364

2218

Raynaud syndrome

553

1.12

0.37

1.0

1.1

3.44

2.98

u/ml

0.08

250

Postpartum haemorrhage

298

2386

1.05

0.37

1.1

3.99

4.56

u/ml

0.21

126

1096

Abnormal results of function studies

449

1.14

0.37

1.1

4.68

3.56

u/ml

0.17

214

Carcinoma in situ of skin

125

1.28

0.37

1.0

1.02

1.40

u/ml

0.31

Haemorrhagic and haematological disorders of fetus and newborn

347

0.85

0.36

1.2

1.1

9.41

7.10

u/ml

0.17

226

Mixed specific developmental disorders

336

0.85

0.36

1.1

13.22

7.67

u/ml

0.57

215

Other/unspecified reactive arthropathies

365

1.15

0.36

1.0

1.1

1.66

3.34

u/ml

0.82

176

Viral infections of the central nervous system

412

1.14

0.36

1.1

1.0

5.40

3.64

u/ml

0.30

193

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

1.34

0.36

1.3

1.1

2.38

5.23

u/ml

—

Early lumbar disc prolapse, operated

100

917

1.09

0.36

1.0

1.1

4.37

3.15

u/ml

0.35

425

Juvenile rheumatoid arthirtis

180

1.23

0.36

1.0

1.1

1.16

3.10

u/ml

—

Intestinal stricture

102

1110

0.92

0.36

1.0

1.1

2.68

3.78

u/ml

0.58

509

Melanocytic naevi of lower limb, including hip

263

1.18

0.36

1.0

2.87

3.57

u/ml

0.20

127

Maxillary retrognathism

162

1.24

0.36

1.2

1.0

0.49

5.01

u/ml

—

Familial hypercholesterolemia

328

1.16

0.36

1.0

1.1

3.56

2.61

u/ml

0.29

153

Use of interferon beta-1a

179

0.78

0.36

1.0

2.16

3.16

u/ml

—

Aneurysms, operations, SAH

576

0.88

0.35

1.1

5.19

2.33

u/ml

0.69

264

Obesity due to excess calories

389

3730

1.04

0.35

1.1

5.71

4.27

u/ml

0.48

199

1751

Diabetic retinopathy, strict definition

464

1.12

0.35

1.1

5.07

3.44

u/ml

0.35

225

Early complications of trauma

201

0.79

0.35

1.1

1.0

6.80

3.34

u/ml

—

!Aliquae complicationes praecoces traumatis

201

0.79

0.35

1.1

1.0

6.80

3.34

u/ml

—

6-mercaptopurine

277

0.83

0.35

1.2

1.1

0.73

3.79

u/ml

—

145

Other diseases of arteries and capillaries

319

1.16

0.35

1.0

1.1

4.73

2.90

u/ml

0.19

150

Malignant neoplasm of kidney, except renal pelvis

201

0.80

0.35

1.1

2.88

2.38

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

717

1.10

0.35

1.1

1.23

4.80

u/ml

2.49

326

Osteoporosis

598

1.11

0.35

1.0

1.1

4.95

2.91

u/ml

0.35

283

Bacterial intestinal infections, IBD co-morbidities

755

1.10

0.35

1.1

8.60

3.71

u/ml

0.39

349

Other arrhythmias

475

3448

1.04

0.35

1.1

3.19

4.17

u/ml

0.84

229

1583

Other metabolic disorders

869

0.91

0.35

1.2

1.1

4.58

3.09

u/ml

0.36

394

Psoriatic and enteropathic arthropathies

691

0.90

0.35

1.0

1.1

2.21

3.03

u/ml

0.27

305

Hyperlipidaemia, other/unspecified

106

1059

0.92

0.35

1.1

1.0

3.65

3.03

u/ml

0.16

468

Benign neoplasm: Long bones of lower limb

199

1.21

0.35

1.0

1.1

2.12

3.18

u/ml

—

102

Benign mammary dysplasia

584

1.11

0.35

1.1

1.71

3.68

u/ml

1.26

251

Malignant melanoma, including Hilmo

522

0.88

0.34

1.0

1.1

1.47

2.63

u/ml

0.64

235

Strabismus

194

2052

0.94

0.34

1.1

4.94

4.97

u/ml

0.00

104

1047

Hyperparathyroidism

465

1.13

0.34

1.1

1.0

3.10

3.14

u/ml

0.01

201

Lung diseases due to external agents

348

1.15

0.34

1.1

1.93

2.62

u/ml

0.35

169

Spontaneous rupture of synovium and tendon

264

1.18

0.34

1.0

2.33

2.93

u/ml

—

114

Generalized epilepsy, mode (most common among epilepsy diagnosis)

255

1.18

0.34

1.0

1.1

6.74

5.05

u/ml

0.11

136

Misadventures to patients during surgical and medical care

661

1.11

0.34

1.1

1.85

3.26

u/ml

1.05

308

Other congenital malformations of female genitalia

1.33

0.34

1.0

1.1

1.39

4.37

u/ml

—

Hydrocele

339

1.15

0.34

1.1

0.59

3.15

u/ml

4.14

182

Pain, not elsewhere classified

203

1917

1.06

0.34

1.1

5.14

4.19

u/ml

0.29

921

Mandibular retrognathia AND surgery (BSSO)

209

1.20

0.34

1.2

1.0

7.66

3.27

u/ml

0.46

102

Disorders of speech understanding and production

438

0.87

0.34

1.2

1.1

8.45

6.80

u/ml

0.16

272

Algoneurodystrophy

209

1.20

0.34

1.1

2.74

4.15

u/ml

0.29

102

Maternal care for known or suspected malpresentation of fetus

252

1734

1.05

0.34

1.1

4.42

5.24

u/ml

0.25

120

807

Secondary hypertension

399

0.86

0.34

1.0

1.1

4.61

4.38

u/ml

0.03

202

Acute alcohol intoxication ICD-9

1.32

0.33

1.0

1.1

8.99

2.45

u/ml

—

Anorexia (incl.atypical)

583

0.89

0.33

1.1

7.36

4.85

u/ml

0.33

304

Pediculosis, acariasis and other infestations

160

1501

1.07

0.33

1.0

1.1

3.59

4.20

u/ml

0.26

763

Benign neoplasm of brain and other parts of central nervous system

286

0.84

0.33

1.1

1.03

2.94

u/ml

1.44

141

Open wound of abdomen, lower back and pelvis

191

1.21

0.33

1.1

1.0

7.94

3.84

u/ml

0.32

101

Lesion of ulnar nerve

691

1.10

0.33

1.0

1.1

0.92

3.46

u/ml

4.30

308

Sequelae of injuries of lower limb

529

1.12

0.33

1.1

3.36

3.59

u/ml

0.05

239

Gonarthrosis

350

2082

0.96

0.33

1.1

3.29

3.19

u/ml

0.05

165

872

Obstructed labour due to maternal pelvic abnormality

835

1.09

0.33

1.0

1.1

0.93

2.96

u/ml

4.17

349

Benign neoplasm: Adrenal gland

228

1.19

0.33

1.0

1.1

5.39

2.14

u/ml

—

103

Cholesteatoma of middle ear

155

0.77

0.33

1.0

1.1

19.73

3.52

u/ml

—

Complications of labour and delivery

571

3069

1.03

0.33

1.1

4.91

4.46

u/ml

0.13

264

1440

Respiratory insufficiency

1.32

0.33

1.1

1.0

3.29

1.85

u/ml

—

Conductive and sensorineural hearing loss

390

2739

0.96

0.33

1.1

3.25

3.63

u/ml

0.22

179

1251

Papillary adenocarcinoma of thyroid gland

242

0.82

0.32

1.1

1.60

2.69

u/ml

—

112

Conduction disorders

114

856

1.08

0.32

1.1

2.68

3.44

u/ml

0.37

388

Abnormal weight loss

350

1.14

0.32

1.1

3.32

5.19

u/ml

0.44

178

Cyst of kidney

164

1.22

0.32

1.2

1.0

0.06

2.90

u/ml

—

Congenital malformations and deformations of the musculoskeletal system

983

0.92

0.32

1.1

12.07

5.55

u/ml

0.53

545

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

231

0.82

0.32

1.1

2.58

2.40

u/ml

—

115

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

540

1.11

0.32

1.1

2.83

3.65

u/ml

0.27

259

Scarlet fever

1.34

0.32

1.0

1.1

5.21

4.26

u/ml

—

Crohn's disease NAS

455

0.88

0.32

1.1

5.00

4.13

u/ml

0.17

217

Malignant neoplasm of urinary organs

209

0.81

0.32

1.1

2.88

2.35

u/ml

—

100

Other (seronegative) rheumatoid arthritis, wide

749

0.91

0.32

1.1

2.82

3.54

u/ml

0.21

338

Abnormal findings on examination of urine, without diagnosis

192

1.20

0.32

1.0

0.31

3.49

u/ml

4.38

Family history of other conditions

119

1.27

0.32

1.1

2.68

6.05

u/ml

—

Sequelae of other and unspecified infectious and parasitic diseases

332

1.15

0.32

1.2

1.0

2.20

2.81

u/ml

0.23

145

276

0.85

0.32

1.1

1.0

0.49

1.82

u/ml

1.46

128

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

347

0.86

0.32

1.1

4.63

6.55

u/ml

0.33

201

Viral and other specified intestinal infections

248

2306

1.05

0.32

1.1

6.77

5.33

u/ml

0.35

149

1267

Other bullous disorders

101

1.29

0.31

1.0

20.52

3.53

u/ml

—

Other aneurysm

110

1.27

0.31

1.0

3.18

2.08

u/ml

—

Chronic pancreatitis

412

0.87

0.31

1.0

4.26

2.22

u/ml

0.38

198

Hypertrophic disorders of skin

427

1.13

0.31

1.0

1.80

3.89

u/ml

1.54

206

Other eating disorders

608

1.10

0.31

1.1

2.54

5.52

u/ml

1.21

329

Phlebitis and thrombophlebitis (not including DVT)

111

1031

1.08

0.31

1.1

1.0

4.43

3.33

u/ml

0.30

455

Disorders of parathyroid gland

591

1.10

0.31

1.1

1.0

3.18

3.00

u/ml

0.04

266

Maternal care for known or suspected fetal abnormality and damage

183

1664

0.94

0.31

1.1

5.03

5.14

u/ml

0.02

792

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

258

0.84

0.31

1.0

1.1

9.83

8.08

u/ml

0.12

171

Degeneration of macula and posterior pole

736

0.92

0.31

1.0

0.97

2.25

u/ml

2.25

330

Cardiovascular diseases (excluding rheumatic etc)

774

4572

0.97

0.31

1.1

3.93

4.68

u/ml

0.63

383

2234

Other specified/unspecified inflammatory spondylopathies

324

1.14

0.30

1.1

2.43

3.24

u/ml

0.29

152

Graves disease, strict definition

715

0.91

0.30

1.1

3.41

3.45

u/ml

0.01

322

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

744

1.09

0.30

1.1

1.0

1.69

3.56

u/ml

1.63

316

Secondary polycythaemia

1.34

0.30

1.0

4.36

2.72

u/ml

—

Chronic tubulo-interstitial nephritis

129

1.24

0.30

1.2

1.0

11.11

3.50

u/ml

0.82

Benign neoplasm of thyroid gland

120

1.25

0.30

1.2

1.0

1.20

3.04

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP)

706

1.09

0.30

1.1

1.27

4.51

u/ml

2.02

308

Pneumonia due to other infectious organisms, not elsewhere classified

111

1.26

0.30

1.1

1.0

1.14

2.64

u/ml

—

Superficial injury of ankle and foot

120

1121

1.07

0.30

1.1

7.76

4.27

u/ml

0.44

576

Foreign body or object entering through skin

391

1.13

0.30

1.1

1.83

4.16

u/ml

1.55

188

Disorder of lipoprotein metabolism, unspecified

306

1.14

0.29

1.0

3.26

2.09

u/ml

0.22

142

Failed induction of labour

713

0.91

0.29

1.1

3.80

4.27

u/ml

0.07

338

Iron deficiency anaemia

222

2083

1.05

0.29

1.1

3.35

4.52

u/ml

0.53

114

991

All dysplastic lesions of the cervix uteri

280

2660

1.04

0.29

1.1

3.80

4.40

u/ml

0.20

119

1216

Zoster [herpes zoster]

640

0.91

0.29

1.1

4.39

2.51

u/ml

0.68

296

Polycystic ovarian syndrome, broad definition

142

1336

1.06

0.29

1.0

1.1

5.70

4.82

u/ml

0.17

644

Congenital malformations and deformations of the musculoskeletal system

110

1172

0.93

0.29

1.0

1.1

11.22

5.02

u/ml

0.61

649

Foreign body on external eye

919

1.08

0.29

1.0

1.1

2.85

4.06

u/ml

0.69

455

Crohn disease (strict definition, require KELA)

506

1.11

0.29

1.0

1.1

2.93

3.72

u/ml

0.24

240

Other ulcerative colitis

392

1.12

0.29

1.1

1.20

3.62

u/ml

2.74

192

Examination and encounter for administrative purposes

139

1.22

0.29

1.2

1.0

1.14

2.78

u/ml

—

Weight loss

430

1.12

0.29

1.1

3.62

5.14

u/ml

0.37

221

Primary gonarthrosis, bilateral

171

1385

1.06

0.29

1.1

2.21

3.12

u/ml

0.75

577

Open wound of head

320

3207

0.96

0.29

1.1

6.33

4.31

u/ml

1.00

160

1597

Anosmia

1.28

0.28

1.0

1.1

1.52

2.03

u/ml

—

Caught, crushed, jammed or pinched in or between objects

345

1.13

0.28

1.1

5.88

4.71

u/ml

0.14

166

Nephrotic syndrome

173

0.81

0.28

1.0

1.1

0.44

5.51

u/ml

—

104

Psoriasis (vulgaris), strict definition

173

0.81

0.28

1.1

1.0

11.00

2.30

u/ml

—

Endocrine, nutritional and metabolic diseases

911

4505

1.02

0.28

1.1

3.82

4.84

u/ml

1.17

450

2217

Superficial injuries involving multiple body regions

151

0.79

0.28

1.1

0.49

4.03

u/ml

—

Benign neoplasm of meninges

298

1.14

0.28

1.0

1.1

8.77

2.30

u/ml

—

130

Benign neoplasm: Parotid gland

251

1.16

0.28

1.0

4.38

3.06

u/ml

—

116

Ulcerative colitis

167

1763

0.95

0.28

1.1

2.27

4.30

u/ml

1.79

871

Myeloproliferative diseases

216

0.83

0.28

1.1

1.0

1.59

2.32

u/ml

—

Other noninflammatory disorders of cervix uteri

158

1.20

0.28

1.0

2.66

3.25

u/ml

—

Antepartum haemorrhage, not elsewhere classified

918

0.92

0.28

1.1

4.17

4.04

u/ml

0.03

430

Benign neoplasm: Rectum, anus and anal canal

536

1.10

0.28

1.0

1.1

2.74

2.51

u/ml

0.05

251

Contact with other hot fluids

214

1.17

0.28

1.0

1.1

12.62

5.37

u/ml

0.58

112

Other noninflammatory disorders of uterus, except cervix

535

1.08

0.27

1.1

1.0

1.90

4.45

u/ml

1.57

221

Other hearing loss

713

1.08

0.27

1.0

5.75

3.34

u/ml

0.63

340

Other psoriatic arthropathies

522

0.90

0.27

1.0

1.1

2.67

2.58

u/ml

0.02

233

Inflammatory diseases of the central nervous system

459

0.89

0.27

1.0

1.1

6.73

3.81

u/ml

0.35

213

Pneumonitis due to solids and liquids

183

0.82

0.27

1.1

1.22

2.66

u/ml

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

417

0.89

0.27

1.1

1.96

2.79

u/ml

0.31

190

Methotrexate

616

0.91

0.27

1.0

4.70

2.76

u/ml

0.30

260

Endometriosis ASRM stages 3,4

170

1613

1.05

0.27

1.1

1.85

4.11

u/ml

2.60

729

Carbimazole or st.post thyroidectomy, condition for graves disease

121

1288

0.94

0.27

1.1

2.51

3.36

u/ml

0.36

580

Myocarditis

252

1.15

0.27

1.2

1.0

1.14

2.62

u/ml

1.22

114

Influenza and pneumonia

940

5845

1.02

0.27

1.1

4.97

4.33

u/ml

0.44

515

2783

Myocardial infarction, unclassifiable

268

0.87

0.26

1.2

1.1

8.03

2.93

u/ml

0.63

131

234

1.16

0.26

1.1

0.93

6.29

u/ml

4.24

134

Injuries to the shoulder and upper arm

567

4695

0.97

0.26

1.1

3.22

4.32

u/ml

1.30

279

2274

Crohn disease (strict definition, require KELA, min 2 HDR)

500

1.10

0.26

1.0

1.1

3.05

3.61

u/ml

0.15

238

Assault

114

1214

0.94

0.26

1.1

9.56

3.43

u/ml

1.42

598

Traumatic subarachnoid haemorrhage

1.27

0.26

1.0

1.1

8.92

2.50

u/ml

—

Other bacterial intestinal infections

760

1.08

0.26

1.1

8.44

3.13

u/ml

0.42

364

Myositis

1.28

0.26

1.0

1.10

2.73

u/ml

—

Myocardial infarction, with ST-elevation

310

0.87

0.26

1.1

1.0

0.85

2.11

u/ml

—

148

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

499

0.90

0.26

1.2

1.1

3.75

3.99

u/ml

0.04

244

Infections of breast associated with childbirth

348

1.12

0.26

1.1

1.0

1.72

4.08

u/ml

1.18

159

Drug-induced neutropenia

246

0.85

0.26

1.0

3.15

2.76

u/ml

—

107

Hemiplegia

203

0.84

0.26

1.1

1.0

4.13

2.54

u/ml

0.21

100

Benign neoplasm of major salivary glands

310

1.13

0.26

1.0

1.1

3.54

3.59

u/ml

0.01

145

Medical treatment for female infertility

250

2385

1.04

0.26

1.1

3.68

4.10

u/ml

0.15

114

1068

Malignant neoplasm of thyroid gland

320

0.87

0.25

1.0

1.1

1.70

2.66

u/ml

0.52

147

Benign neoplasm: Rectum

453

1.10

0.25

1.0

1.1

2.98

2.53

u/ml

0.09

216

Rubella [German measles]

138

0.80

0.25

1.1

1.0

0.41

3.27

u/ml

—

Generalized epilepsy

358

1.12

0.25

1.1

4.93

6.30

u/ml

0.13

183

Ankylosing spondylitis, strict definition

309

0.87

0.25

1.0

2.29

3.18

u/ml

0.39

143

Other secondary gonarthrosis

160

1.19

0.25

1.0

1.1

1.78

2.86

u/ml

0.52

Pathological resorption of teeth

181

0.83

0.25

1.0

3.15

3.98

u/ml

—

Other symptoms and signs involving cognitive functions and awareness

169

1617

0.95

0.25

1.1

2.43

3.34

u/ml

0.45

741

Phobic anxiety disorders

152

1440

1.06

0.25

1.1

4.97

4.66

u/ml

0.07

745

Other disorders of breast and lactation associated with childbirth

179

1.18

0.25

1.1

1.21

4.05

u/ml

1.73

Artificial opening status

213

0.84

0.25

1.1

2.06

5.28

u/ml

0.92

113

Non-Hodgkin lymphoma, all, including Hilmo

340

0.88

0.24

1.0

1.1

7.13

2.93

u/ml

0.25

168

Benign neoplasm: Skin of other and unspecified parts of face

361

0.89

0.24

1.1

2.52

3.12

u/ml

0.19

169

Missing teeth due to accident, extraction or parodontitis

250

2450

0.96

0.24

1.1

3.80

3.41

u/ml

0.19

129

1101

Cholecystitis

416

1.11

0.24

1.1

4.32

2.53

u/ml

0.32

192

Ulcer of oesophagus

142

1.20

0.24

1.1

1.96

2.02

u/ml

—

AV-block

344

0.89

0.24

1.1

1.0

0.77

2.24

u/ml

2.77

167

Crohn disease (strict definition, all UC cases excluded)

388

1.11

0.24

1.0

1.1

2.87

3.99

u/ml

0.27

184

Ankylosing spondylitis

503

1.09

0.24

1.0

1.1

2.07

2.64

u/ml

0.35

236

Hordeolum and other deep inflammation of eyelid

369

1.11

0.24

1.1

5.52

4.08

u/ml

0.16

189

Specific development disorders of speech and language

633

1.08

0.24

1.1

4.82

6.29

u/ml

0.31

386

Dislocation, sprain and strain of joints and ligaments of head

339

0.88

0.24

1.1

1.0

9.52

4.64

u/ml

—

163

Sulfasalazine

168

1601

1.05

0.24

1.0

1.1

3.10

3.25

u/ml

0.06

699

Tooth eruption problems

202

1886

1.05

0.24

1.1

5.22

5.11

u/ml

0.01

118

1053

Other abnormal findings of blood chemistry

208

1.16

0.24

1.0

1.1

8.54

3.16

u/ml

0.57

100

Exposure to other and unspecified inanimate mechanical forces

494

1.09

0.24

1.1

4.46

3.78

u/ml

0.14

248

Pregnancy hypertension

381

3519

0.97

0.24

1.1

2.22

4.44

u/ml

4.46

163

1578

Other specified/unspecified arthritis

171

1631

1.05

0.24

1.1

4.64

3.86

u/ml

0.25

751

Other disorders of amniotic fluid and membranes

166

1545

1.05

0.23

1.1

6.06

4.83

u/ml

0.28

735

Hyperprolactinaemia

284

1.13

0.23

1.1

0.76

4.54

u/ml

3.48

126

Postpartum haemorrhage due to retained placenta

131

1241

1.06

0.23

1.0

1.1

4.93

4.71

u/ml

0.04

555

Assault by bodily force

703

0.92

0.23

1.1

8.65

3.41

u/ml

0.83

344

Car occupant injured in noncollision transport accident

254

0.86

0.23

1.2

1.1

8.24

3.86

u/ml

0.34

127

Scoliosis

651

0.92

0.23

1.0

1.1

5.42

4.52

u/ml

0.16

345

Abnormalities of forces of labour

901

1.07

0.23

1.1

5.64

3.63

u/ml

0.35

386

Other condition

901

1.07

0.23

1.1

5.70

3.71

u/ml

0.61

419

Wide developmental disorders, excluding more controls

425

0.90

0.23

1.1

3.57

6.15

u/ml

0.60

254

Cerebral palsy and other paralytic syndromes

609

0.92

0.23

1.0

1.1

4.35

3.88

u/ml

0.08

293

Disorders of optic nerve and visual pathways

630

1.08

0.23

1.1

5.60

4.11

u/ml

0.32

316

Other specified/unspecified systemic involvement of connective tissue

275

1.13

0.23

1.1

5.28

3.03

u/ml

0.24

126

Excessive vomiting in pregnancy

756

1.07

0.23

1.1

1.49

4.37

u/ml

2.13

352

Thrombocytopenia, unspecified

285

0.88

0.23

1.0

1.1

0.72

3.52

u/ml

3.79

149

Benign neoplasm of breast

611

1.08

0.23

1.1

2.09

3.28

u/ml

0.51

272

Malignant neoplasm of endocrine gland

348

0.89

0.23

1.0

1.1

1.71

2.89

u/ml

0.77

167

Sequelae of external causes of morbidity and mortality

122

1155

1.06

0.22

1.1

3.61

3.68

u/ml

0.02

539

Implicit fungal Sepsis

228

1.14

0.22

1.2

1.0

1.24

3.65

u/ml

1.46

103

Colectomy operation

494

0.91

0.22

1.0

1.1

0.70

3.00

u/ml

3.79

235

Dissociative [conversion] disorders

337

0.89

0.22

1.1

6.77

5.02

u/ml

0.13

165

Polycystic ovarian syndrome

670

1.08

0.22

1.0

1.1

3.15

5.72

u/ml

1.03

333

Special screening examination for other diseases and disorders

650

1.08

0.22

1.2

1.0

3.59

4.01

u/ml

0.11

295

Other infectious diseases

368

0.90

0.22

1.1

1.99

3.50

u/ml

0.90

182

Crohn's disease of small intestine

516

1.09

0.22

1.0

1.1

2.88

4.23

u/ml

0.47

243

Burkitt lymphoma

0.00

0.22

0.0

1.2

—

4.85

—

Burkitt lymphoma, helper endpoint

0.00

0.22

0.0

1.2

—

4.85

—

Burkitt lymphoma, including Hilmo

0.00

0.22

0.0

1.2

—

4.85

—

Other diseases of pancreas

231

0.86

0.22

1.0

1.34

2.56

u/ml

—

111

Transient global amnesia

191

1.15

0.21

1.0

2.77

2.03

u/ml

—

Congenital absence of the vagina

0.00

0.21

0.0

1.0

—

11.50

—

Whooping cough

107

1.22

0.21

1.2

1.1

2.07

4.54

u/ml

—

Lumbosacral spina bifida and hydrocephalus

0.00

0.21

0.0

1.0

—

2.00

—

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.21

0.0

1.0

—

0.60

—

Fungal Sepsis

124

0.81

0.21

1.4

1.0

1.68

3.21

u/ml

—

Mental and behavioural disorders due to tobacco

430

0.91

0.21

1.1

13.90

3.25

u/ml

1.02

193

Other leukaemias of specified cell type

0.00

0.21

0.0

1.0

—

0.57

—

Other parasitologically confirmed or unspecified malaria

0.00

0.21

0.0

1.0

—

2.70

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

2.01

—

Personality disorders, excluding more controls

231

2396

0.96

0.21

1.1

3.03

4.25

u/ml

0.91

129

1142

Chondrosarcoma, including Hilmo

0.00

0.21

0.0

1.0

—

4.68

—

Purulent endophthalmitis

0.00

0.21

0.0

1.1

—

5.75

—

Malignant neoplasm of nasal cavity and sinuses

0.00

0.21

0.0

1.0

—

3.03

—

Drug-induced dystonia

0.00

0.21

0.0

1.0

—

0.94

—

Traumatic cerebral oedema

0.00

0.21

0.0

1.0

—

4.86

—

Hereditary hypogammaglobulinemia

0.00

0.21

0.0

1.0

—

0.94

—

Hypersplenism

0.00

0.21

0.0

1.0

—

1.06

—

Typhoid and paratyphoid fevers

0.00

0.21

0.0

1.1

—

1.54

—

Mucosal proctocolitis

946

0.94

0.21

1.1

2.45

3.77

u/ml

0.66

454

Malignant melanoma

419

0.91

0.21

1.0

1.1

1.81

2.23

u/ml

0.15

189

Profound mental retardation

0.00

0.21

0.0

1.1

—

3.50

—

Benign lipomatous neoplasm of other sites/unspecified

239

1.13

0.21

1.0

34.73

2.81

u/ml

—

109

Labyrinthitis

0.00

0.21

0.0

1.0

—

1.60

—

Other primary thrombocytopenia

0.00

0.21

0.0

1.1

—

0.97

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

0.00

0.21

0.0

1.0

—

4.17

—

Neuroendocrine tumor and carcinoma of lung

0.00

0.21

0.0

1.1

—

3.22

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

0.21

0.0

1.1

—

3.37

—

Unattended death

0.00

0.21

0.0

1.1

—

2.42

—

Other drug-induced secondary parkinsonism

0.00

0.21

0.0

1.1

—

4.91

—

Male infertility

354

1.10

0.21

1.1

0.88

4.41

u/ml

3.98

188

Bulimia nervosa (incl. atypical)

383

1.10

0.20

1.1

3.63

3.52

u/ml

0.02

177

Superficial injury of forearm

760

1.07

0.20

1.1

3.32

4.03

u/ml

0.22

383

Congenital malformations of the nervous system

219

0.86

0.20

1.0

1.1

8.01

8.13

u/ml

0.01

124

Other diseases of pericardium

134

0.82

0.20

1.1

1.0

11.67

3.74

u/ml

—

Other and unspecified psoriasis

249

1.13

0.20

1.1

1.91

2.76

u/ml

—

114

Exposure to smoke, fire and flames

117

1.20

0.20

1.1

12.85

3.19

u/ml

—

Multiple congenital exostoses

0.00

0.20

0.0

1.0

—

1.63

—

Other strabismus

180

1867

0.96

0.20

1.1

5.36

4.80

u/ml

0.10

958

Hypertrophy of bone

0.00

0.20

0.0

1.1

—

1.58

—

Pediculosis and phthiriasis

0.00

0.20

0.0

1.1

—

5.70

—

Acanthosis nigricans

0.00

0.20

0.0

1.0

—

0.40

—

Cholangitis (primary sclerosing, PSC)

240

0.87

0.20

1.0

1.1

1.99

4.40

u/ml

1.15

129

LSIL lesion of the cervix uteri, vagina or vulva

122

1282

0.95

0.20

1.0

1.1

1.15

4.18

u/ml

3.95

574

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

0.00

0.20

0.0

1.1

—

4.05

—

Blindness or visual impairment, binocular

0.00

0.20

0.0

1.0

—

2.44

—

Colitis due to radiation

0.00

0.20

0.0

1.1

—

2.87

—

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.20

0.0

1.1

—

6.70

—

Endometriosis of intestine

136

1.18

0.20

1.1

1.0

4.48

3.17

u/ml

—

Ovarian dysfunction

839

1.06

0.20

1.1

3.30

5.21

u/ml

0.73

404

Frostbite

1.23

0.20

1.3

1.0

0.32

1.64

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

742

1.07

0.20

1.1

1.23

4.46

u/ml

2.15

326

Placenta praevia

469

0.91

0.20

1.0

1.1

2.28

3.96

u/ml

0.41

215

Non-follicular lymphoma

229

0.87

0.20

1.0

1.1

15.35

2.57

u/ml

—

110

Infections, IBD-co-morbidities

108

731

1.06

0.19

1.1

7.47

3.93

u/ml

0.34

363

Hyperfunction of pituitary gland

396

0.91

0.19

1.1

0.76

4.17

u/ml

4.65

191

Essential (haemorrhagic) thrombocythaemia

1.21

0.19

1.1

1.0

1.58

3.10

u/ml

—

Hyperhidrosis

212

1.13

0.19

1.1

1.0

1.80

4.11

u/ml

0.96

Abscess of anal and rectal regions

510

0.92

0.19

1.0

1.1

1.92

3.54

u/ml

1.23

247

Sequelae of injuries of neck and trunk

133

0.83

0.19

1.0

1.1

0.49

2.35

u/ml

—

Assault by unspecified means

165

1.16

0.19

1.1

10.26

3.47

u/ml

0.41

Other and unspecified acne

118

1.19

0.19

1.0

1.62

5.95

u/ml

—

Benign neoplasm of colon, rectum, anus and anal canal

241

2023

1.03

0.19

1.1

2.34

3.24

u/ml

0.59

101

893

Primary coxarthrosis, bilateral

607

1.07

0.19

1.1

1.0

0.91

2.39

u/ml

2.25

269

Persistent mood disorders

126

1202

1.05

0.19

1.1

7.27

3.04

u/ml

0.75

563

Contact with sharp object, undetermined intent

154

0.84

0.19

1.0

1.1

3.60

3.30

u/ml

—

Social phobias

941

0.94

0.19

1.0

1.1

7.24

4.31

u/ml

0.53

484

Anaemias

271

1714

1.03

0.19

1.1

2.61

5.76

u/ml

3.39

145

879

Nonspecific lymphadenitis

366

1.09

0.19

1.1

1.0

2.49

3.13

u/ml

0.19

166

Smoking dependency

426

0.91

0.19

1.1

13.90

3.28

u/ml

1.01

193

Arthropod-borne viral fevers and viral haemorrhagic fevers

426

0.91

0.19

1.1

9.02

2.78

u/ml

0.50

194

Injury of muscle and tendon at wrist and hand level

756

0.94

0.18

1.1

4.61

3.09

u/ml

0.37

350

Personal history of other diseases and conditions

135

1286

1.05

0.18

1.1

4.58

5.30

u/ml

0.16

688

Diplopia

579

1.07

0.18

1.1

3.06

3.20

u/ml

0.03

263

Follicular cysts of skin and subcutaneous tissue

105

998

1.05

0.18

1.1

3.02

3.36

u/ml

0.08

462

Agoraphobia

311

0.90

0.18

1.1

1.0

1.99

4.33

u/ml

0.87

149

Benign neoplasm: Cerebral meninges

280

1.11

0.18

1.0

8.77

2.00

u/ml

—

123

Carrier of infectious disease

147

1.16

0.18

1.1

1.0

5.98

3.34

u/ml

—

Infective bursitis

100

1.20

0.18

1.0

1.1

1.21

2.80

u/ml

—

Bacterial pneumoniae

215

1832

1.03

0.18

1.1

5.57

4.11

u/ml

0.33

129

852

Psoriatic arthropathies

528

0.93

0.18

1.0

1.1

2.54

2.75

u/ml

0.05

240

Other infectious diseases

279

0.90

0.17

1.1

2.25

3.43

u/ml

0.53

135

Need for other prophylactic measures

300

1.10

0.17

1.1

2.21

3.84

u/ml

0.47

160

Idiopathic gout

174

0.86

0.17

1.2

1.1

1.34

2.32

u/ml

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

795

0.94

0.17

1.1

4.54

3.04

u/ml

0.34

352

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

195

0.87

0.17

1.0

8.36

2.78

u/ml

—

Normotensive glaucoma

119

1.18

0.17

1.0

1.18

1.27

u/ml

—

Calcific aortic valvular stenosis, including rheumatic fever

421

0.92

0.17

1.1

3.21

2.15

u/ml

0.49

204

Distal bite

500

1.08

0.17

1.1

8.15

5.13

u/ml

0.58

297

Other pulmonary heart/vessel disease

1.21

0.17

1.2

1.0

1.22

2.81

u/ml

—

Benign neoplasm: Caecum

233

1.12

0.17

1.0

1.1

3.94

2.35

u/ml

0.35

103

Torsion of testis

176

1.14

0.17

1.1

3.44

2.69

u/ml

0.23

Other and unspecified coagulation defects

341

0.91

0.17

1.1

1.21

4.53

u/ml

2.17

160

Other follicular disorders

513

1.07

0.17

1.1

1.0

7.98

3.42

u/ml

0.59

238

Conductive hearing loss, unspecified

424

0.92

0.17

1.1

4.10

3.57

u/ml

0.09

202

Other blood glucose lowering drugs, excl. Insulins

393

0.92

0.17

1.1

1.0

3.18

2.12

u/ml

0.19

178

Disorders of puberty, all

226

0.88

0.17

1.1

7.16

5.32

u/ml

0.22

136

Sequelae of injuries of head

262

1.11

0.17

1.1

1.0

6.86

3.56

u/ml

—

125

Pedal cyclist injured in other and unspecified transport accidents

702

0.94

0.17

1.0

1.1

3.94

3.62

u/ml

0.07

332

Calcific tendinitis of shoulder

262

1.11

0.17

1.0

7.56

2.55

u/ml

0.50

108

Calcific aortic valvular stenosis, diagnosis (helper)

421

0.92

0.17

1.1

3.21

2.15

u/ml

0.49

204

Operations 2 for CAVS

421

0.92

0.17

1.1

3.21

2.15

u/ml

0.49

204

Ulcerative rectosigmoiditis

527

0.93

0.17

1.0

1.1

1.23

3.67

u/ml

2.85

243

Scabies

320

1.10

0.17

1.1

2.96

4.50

u/ml

0.31

162

Purpura and other haemorrhagic conditions

691

0.94

0.17

1.1

0.78

3.92

u/ml

6.60

350

Elevated blood glucose level

392

0.92

0.17

1.1

1.49

3.97

u/ml

2.22

199

Benign neoplasm: salivary glands, exclude unknown (D119)

282

1.10

0.16

1.0

1.1

4.01

3.63

u/ml

—

133

Polymyalgia rheumatica

194

0.88

0.16

1.0

1.1

0.77

1.58

u/ml

—

Haemorrhage, not elsewhere classified

101

1.19

0.16

1.2

1.0

2.94

4.43

u/ml

—

Postpartum hemorraghe, all women as controls

298

2857

1.03

0.16

1.1

3.99

4.81

u/ml

0.32

126

1330

Iron deficiency anaemia secondary to blood loss (chronic)

567

0.93

0.16

1.1

1.87

3.01

u/ml

0.87

266

Complications of internal orthopaedic prosthetic devices, implants and grafts

563

1.07

0.16

1.1

1.0

4.20

2.96

u/ml

0.22

248

Myocardial infarction, without ST-elevation

726

1.05

0.16

1.1

1.0

3.85

2.78

u/ml

0.30

321

Abnormal blood-pressure reading, without diagnosis

196

1.12

0.16

1.0

1.04

3.23

u/ml

1.54

Polyhydramnios

476

1.07

0.16

1.1

1.75

3.78

u/ml

0.66

224

117

1121

1.04

0.16

1.1

3.78

4.40

u/ml

0.15

510

Single delivery by forceps and vacuum extractor

199

1238

0.97

0.16

1.1

5.63

5.27

u/ml

0.04

624

Adjustment and management of implanted device

389

1.08

0.16

1.1

3.50

3.18

u/ml

0.05

177

Other renal tubulo-interstitial diseases

130

0.84

0.16

1.1

1.0

0.12

2.03

u/ml

—

Senile cataract

208

1315

0.97

0.16

1.0

3.77

3.10

u/ml

0.31

103

550

Malignant neoplasm of thyroid gland, including Hilmo

370

0.92

0.16

1.0

1.1

1.49

2.57

u/ml

0.74

174

Congenital vesicoureteral reflux

0.77

0.16

1.0

1.1

36.46

6.17

u/ml

—

Diseases caused by chlamydiae

111

1.18

0.16

1.1

1.0

8.32

5.89

u/ml

—

Hypercalcemia

111

1.17

0.15

1.0

2.91

2.55

u/ml

—

Benign neoplasm: Stomach

264

1.10

0.15

1.1

1.0

5.37

2.08

u/ml

0.43

118

Open wound of shoulder and upper arm

119

0.84

0.15

1.0

1.1

2.17

3.34

u/ml

—

Disorders of puberty

203

0.88

0.15

1.1

7.16

5.98

u/ml

0.13

124

Mental disorders, not otherwise specified

688

0.94

0.15

1.1

2.08

3.34

u/ml

0.98

332

Other diseases of blood and blood-forming organs, wide

110

1054

1.04

0.15

1.1

6.18

3.52

u/ml

0.50

504

Plantar fascial fibromatosis

493

0.93

0.15

1.0

1.1

1.17

2.97

u/ml

2.39

211

Other endocrine disorders

541

1.06

0.15

1.1

5.21

6.99

u/ml

0.32

319

Speech disturbances, not elsewhere classified

276

0.91

0.15

1.1

8.04

2.88

u/ml

0.61

132

Spondylopathies (FG)

107

1025

1.04

0.15

1.1

2.06

3.80

u/ml

1.97

461

Fracture of rib(s), sternum and thoracic spine

114

1188

0.96

0.15

1.1

7.43

3.26

u/ml

1.04

537

Unspecified maternal hypertension

121

1.16

0.15

1.1

1.0

2.46

3.32

u/ml

—

Paroxysmal tachycardia

163

1318

1.04

0.15

1.1

3.42

4.04

u/ml

0.27

608

Transitory endocrine and metabolic disorders specific to fetus and newborn

259

0.90

0.15

1.1

3.41

7.60

u/ml

1.41

168

Calcific aortic valvular stenosis, operated

427

0.93

0.14

1.0

1.1

3.07

2.58

u/ml

0.18

207

Calcific aortic valvular stenosis

427

0.93

0.14

1.0

1.1

3.07

2.58

u/ml

0.18

207

Abnormal serum enzyme levels

898

0.95

0.14

1.1

2.77

3.04

u/ml

0.12

421

Spondylopathies

467

2843

0.98

0.14

1.1

3.90

3.41

u/ml

0.26

211

1276

Infections specific to the perinatal period

198

1.12

0.14

1.2

1.1

10.90

6.31

u/ml

0.46

126

Disorders of calcium metabolism

217

1.11

0.14

1.1

1.16

3.41

u/ml

1.52

101

Other and unspecified injuries of shoulder and upper arm

150

1.14

0.14

1.2

1.1

1.51

4.13

u/ml

0.94

Meralgia paraesthetica

150

1.14

0.14

1.1

1.0

4.01

2.40

u/ml

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

275

1.09

0.14

1.1

8.30

3.10

u/ml

0.63

125

Overexertion and strenuous or repetitive movements

594

0.94

0.14

1.1

5.39

3.40

u/ml

0.43

274

Hypoparathyroidism

112

1.16

0.14

1.3

1.0

3.43

3.18

u/ml

—

Visual field defects

304

1.09

0.14

1.0

9.26

2.57

u/ml

0.55

141

Aortic aneurysm

460

1.07

0.14

1.0

2.08

2.35

u/ml

0.11

222

Meningitis

264

0.91

0.14

1.0

5.28

2.91

u/ml

0.36

126

Gonarthrosis, primary, with knee surgery

166

1364

0.97

0.14

1.0

2.69

3.13

u/ml

0.23

562

All dysplastic lesions of the cervix uteri, vagina or vulva

298

2869

1.02

0.14

1.1

3.62

4.29

u/ml

0.25

127

1300

Follow-up care involving plastic surgery

160

1.13

0.14

1.1

1.0

0.50

2.89

u/ml

—

Varicella [chickenpox]

324

1.08

0.14

1.1

12.31

3.87

u/ml

0.82

167

Anorexia

1.19

0.14

1.0

4.93

3.64

u/ml

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

324

1.08

0.14

1.1

1.26

2.76

u/ml

1.35

152

Congenital musculoskeletal deformities of head, face, spine and chest

122

1.15

0.14

1.1

35.66

5.23

u/ml

—

Other superficial mycoses

122

1.15

0.14

1.4

1.0

9.73

3.56

u/ml

—

Congenital malformations of the circulatory system

115

1158

0.96

0.13

1.1

6.31

4.89

u/ml

0.33

632

Impacted maxillary molar

766

0.95

0.13

1.1

2.57

5.27

u/ml

1.86

404

Bicipital tendinitis

170

1.12

0.13

1.1

1.29

2.56

u/ml

—

Recurrent dislocation of patella

539

1.06

0.13

1.1

11.50

3.84

u/ml

0.69

258

Autism

335

0.92

0.13

1.1

3.89

6.33

u/ml

0.42

191

DVT of lower extremities and pulmonary embolism

155

1496

1.03

0.13

1.1

2.70

3.39

u/ml

0.31

674

Diseases of the digestive system

230

2232

1.03

0.13

1.1

4.45

4.37

u/ml

0.03

109

1086

Effects of other external causes

211

0.90

0.13

1.0

0.47

2.65

u/ml

—

110

Fracture of foot, except ankle

184

1892

0.97

0.13

1.1

3.95

4.31

u/ml

0.12

102

918

Other CVD

432

1.06

0.13

1.0

1.1

2.49

2.72

u/ml

0.06

213

Respiratory and cardiovascular disorders specific to the perinatal period

395

1.07

0.13

1.1

13.30

6.16

u/ml

0.99

263

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

222

2165

1.03

0.13

1.1

3.25

4.45

u/ml

0.50

1036

Autoimmune diseases related-to ILD

655

5679

0.99

0.12

1.1

3.41

4.37

u/ml

1.05

298

2708

LSIL lesion of the cervix uteri

106

1100

0.96

0.12

1.0

1.1

1.18

4.34

u/ml

3.43

500

Behavioural disorders

231

0.91

0.12

1.1

6.59

5.00

u/ml

0.13

134

Crohn's disease of large intestine

365

1.07

0.12

1.0

1.1

1.04

3.99

u/ml

2.83

171

Disorders in reading

181

1.11

0.12

1.2

1.0

12.38

6.47

u/ml

0.34

104

Toxic effect of ethanol

272

0.92

0.12

1.0

7.04

4.39

u/ml

—

139

Congenital malformations of the musculoskeletal system, not elsewhere classified

158

0.88

0.12

1.0

1.1

4.23

6.03

u/ml

—

Burns and corrosions

102

983

1.04

0.12

1.0

1.1

6.67

4.41

u/ml

0.38

497

Intentional self-harm by sharp object

239

1.09

0.12

1.1

5.98

4.44

u/ml

0.27

132

Female infertility, associated with anovulation

895

1.04

0.12

1.0

1.1

7.33

5.32

u/ml

0.26

430

Benign neoplasm: Pituitary gland, craniopharyngeal duct

278

1.08

0.12

1.0

1.1

1.00

3.08

u/ml

—

131

Myeloproliferative diseases (CML excluded)

189

0.90

0.12

1.1

1.0

1.59

2.35

u/ml

—

Nonischemic cardiomyopathy

292

0.92

0.12

1.2

1.0

5.52

2.57

u/ml

0.43

135

Other diseases caused by chlamydiae

114

1.14

0.12

1.1

1.0

8.32

5.89

u/ml

—

Abnormal spermatozoa

220

1.09

0.11

1.0

1.1

3.03

2.28

u/ml

—

110

Family history of certain disabilities and chronic diseases leading to disablement

456

0.94

0.11

1.1

7.25

3.56

u/ml

0.60

216

Cerebral aneurysm, nonruptured

333

0.93

0.11

1.1

4.51

2.91

u/ml

—

142

Other and unspecified iridocyclitis

230

0.91

0.11

1.1

10.04

2.65

u/ml

0.47

115

Acute gastritis

230

1.09

0.11

1.0

1.1

2.42

2.59

u/ml

0.05

105

Postprocedural musculoskeletal disorders, not elsewhere classified

201

1.10

0.11

1.0

2.78

2.72

u/ml

0.01

Unspecified lump in breast

798

1.04

0.11

1.1

1.0

2.77

3.89

u/ml

0.22

345

Other arthritis (FG)

193

1977

0.98

0.11

1.1

4.50

4.07

u/ml

0.14

906

Diabetic neuropathy

229

1.09

0.11

1.0

1.1

4.33

3.11

u/ml

0.16

103

Nutritional anaemias

244

2302

1.02

0.11

1.1

3.10

4.40

u/ml

0.69

126

1090

Vitamin deficiency, wide

211

1.09

0.11

1.0

0.60

3.11

u/ml

3.32

102

Vitamin deficiency

211

1.09

0.11

1.0

0.60

3.11

u/ml

3.32

102

Other juvenile arthritis

414

0.94

0.11

1.0

1.1

1.88

5.08

u/ml

1.98

224

Other diseases of intestine

455

1.06

0.11

1.0

1.1

2.55

2.99

u/ml

0.11

225

Hypertrophic cardiomyopathy

136

0.88

0.11

1.0

1.1

4.31

3.72

u/ml

—

Monoarthritis, not elsewhere classified

198

0.91

0.10

1.1

2.44

2.52

u/ml

—

Cardiomyopathy

587

0.95

0.10

1.1

5.04

3.69

u/ml

0.25

274

Malignant neoplasm of bladder, including Hilmo

162

1.10

0.10

1.1

0.40

1.98

u/ml

—

Other assisted single delivery

173

1.10

0.10

1.0

0.73

2.83

u/ml

1.64

Extreme obesity with alveolar hypoventilation

144

1.11

0.10

1.0

6.04

2.49

u/ml

—

Cardiomyopathy, other and unspecified

241

1.08

0.10

1.1

1.0

5.10

2.33

u/ml

0.37

113

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

613

1.04

0.10

1.0

1.1

2.80

3.45

u/ml

0.23

287

Open wound of lower leg

869

1.04

0.10

1.1

5.52

3.79

u/ml

0.36

441

Motor disorders, excluding more controls

228

1.08

0.10

1.2

1.1

7.63

8.47

u/ml

0.07

156

Other specified congenital malformation syndromes affecting multiple systems

187

0.91

0.10

1.1

4.26

5.29

u/ml

—

112

Lung cancer and mesothelioma

173

1.09

0.10

1.1

1.0

6.76

2.34

u/ml

—

Motorcycle rider injured in other and unspecified transport accidents

476

1.05

0.10

1.1

1.33

4.06

u/ml

3.44

246

Other diseases of pleura

144

1229

1.03

0.10

1.1

4.87

3.78

u/ml

0.34

569

Brain meningioma, including Hilmo

156

0.90

0.10

1.1

1.0

4.57

2.35

u/ml

—

Conduct disorder

228

0.92

0.10

1.1

6.59

5.73

u/ml

0.07

132

Emotional disorders and disorders of social functioning with onset specific to childhood

768

1.04

0.10

1.1

4.92

5.52

u/ml

0.16

458

Brachial plexus disorders

693

1.04

0.09

1.1

4.37

3.43

u/ml

0.15

305

Specific development disorders of scholastic skills

577

1.04

0.09

1.1

7.90

5.05

u/ml

0.45

336

Other disorders of glucose regulation and pancreatic internal secretion

473

0.95

0.09

1.2

1.1

3.64

4.82

u/ml

0.23

243

Ankylosing spondylitis, ICD10

526

1.05

0.09

1.0

1.1

2.07

2.79

u/ml

0.49

238

Pneumonia, organism unspecified

700

4957

0.99

0.09

1.1

5.12

4.37

u/ml

0.41

380

2350

Colon adenocarcinoma

207

0.92

0.09

1.0

1.1

4.14

1.83

u/ml

—

Venous thromboembolism

220

2166

0.98

0.09

1.1

3.50

3.27

u/ml

0.08

103

977

Malignant neoplasm of colon, including Hilmo

411

0.95

0.09

1.0

1.1

5.58

2.55

u/ml

0.44

199

Gestational diabetes (for exclusion)

465

3193

1.01

0.09

1.1

2.78

5.00

u/ml

2.57

211

1482

Gender identity disorders

155

0.90

0.09

1.1

2.12

5.01

u/ml

—

Preterm labour and delivery

199

1950

1.02

0.09

1.1

3.97

3.91

u/ml

0.02

862

Pneumococcal septicemia

155

0.90

0.09

1.0

7.97

4.07

u/ml

—

Other obstetric trauma

543

0.96

0.09

1.0

1.1

5.70

3.32

u/ml

0.48

239

Other osteochondropathies

419

1.05

0.09

1.0

1.1

1.01

4.06

u/ml

3.55

196

Inflammatory bowel disease

232

2362

0.98

0.09

1.1

2.78

4.39

u/ml

1.48

101

1154

Crohn disease

101

981

1.03

0.09

1.0

1.1

3.13

3.65

u/ml

0.20

474

Hypopituitarism

502

0.96

0.09

1.1

9.37

5.28

u/ml

0.44

267

Paralytic strabismus

237

0.93

0.09

1.0

1.1

0.87

2.74

u/ml

1.62

112

Lactose intolerance, other/unspecified

165

0.91

0.09

1.0

1.17

2.90

u/ml

—

Other and unspecified mononeuropathies of upper limb

134

0.89

0.08

1.1

1.0

0.14

2.46

u/ml

—

Superficial injury of abdomen, lower back and pelvis

100

1029

0.97

0.08

1.1

3.77

4.01

u/ml

0.06

508

Other diseases of biliary tract

247

0.93

0.08

1.2

1.1

5.79

3.10

u/ml

—

119

Inflammatory bowel disease, strict (require KELA)

182

1857

0.98

0.08

1.0

1.1

2.47

4.51

u/ml

2.15

915

Diabetic retinopathy

604

0.97

0.08

1.1

4.74

3.57

u/ml

0.32

292

Spondyloarthritis

113

1100

1.03

0.08

1.1

3.51

3.57

u/ml

0.02

510

Isolated proteinuria

136

1.10

0.08

1.0

1.1

0.44

2.93

u/ml

—

Bell's palsy

593

0.96

0.08

1.0

1.1

6.33

3.48

u/ml

0.39

269

Superficial injury of neck

144

0.90

0.08

1.2

1.1

0.44

5.36

u/ml

—

Superficial injury of head

152

1487

1.02

0.08

1.1

3.33

4.32

u/ml

0.58

744

Other problems related to primary support group, including family circumstances

127

1265

0.98

0.08

1.1

5.13

4.75

u/ml

0.09

684

Other congenital malformations of limb(s)

1.14

0.08

1.1

0.17

5.52

u/ml

—

Erosion and ectropion of cervix uteri

1.14

0.08

1.1

0.31

4.01

u/ml

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

251

0.93

0.08

1.1

3.41

7.53

u/ml

1.36

163

Brain meningioma

154

0.91

0.08

1.1

1.0

4.57

2.37

u/ml

—

Lesion of lateral popliteal nerve

195

0.92

0.08

1.1

1.0

7.02

2.64

u/ml

—

Polycystic ovarian syndrome, consortium definition

670

3931

1.01

0.08

1.1

3.46

4.70

u/ml

1.30

316

1837

Gastric ulcer

391

1.05

0.08

1.0

3.08

3.03

u/ml

0.01

180

Unspecified abortion

297

0.94

0.08

1.0

1.1

1.23

3.64

u/ml

1.14

127

Osteonecrosis

205

0.93

0.08

1.0

1.01

3.16

u/ml

—

Periodontal disease, other/unspecified

127

1.10

0.08

1.0

1.1

3.35

4.81

u/ml

—

Tobacco use

303

1.06

0.08

1.0

1.1

17.36

3.77

u/ml

0.41

137

Malignant neoplasm of colon

307

0.94

0.07

1.0

1.1

5.58

2.80

u/ml

0.39

152

Pneumothorax

215

0.93

0.07

1.2

1.1

5.12

2.09

u/ml

0.43

106

Injuries to the thorax

232

2282

1.02

0.07

1.1

5.97

3.88

u/ml

0.85

105

1074

Sequelae with surgical and medical care as external cause

826

1.03

0.07

1.1

1.0

3.11

3.27

u/ml

0.05

383

Biomechanical lesions, not elsewhere classified

176

1.08

0.07

1.1

1.0

4.12

3.00

u/ml

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

186

1.08

0.07

1.1

1.0

9.94

3.29

u/ml

0.54

IBD patients in KELA-register

182

1852

0.98

0.07

1.0

1.1

2.47

4.57

u/ml

2.24

914

Implicit fungal Sepsis

112

0.89

0.07

1.4

1.0

1.68

3.55

u/ml

—

Other or unspecified ileus, impaction or obstruction

540

1.04

0.07

1.0

2.53

3.64

u/ml

0.31

259

Other and unspecified diseases of blood and blood-forming organs

1.07

0.07

1.0

0.24

3.33

u/ml

—

Abscess of Bartholin gland

204

0.93

0.07

1.1

1.0

1.47

2.97

u/ml

—

Psoriasis vulgaris

994

0.98

0.07

1.1

4.78

3.26

u/ml

0.46

455

Viral agents as the cause of diseases classified to other chapters

128

1.10

0.06

1.1

1.0

11.03

6.15

u/ml

—

Congenital deformities of hip

216

1.07

0.06

1.1

16.25

7.81

u/ml

0.56

111

Abnormal findings on antenatal screening of mother

109

1066

1.02

0.06

1.1

6.98

5.44

u/ml

0.26

518

Thyrotoxicosis

141

1437

0.98

0.06

1.1

2.71

3.81

u/ml

0.51

651

Wet age-related macular degeneration

128

0.91

0.06

1.0

0.28

0.94

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

835

5642

0.99

0.06

1.1

5.08

4.30

u/ml

0.51

459

2675

Thyrotoxicosis with diffuse goitre

892

0.98

0.06

1.1

3.20

3.40

u/ml

0.05

396

Other orthopaedic follow-up care

236

1.06

0.06

1.0

4.17

3.06

u/ml

0.14

105

Idiopathic thrombocytopenic purpura

142

0.91

0.06

1.2

1.0

0.59

4.17

u/ml

—

Disorder of external ear, unspecified

142

0.91

0.06

1.1

1.0

24.28

2.85

u/ml

—

Otosclerosis

246

1.06

0.06

1.1

0.73

2.37

u/ml

2.28

107

Other surgical follow-up care

197

1.07

0.06

1.1

21.22

4.85

u/ml

—

Gonococcal infection

197

1.07

0.06

1.0

0.92

2.87

u/ml

—

103

Scissor bite

351

1.04

0.06

1.1

5.39

4.97

u/ml

0.06

224

Other fall from one level to another

170

1726

0.98

0.06

1.1

3.04

4.66

u/ml

1.13

911

Dental caries

156

1475

1.02

0.06

1.1

2.74

5.77

u/ml

2.38

696

Vitamin B12 deficiency anaemia

233

0.94

0.05

1.0

0.63

2.71

u/ml

2.31

104

Hyperkinetic disorders (excl. ADHD)

254

1.05

0.05

1.1

4.09

6.62

u/ml

0.90

163

Cardiodefibrillation

799

1.02

0.05

1.0

1.58

2.86

u/ml

1.17

372

Benign neoplasm: Sigmoid colon

494

1.03

0.05

1.0

1.1

1.25

2.62

u/ml

1.05

230

Benign leiomyoma with endometriosis

623

1.03

0.05

1.1

3.75

3.03

u/ml

0.14

256

Recurrent dislocation and subluxation of joint

556

0.97

0.05

1.0

1.1

2.99

3.44

u/ml

0.13

267

Infliximab

149

1.08

0.05

1.1

1.0

5.12

3.10

u/ml

—

Other CVD (FINNGEN)

268

1.04

0.05

1.0

2.76

3.70

u/ml

0.24

114

Other congenital malformations of face and neck

212

0.94

0.05

1.1

1.0

0.99

4.58

u/ml

—

105

Glaucoma, exfoliation

100

1.10

0.05

1.0

0.25

1.62

u/ml

—

218

1.06

0.05

1.1

1.0

4.96

3.60

u/ml

—

Iridocyclitis

126

1239

1.02

0.05

1.0

1.1

3.76

3.55

u/ml

0.05

570

Pediculosis, acariasis and other infestations

384

0.96

0.05

1.1

2.84

4.24

u/ml

0.30

187

Benign neoplasm: Skin, unspecified

161

0.93

0.05

1.0

10.98

2.88

u/ml

—

Disorders of continuity of bone

584

1.03

0.05

1.1

5.26

3.58

u/ml

0.25

272

Other peripheral vascular diseases

396

1.04

0.05

1.1

4.79

2.94

u/ml

0.25

181

Diverticular disease of intestine

342

2163

1.01

0.05

1.0

1.1

2.10

3.55

u/ml

2.01

141

947

Gestational [pregnancy-induced] hypertension

253

2551

0.99

0.05

1.1

2.26

4.37

u/ml

2.78

107

1167

Acute and subacute iridocyclitis

107

1051

1.02

0.05

1.0

1.1

2.68

3.26

u/ml

0.33

473

Exclusion endpoint for supernumerary teeth

120

1.09

0.05

1.2

1.1

6.37

4.70

u/ml

—

Other and unspecified mood [affective] disorders

706

0.98

0.04

1.1

2.69

3.86

u/ml

0.69

349

Hodgkin lymphoma, hilmo

130

0.92

0.04

1.2

1.1

6.27

3.98

u/ml

—

Intracranial trauma

520

3631

1.01

0.04

1.1

5.93

4.33

u/ml

0.74

271

1827

Other embolism and thrombosis

486

1.03

0.04

1.0

1.1

4.81

3.39

u/ml

0.16

218

Retinal vascular occlusion

209

1.05

0.04

1.0

1.1

4.60

1.85

u/ml

0.41

Artificial joint operation, meniscal resection

503

3286

0.99

0.04

1.1

3.30

3.47

u/ml

0.10

238

1475

Motor disorders

270

0.96

0.04

1.2

1.1

7.63

8.01

u/ml

0.03

184

Haemolytic anaemias

150

0.93

0.04

1.1

2.83

7.48

u/ml

—

Traumatic amputation of wrist and hand

150

1.07

0.04

1.1

1.34

2.04

u/ml

—

Optic neuritis

318

1.04

0.04

1.0

1.1

2.01

3.74

u/ml

0.88

151

Early lumbar disc prolapse operation

103

1047

0.98

0.04

1.0

1.1

4.22

3.22

u/ml

0.28

488

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

160

1.06

0.04

1.1

1.0

1.82

3.27

u/ml

—

Hallux valgus (acquired)

170

1237

0.99

0.04

1.1

3.47

3.25

u/ml

0.06

521

Golimumab

251

0.96

0.04

1.0

1.1

1.51

3.44

u/ml

1.29

123

Visual impairment including blindness (binocular or monocular)

251

0.96

0.04

1.0

6.04

4.56

u/ml

0.17

130

Other and unspecified injuries of head

362

0.97

0.04

1.1

3.82

4.68

u/ml

0.21

178

Exclusion endpoint for clefts

210

0.95

0.04

1.1

3.87

6.61

u/ml

0.53

128

Congenital malformations of ovaries, fallopian tubes and broad ligaments

487

1.03

0.04

1.1

3.60

3.75

u/ml

0.02

223

Diseases of peritoneum

368

1.03

0.04

1.0

1.1

2.85

3.12

u/ml

0.05

169

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

111

1.08

0.04

1.1

1.0

51.48

6.26

u/ml

—

Burn and corrosion of wrist and hand

279

1.04

0.04

1.1

2.84

4.01

u/ml

0.33

152

Overjet

307

1.04

0.04

1.1

9.84

5.62

u/ml

0.43

177

Unspecified haematuria

155

1300

0.99

0.04

1.1

4.15

3.59

u/ml

0.13

622

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

553

0.98

0.03

1.1

1.0

4.77

3.58

u/ml

0.11

246

Open wound of forearm

557

1.02

0.03

1.1

4.27

4.04

u/ml

0.05

266

Autism spe, excluding more controls

311

0.96

0.03

1.1

3.89

5.74

u/ml

0.30

179

Anankastic personality disorder

309

1.04

0.03

1.1

1.0

1.79

3.36

u/ml

0.75

147

Enterocolitis due to Clostridium difficile

311

0.96

0.03

1.1

0.78

3.57

u/ml

2.69

150

Congenital deformities of hip

200

1.05

0.03

1.1

16.25

8.04

u/ml

0.54

107

Ulcerative colitis, NAS

965

0.98

0.03

1.1

1.14

3.07

u/ml

4.07

457

Psychotic depression

319

1.03

0.03

1.1

1.0

2.06

2.54

u/ml

0.18

148

Other disorders of nervous system

220

0.95

0.03

1.1

3.37

2.44

u/ml

—

Congenital malformations of eye, ear, face and neck

617

1.02

0.03

1.1

3.58

5.10

u/ml

0.40

325

Other specified/unspecified dorsopathies

139

0.93

0.03

1.0

3.27

1.84

u/ml

—

Fibrosis and cirrhosis of liver

230

0.96

0.03

1.0

1.80

3.07

u/ml

0.49

107

Pneumonia derived septicemia

141

1.06

0.03

1.0

7.97

3.40

u/ml

—

Varicella [chickenpox]

431

0.97

0.03

1.1

11.17

4.65

u/ml

0.80

234

Other disorders of ear

619

4033

1.00

0.03

1.1

3.62

4.24

u/ml

0.48

295

1919

In situ neoplasms

170

1683

1.01

0.03

1.0

1.1

3.35

3.80

u/ml

0.12

771

Thiazolidinediones

260

1.04

0.03

1.0

1.1

0.87

2.35

u/ml

1.63

125

All pneumoniae

844

5659

1.00

0.03

1.1

5.06

4.29

u/ml

0.50

462

2687

Bacterial, viral and other infectious agents

568

1.02

0.03

1.1

4.76

4.26

u/ml

0.12

270

Seronegative juvenile rheumatoid arthritis

179

0.95

0.03

1.0

1.1

2.50

6.18

u/ml

—

Contusion of ankle

300

1.03

0.03

1.0

1.1

3.42

4.13

u/ml

0.14

154

Eating disorder

114

1124

1.01

0.03

1.1

4.67

5.40

u/ml

0.15

597

Eating disorders

123

1214

1.01

0.03

1.1

5.67

5.13

u/ml

0.11

647

Short stature, not elsewhere classified

370

1.03

0.03

1.1

5.74

7.96

u/ml

0.33

236

Arthrosis

489

2670

1.00

0.03

1.1

3.47

3.35

u/ml

0.06

239

1167

Retinal vascular disorders

211

1.04

0.03

1.0

1.1

4.60

1.84

u/ml

0.42

Injuries to unspecified part of trunk, limb or body region

549

1.02

0.03

1.1

8.24

3.40

u/ml

0.74

266

Motorcycle rider injured in noncollision transport accidents

229

0.96

0.03

1.0

1.1

3.70

4.63

u/ml

0.18

116

Abnormalities of gait and mobility

380

0.97

0.02

1.1

10.93

4.67

u/ml

0.44

189

Diabetic nephropathy

355

0.97

0.02

1.1

7.61

2.32

u/ml

0.73

172

Spinal instabilities

128

0.94

0.02

1.1

1.0

1.53

1.98

u/ml

—

Sleep disorders, other/unspecified

259

0.96

0.02

1.1

1.0

0.45

3.28

u/ml

3.78

129

Emotional disorders starting during childhood or adolescence

732

1.02

0.02

1.1

4.92

5.54

u/ml

0.16

431

Abnormal findings on examination of blood, without diagnosis

202

1868

0.99

0.02

1.1

4.46

3.80

u/ml

0.27

892

LSIL lesion of the vulva

158

0.95

0.02

1.1

1.0

0.95

2.77

u/ml

—

Atrophic disorders of skin

761

0.99

0.02

1.1

3.50

3.62

u/ml

0.03

344

Obstructed labour due to malposition and malpresentation of fetus

247

2289

1.01

0.02

1.1

3.28

4.07

u/ml

0.43

118

1024

Orchitis and epididymitis

349

0.97

0.02

1.0

1.1

0.44

3.58

u/ml

6.00

191

Bipolar affective disorders

167

1657

1.01

0.02

1.0

1.1

3.21

3.94

u/ml

0.31

794

Memory loss

188

0.96

0.02

1.0

0.99

2.70

u/ml

1.39

Congenital malformations of genital organs

101

1015

0.99

0.02

1.0

1.1

4.16

4.06

u/ml

0.02

528

Superficial injury of shoulder and upper arm

660

1.02

0.02

1.1

5.95

3.46

u/ml

0.58

314

Autoimmune hyperthyroidism

409

0.98

0.02

1.0

1.1

0.96

3.80

u/ml

2.92

177

Other salmonella infections

218

0.96

0.02

1.0

5.31

4.28

u/ml

—

112

Injury of nerves at wrist and hand level

222

1.04

0.02

1.0

1.01

2.85

u/ml

—

109

Diabetes mellitus in pregnancy

423

2718

1.00

0.02

1.1

3.71

5.16

u/ml

1.00

199

1281

Cluster headache, wide

232

1.03

0.02

1.1

5.80

3.19

u/ml

0.22

104

Prolonged pregnancy

193

1699

0.99

0.02

1.0

1.1

4.99

5.27

u/ml

0.07

100

819

Salpingitis and oophoritis

920

1.01

0.02

1.1

1.0

3.34

3.81

u/ml

0.12

390

Respiratory distress of newborn

276

0.97

0.01

1.1

11.51

6.95

u/ml

0.40

184

Mandibular prognathia

123

1.06

0.01

1.3

1.1

2.43

5.49

u/ml

—

Other symptoms and signs involving the urinary system

392

1.02

0.01

1.1

2.44

2.96

u/ml

0.18

194

Maternal care for known or suspected disproportion

418

0.98

0.01

1.0

1.1

9.15

2.65

u/ml

0.47

178

Diseases of the myoneural junction and muscle

448

0.98

0.01

1.1

9.05

3.04

u/ml

0.64

221

Other specified and unspecified disorders of eye and adnexa

163

1.04

0.01

1.0

9.55

3.45

u/ml

—

Other disorders involving the immune mechanism, not elsewhere classified

167

0.96

0.01

1.1

1.37

4.87

u/ml

—

Left bundle-branch block

177

0.96

0.01

1.2

1.0

2.86

2.46

u/ml

—

Lactose intolerance

193

1.04

0.01

1.1

1.13

4.53

u/ml

—

Degenerative macular diseases

203

1.03

0.01

1.0

1.1

1.21

2.33

u/ml

—

Amenorrhoea

698

0.99

0.01

1.0

1.1

5.60

5.06

u/ml

0.05

351

Additional codes for the location of defect, injury or illness

283

1.03

0.01

1.1

1.0

1.39

4.58

u/ml

2.16

140

Glucagon-like peptide-1 (GLP-1) analogues

157

1561

1.01

0.01

1.1

1.0

2.21

3.11

u/ml

0.62

677

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

157

1561

1.01

0.01

1.1

1.0

2.21

3.11

u/ml

0.62

677

Congenital deformities of feet

333

1.02

0.01

1.0

1.1

4.56

5.59

u/ml

0.24

170

Constipation

585

4039

1.00

0.01

1.1

2.73

4.60

u/ml

2.78

259

1969

Cluster headache, wide,, including avohilmo

373

1.02

0.01

1.1

4.67

3.25

u/ml

0.18

171

Lichen sclerosus et atrophicus

413

1.02

0.01

1.1

1.0

2.22

3.08

u/ml

0.36

190

Pregnancy examination and test

220

1372

1.00

0.01

1.1

4.07

5.61

u/ml

0.57

104

663

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

415

3616

1.00

0.01

1.1

2.58

4.56

u/ml

2.35

175

1639

Malignant neoplasm of mesothelium and soft tissue

1.06

0.01

1.1

1.0

0.62

2.95

u/ml

—

Cytomegaloviral disease

106

0.94

0.01

1.0

1.23

3.37

u/ml

—

Entropion and trichiasis of eyelid

116

0.95

0.01

1.0

1.07

1.59

u/ml

—

Problems related to social environment

136

0.96

0.00

1.1

1.26

4.34

u/ml

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

114

1.05

0.00

1.0

22.38

4.20

u/ml

—

Assault by sharp object

116

0.95

0.00

1.0

1.1

7.13

1.64

u/ml

—

Granulomatous disorders of skin and subcutaneous tissue

136

0.96

0.00

1.2

1.0

1.28

2.93

u/ml

—

Other disorders of bone density and structure

136

0.96

0.00

1.0

1.1

2.25

4.20

u/ml

—

Benign neoplasm: Descending colon

154

1.04

0.00

1.1

1.0

0.37

2.69

u/ml

—

Other and unspecified vascular occlusions

154

1.04

0.00

1.1

5.34

1.74

u/ml

—

Personal history of certain other diseases

176

0.97

0.00

1.1

1.04

5.52

u/ml

—

Other disorders of pigmentation

184

1.03

0.00

1.1

1.0

1.48

3.24

u/ml

—

Maternal care for cervical incompetence

234

1.03

0.00

1.0

1.45

4.06

u/ml

—

101

Autism spe

306

0.98

0.00

1.1

3.89

5.38

u/ml

0.23

173

Viral haemorrhagic fevers, not elsewhere classified/unspecified

354

1.02

0.00

1.1

1.0

10.30

2.74

u/ml

0.54

170

Other disorders of the genitourinary system

364

1.02

0.00

1.1

1.0

2.83

2.81

u/ml

0.00

154

Congenital ovarian cysts

404

1.02

0.00

1.1

4.18

3.59

u/ml

0.09

183

Hypoglycaemia, other or unspecified

384

1.02

0.00

1.2

1.1

4.14

4.37

u/ml

0.04

202

Dislocation, sprain and strain of joints and ligaments of elbow

506

0.99

0.00

1.2

1.1

4.13

5.15

u/ml

0.25

255

Liveborn infants according to place of birth

143

1.04

0.00

1.0

1.1

2.29

9.19

u/ml

—

Coxarthrosis, primary

177

1493

1.00

0.00

1.1

1.0

1.97

3.05

u/ml

0.85

659

Hypermetropia

545

0.99

0.00

1.1

13.81

5.87

u/ml

0.64

310

Pacemaker

589

1.01

0.00

1.1

4.41

2.43

u/ml

0.38

287

Sensorineural hearing loss

348

2364

1.00

0.00

1.1

3.21

3.57

u/ml

0.19

161

1072

Caries of dentine

133

1289

1.00

0.00

1.2

1.1

3.06

5.85

u/ml

1.78

609

Anterior Iridocyclitis

111

1107

1.00

0.00

1.0

1.1

2.65

3.52

u/ml

0.56

505

Thyrotoxicosis, other and/or unspecified

120

1203

1.00

0.00

1.1

2.52

4.03

u/ml

0.66

551

Coxarthrosis, primary, with hip surgery

112

1047

1.00

0.00

1.1

1.0

2.41

3.04

u/ml

0.26

452

Impotence

145

0.97

0.00

1.0

1.1

1.83

2.69

u/ml

—

Disorders of psychological development

154

1432

1.00

0.00

1.1

6.77

5.46

u/ml

0.37

831

Other inflammatory liver diseases

289

1.00

0.00

1.0

2.40

2.73

u/ml

0.12

143

Injury of unspecified body region

397

1.01

0.00

1.1

9.32

3.85

u/ml

0.62

198

Urethral stricture

134

0.97

0.00

1.1

1.45

2.30

u/ml

—

Other Crohn's disease

549

1.00

0.00

1.1

2.93

3.93

u/ml

0.33

261

Congenital malformations of the musculoskeletal system, not elsewhere classified

125

0.96

0.00

1.0

1.1

4.23

6.08

u/ml

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

154

0.97

0.00

1.1

1.37

5.23

u/ml

—

Gonococcal infection

166

1.02

0.00

1.1

1.0

0.99

2.84

u/ml

—

Ulcerative enterocolitis

186

1.02

0.00

1.1

3.48

3.28

u/ml

—

Premature separation of placenta [abruptio placentae]

196

1.02

0.00

1.0

1.1

1.87

2.50

u/ml

0.24

Congenital malformations of uterus and cervix

206

1.02

0.00

1.0

1.1

1.28

4.36

u/ml

—

Nontoxic single thyroid nodule

326

1.01

0.00

1.0

1.25

2.83

u/ml

1.56

142

Patent foramen ovale

183

0.98

0.00

1.1

8.63

8.11

u/ml

—

104

Other disorders of skin and subcutaneous tissue, not elsewhere classified

582

1.00

0.00

1.1

2.45

3.38

u/ml

0.23

269

Other and unspecified disorders of psychological development

189

0.98

0.00

1.2

1.1

3.98

7.09

u/ml

0.39

126

Hypokalaemia

414

0.99

0.00

1.1

4.53

2.96

u/ml

0.25

199

Seronegative rheumatoid arthritis

476

1.01

0.00

1.1

1.29

2.56

u/ml

1.35

200

Other obstructed labour

546

1.01

0.00

1.1

1.0

1.01

3.64

u/ml

2.60

233

Injury of muscle and tendon at ankle and foot level

142

0.99

0.00

1.0

0.52

2.69

u/ml

—

Other salmonella infections

152

0.99

0.00

1.0

7.75

3.87

u/ml

—

Melanocytic naevi of trunk

706

1.01

0.00

1.1

2.77

3.15

u/ml

0.13

334

Torsion of ovary, ovarian pedicle and fallopian tube

162

0.99

0.00

1.1

0.75

4.86

u/ml

—

Cluster headache, strict

222

0.99

0.00

1.1

6.28

3.32

u/ml

0.24

Dermatophytosis

537

1.01

0.00

1.0

1.1

2.70

2.87

u/ml

0.06

264

Mixed connective tissue disease

312

0.99

0.00

1.1

4.35

3.00

u/ml

0.13

136

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

132

0.98

0.00

1.0

0.18

2.20

u/ml

—

Burns and corrosions of external body surface, specified by site

757

1.00

0.00

1.0

1.1

8.41

4.46

u/ml

0.55

375

Benign neoplasm of ovary

732

1.00

0.00

1.1

2.83

4.00

u/ml

0.56

311

Carcinoma in situ of cervix uteri

893

1.00

0.00

1.0

1.1

4.77

3.90

u/ml

0.12

425

Specific developmental disorder of motor function

257

0.99

0.00

1.2

1.1

7.63

8.07

u/ml

0.03

173

Disorder of the sleep-wake schedule

139

1.01

0.00

1.1

0.40

5.49

u/ml

—

Bacterial meningitis

161

0.99

0.00

1.1

1.0

5.89

2.37

u/ml

—

Other obstructive and reflux uropathy

273

0.99

0.00

1.1

1.0

16.44

4.20

u/ml

0.71

129

Behavioural disorders, excluding more controls

207

1.01

0.00

1.1

1.0

6.59

5.69

u/ml

0.07

114

Ulcerative ileocolitis

259

1.00

0.00

1.1

2.09

2.95

u/ml

0.43

125

Cluster headache, strict, including avohilmo

362

0.99

0.00

1.1

4.92

3.32

u/ml

0.20

167

Lack of expected normal physiological development

313

1.01

0.00

1.1

12.82

7.30

u/ml

0.46

215

Protozoal diseases

1.03

0.00

1.0

1.02

2.74

u/ml

—

Congenital deformities of feet

213

0.99

0.00

1.0

3.48

6.25

u/ml

0.87

108

Bicuspidal aortic valve syndrome

197

1.02

0.00

1.0

1.1

0.98

4.20

u/ml

—

102

Herpesviral keratitis and keratoconjunctivitis

177

1.02

0.00

1.1

13.18

2.69

u/ml

—

Ulcerative proctitis

433

0.99

0.00

1.0

1.1

2.46

4.16

u/ml

0.76

199

Contact with sharp glass

293

0.99

0.00

1.0

1.18

3.94

u/ml

1.59

147

Paralytic ileus and intestinal obstruction

887

1.00

0.00

1.0

1.1

3.81

3.54

u/ml

0.06

414

Cyst of Bartholin Gland

265

0.98

0.00

1.2

1.0

2.07

2.95

u/ml

0.28

115

Burn and corrosion of trunk

155

1.03

0.00

1.0

1.1

13.65

5.11

u/ml

—

Other and unspecified intracranial injuries

135

1.04

0.00

1.3

1.0

0.80

3.73

u/ml

—

Manic episode

195

0.97

0.00

1.0

10.70

3.67

u/ml

0.51

104

Other vitreous opacities

125

0.96

0.00

1.2

1.0

1.19

1.78

u/ml

—

All dysplastic lesions of the vulva

235

0.98

0.00

1.1

1.0

0.93

2.58

u/ml

—

101

Congenital malformations of pulmonary and tricuspid valves

106

1.04

0.00

1.0

1.1

8.76

8.02

u/ml

—

Progressive systemic sclerosis

0.00

-0.00

0.0

1.0

—

Necrotizing enterocolitis of fetus and newborn

0.00

-0.00

0.0

1.3

—

15.23

—

Malignant neoplasm of cervix uteri, including Hilmo

130

1.00

-0.00

1.0

13.06

3.23

u/ml

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

-0.00

0.0

1.0

—

Multiple superficial injuries of ankle and foot

0.00

-0.00

0.0

1.0

—

Other diseases of blood and blood-forming organs

260

1.00

-0.00

1.0

2.16

2.69

u/ml

0.18

123

Disorder of amino-acid metabolism, other/unspecified

0.00

-0.00

0.0

1.0

—

2.34

—

Convulsions of newborn

0.00

-0.00

0.0

1.1

—

0.29

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dog dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS